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ENGLISH SUMMARY 
Fibromyalgia (FM), recognized by the WHO since 1992, affects about 2-4% of the 
world population. Patients, mostly women, experience chronic widespread pain, 
fatigue, stiffness, sleep disturbances and a variety of psychological disorders, 
especially depression and anxiety. The intervention usually includes 
pharmacological treatments, exercise and psychological therapy. 
Group Music and Imagery therapy (GrpMI) works in a holistic way, focusing on the 
person as a whole, using music as well as spontaneous imagery and the group as 
therapeutic agents.  
The general aim of this study is to assess the effectiveness of GrpMI in women with 
FM, specifically, in the perception of psychological wellbeing, impact on functional 
capacity and health, pain perception, anxiety, depression and anger. 
The study used a randomized controlled trial, with a pretest-posttest control group 
design, and a three months follow-up. The final sample included 56 women (33 
experimental and 26 control), with a mean age of 51.3, assessed with six 
measurement instruments. Intergroup and intragroup analyses were performed and 
additionally, the Reliable Change Index was calculated.  
The results of the analyses of demographic characteristics indicates that 76.6% of 
the participants have multiple associated diagnoses, the most common being osteo-
articular disorders and depression. In addition, participants show low levels of 
subjective psychological wellbeing, a prominent impact of FM on their functional 
capacity and health, high levels of state and trait depression, trait anxiety and a 
present pain perception above that of the general population mean. 
The correlational analyses confirm that there are positive significant relationships 
between the impact of FM on functional capacity and health, subjective 
psychological wellbeing, pain, anxiety, depression and anger. In contrast, negative 
correlations were found between subjective psychological wellbeing and impact of 
FM on functional capacity and health, and the rest of the variables. 
The analyses of covariance, used to compare pretest-posttest results between 
experimental and control groups, showed positive effects (statistically significant) 
in subjective psychological wellbeing and state anxiety. Furthermore, variables of 
impact of FM on functional capacity and health, pain intensity, trait anxiety, and 
state anger showed a statistical tendency. 
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In the intragroup comparison, the experimental group showed significant positive 
changes in all variables: increasing subjective psychological wellbeing, and 
reducing the impact of FM on functional capacity and health, pain intensity, state 
anxiety, state and trait depression, and state and trait anger. In contrast, the control 
group did not experience significant changes. 
The Reliable Change Index (RCI) showed that, after the treatment, 57.6% of 
experimental subjects recovered in at least three of the variables and did not 
deteriorate in any, in contrast with to only 8.7% of the control subjects. 
After three months, the experimental group fared better than before treatment with 
GrpMI intervention, although without statistical significance, except in anxiety. 
These results illustrate the effectiveness of GrpMI intervention in women with FM, 
as a complementary non-pharmacological therapy. It is necessary to continue 
research in group imagery and music with a medium- and long-term follow-up, and 
studies that could evaluate the differential effects of GrpMI elements.
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DANSK RESUME 
Fibromyalgi (FM) er en sygdom, som er anerkendt af WHO siden 1992, og den 
rammer 2-4 % af verdens befolkning. 
Det er overvejende kvinder, der får denne sygdom  og den forårsager kroniske, 
diffuse smerter, træthed, stivhed i muskler og led, søvnbesvær og en vifte af 
psykologiske lidelser, herunder især depression og angstlidelser. Behandlingen 
består almindeligvis af medicinsk behandling, øvelser og psykokologiske 
samtaler/psykoterapi. 
Musiklytning og indre billeder – receptiv gruppemusikterapi (GrpMI) er en 
holistisk behandlingsform, der fokuserer på personen som helhed. Den anvender 
musik, spontant opståede indre billeder og gruppen som terapeutiske faktorer. 
Det overordnede formål med denne undersøgelse er at evaluere effekten af (GrpMI) 
anvendt med kvinder med FM. Evalueringen vedrører specifikt deltagernes 
oplevelse af psykisk velvære, fibromyalgiens indflydelse på funktionsevne og 
livskvalitet, på smerteoplevelser, samt på oplevelser af angst, depression og vrede. 
Undersøgelsen anvender et randomiseret, kontrolleret før- og efter 
undersøgelsesdesign med follow up målinger 3 måneder efter afslutning af 
behandlingen.  Det endelige antal deltagere i undersøgelsen blev 56 (33 kvinder i 
eksperimentalgruppen og 26 kvinder i kontrolgruppen) med en gennemsnitsalder på 
51.3 år. Effekten blev evalueret vha seks standardiserede måleredskaber. Der er 
udført sammenlignende analyser mellem eksperimental og kontrolgrupper 
(intergruppeanalyser) samt intragruppeanalyser. Yderligere blev ”The Reliable 
Change Index” kalkuleret. 
Resultaterne af de socio-demografiske karakteristika i den indledende deskriptive 
analyse indikerer, at 76.6 % af deltagerne havde flere associerede diagnoser, af 
hvilke osteo-articulære lidelser og depression var de oftest forekommende. Hertil 
kommer at resultater af spørgeskemaer viste, at deltagerne havde en subjektiv 
oplevelse af en ringe grad af velvære, en oplevelse af at fibromyalgien har en 
væsentlig indflydelse på deres funktionsniveau og helbred, på en øget grad af 
depression både her og nu og på længere sigt. Fibromylagien har tillige indflydelse 
på oplevelsen af en underliggende angst og en gennemgående smerteoplevelse. 
Disse resultater viste sig at afvige væsentlig fra gennemsnitlige oplevelser hos 
kvinder, som blev undersøgt med samme måleredskaber og som ikke var 
diagnosticeret med FM. 
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Korrelationsanalysen af sammenhængen mellem forskellige variabler bekræftede, at 
der er en positiv signifikant relation mellem fibromyalgiens indflydelse på 
funktionsniveau og helbred, smerte, angst, depression og vrede. I kontrast hertil 
blev der fundet en negativ relation mellem den subjektive oplevelse af velvære og 
de andre variabler.  
Variansanalysen, anvendt til at sammenligne målinger før og efter 
undersøgelsesfasen mellem eksperimental- og kontrolgruppen, viste positiv effekt 
(statistisk signifikant) inden for en subjectiv oplevelse af velvære og en her og nu 
oplevelse af angst. Hertil kommer at FM´s indflydelse på funktionsniveau og 
helbred, oplevelse af smerteintensitet, af en underliggende angst og af en her og nu 
oplevelse af angst viste en statistisk tendens. 
I intra-gruppe analysen viste eksperimentalgruppen signifikante positive 
forandringer inden for alle variabler: en øget subjektiv oplevelse af velvære, og en 
reduktion af FM´s indflydelse på helbred og funktionsniveau, på smerteintensitet, 
på her og nu oplevelser af angst, samt på her og nu oplevelser samt en 
gennemgående oplevelse af depression og vrede. Som kontrast hertil viste 
kontrolgruppen ingen signifikante ændringer i nogen af variablerne. 
The Reliable Change Index (RCI) viste at, efter behandlingen, blev helbreddet 
bedre inden for mindst tre variabler for 57.6 % af deltagerne i eksperimental 
gruppen. De fik ikke tilbagefald inden for nogle af variablerne. Som kontrast hertil 
blev helbreddet kun bedre for 8.7 % af deltagerne i kontrolgruppen. 
Tre måneder efter behandlingens afslutning havde alle deltagerne i 
eksperimentalgruppen det bedre end før GrpMI behandlingen startede, selv om der 
ikke er statistisk signifikans herfor i andre variabler end angst. 
Disse resultater illustrerer effekten af GrpMI i arbejde med kvinder med FM som en 
komplementær, ikke-medicinsk terapiform. Det er nødvendigt at fortsætte 
forskningen indenfor anvendelse af GrpMI med denne målgruppe med en medium 
til lang-tids opfølgning på resultaterne, og med undersøgelser som kan evaluere 
effekten af de enkelte elementer i GrpMI behandlingen. 
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SPANISH SUMMARY 
La fibromialgia (FM), enfermedad reconocida por la OMS desde 1992, afecta entre 
2-4% de la población mundial. Estos pacientes, mayoritariamente mujeres, 
manifiestan dolor difuso generalizado, fatiga, rigidez articular, problemas de sueño 
y una variedad de trastornos psicológicos, entre los que prevalecen ansiedad y 
depresión. La intervención indicada habitualmente incluye tratamientos 
farmacológicos, ejercicio físico y terapia psicológica. 
El tratamiento de Música e Imagen grupal (GrpMI) trabaja holísticamente, 
focalizando en la persona global, donde tanto la música, como las imágenes 
espontáneamente creadas y el grupo son agentes terapéuticos. 
Este estudio se plantea, como objetivo general, valorar la eficacia del GrpMI en 
mujeres con FM en la percepción del bienestar psicológico, en el impacto de la FM 
en la capacidad funcional y calidad de vida, en la percepción del dolor, ansiedad, 
depresión e ira. 
Para ello utiliza un diseño experimental aleatorio pretest, postest con grupo de 
control y seguimiento a los 3 meses. La muestra final estuvo compuesta por 56 
mujeres (33 experimentales y 26 de control), con una media de edad de 51.3 años, 
que cumplimentaron seis instrumentos de evaluación. Se realizaron análisis 
intergrupo e intragrupo, así como el Índice de Cambio Clínico significativo.  
Los resultados de los análisis de las características socio-demográficas de la 
muestra permiten observar que un 76.6% de participantes presentan diagnósticos 
asociados, siendo los más habituales los trastornos osteo-articulares y depresión. 
Además, las participantes muestran niveles bajos de bienestar subjetivo, destacado 
impacto de la FM en su capacidad funcional y calidad de vida, niveles elevados de 
depresión (estado y rasgo), ansiedad rasgo y una percepción del dolor actual 
superior a la media de la población.  
Los análisis correlacionales constatan una relación positiva significativa entre el 
impacto de la FM en la capacidad funcional y calidad de vida y el dolor actual, 
ansiedad, depresión e ira. Contrariamente, existe una correlación negativa 
significativa entre bienestar psicológico subjetivo y  el impacto de la FM en la 
capacidad funcional y calidad de vida y el  resto de las variables. 
Los análisis de covarianza, utilizados para comparar ambas situaciones, 
experimental y control, muestran efectos positivos, estadísticamente significativos, 
en bienestar psicológico subjetivo y ansiedad estado, y tendencialmente 
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significativos en el impacto de la FM en capacidad funcional y calidad de vida, 
intensidad del dolor, ansiedad rasgo e ira estado después del tratamiento.  
En la comparación intragrupo, el grupo experimental evidencia cambios  positivos 
significativos en todas las variables evaluadas, aumentando su percepción  subjetiva 
de bienestar psicológico, y disminuyendo el impacto de la FM en su capacidad 
funcional y calidad de vida, la intensidad del dolor, ansiedad estado, depresión 
estado y rasgo, e ira estado y rasgo. Por el contrario, el grupo de control no 
experimenta cambios significativos. 
El Índice de Cambio Fiable (ICF) evidencia que, al finalizar el tratamiento, un 
57.6% de sujetos experimentales muestran recuperación en al menos tres de las 
variables y ningún empeoramiento, frente a tan solo un 8.7% del grupo control. 
Una vez transcurridos tres meses, el grupo experimental se mantiene mejor que 
antes de empezar el tratamiento GrpMI, aunque sin significatividad estadística, 
salvo en ansiedad. 
Dichos resultados ponen de relieve la idoneidad de esta intervención en FM, como 
terapia complementaria no farmacológica. Es necesario continuar investigando en 
este ámbito con diseños que contemplen seguimientos a medio y largo plazo, y 
estudios que permitan evaluar la eficacia diferencial de los componentes de GrpMI. 
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CHAPTER 1. INTRODUCTION 
The general aim of this study, divided into six chapters, is to assess the 
effectiveness of the Group Music and Imagery method (GrpMI) as a 
complementary therapy for alleviating the general malaise that fibromyalgia (FM) 
patients suffer.  
This first chapter presents the structure of the document, personal motivation and 
initial ideas behind this empirical study. 
The second chapter provides a review of the literature consulted as a basis for the 
study, and focuses on examining the psychological aspects of fibromyalgia (FM), 
the Guided Imagery and Music (GIM) method and its group adaptation, Group 
Music and Imagery (GrpMI) used in this study. Studies related to both these fields 
are reviewed separately and together. Given the scarce bibliography on GIM and 
FM, a series of articles describing the effectiveness of GIM methods for people 
suffering from chronic pain, rheumatoid diseases and other diseases, with similar 
characteristics to those in this research work, are also considered. 
The third chapter lists the study’s general and specific objectives and their related 
hypotheses. The principal objective of this work is to assess the effectiveness of 
Group Music and Imagery (GrpMI) on women suffering from FM. Perception of 
psychological wellbeing and perceived health condition are measured through the 
impact of FM on functional capacity and health, pain perception and other 
variables such as psychological distress (including anxiety and depression) and 
anger. Subjects treated are compared with a control group (intergroup analysis) 
and for both experimental and control conditions intragroup analyses are also 
carried out. What is more, an assessment is made of whether the effects are 
maintained after three months, together with the demographic profile of the 
sample and correlation between variables.  
Chapter four explains the research method used, in this case a randomised 
experimental pretest-posttest control group design with a three-month follow up. 
70 women took part in the study. They were recruited from different FM 
associations in Spain. This chapter also describes the assessment tools and 
statistical analysis method used. Furthermore, it provides a description of the 
GrpMI intervention, in which spontaneous creation of images is encouraged 
whilst group members relax and listen to a selection of different pieces of music. 
This GrpMI approach helps participants become aware of their sensations, 
emotions and feelings towards FM and their own personal history. It also 
stimulates an individual’s inherent potential to change and face adversity when 
seeking greater wellbeing. 
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Data analysis and results are presented in the fifth chapter, which is divided into 
the following sections: a demographic description of participants; characterisation 
of the sample according to the variables considered and correlations between 
them; results obtained from intergroup and intragroup comparison of evaluation 
at pretest, posttest and follow-up, and results of each subject’s clinical change. 
The results of an individual assessment questionnaire filled out by the participants 
in the experimental group at the end of the intervention are also included.  
Chapter six discusses the results obtained relative to the original objectives and 
hypotheses, and compares this study’s findings with those obtained in similar 
studies. Finally, conclusions are drawn and a further two sections deal with 
possible study limitations and a discussion of conceivable future lines of research.  
This study offers reflection and empirical observation on the usefulness and 
effectiveness of GrpMI treatment at improving the subjective, psychological 
wellbeing of women with fibromyalgia (FM), the impact of FM on functional 
capacity and health, and the capacity of GrpMI to reduce the intensity of 
perceived pain and the impact of the psychological variables of anxiety, 
depression and anger. 
1.1. PERSONAL MOTIVATION 
Since finishing my BMGIM training in 2008 I have been using GIM treatment in 
my private psychotherapy practice to assist people who come to express their 
emotional pain, psychological distress and unresolved conflicts. I have found the 
GIM method shows greater ease in making connections between current pain and 
past suffering, but more importantly, clients leave the session with better physical 
wellbeing, emotional release and a greater trust in their own ability to find 
solutions and a possible cure to their problems.  
My experience of using GIM to individually treat FM clients aroused my curiosity 
and led me to explore the usefulness of the GIM method for treating groups of 
patients suffering this condition, in which pain goes hand in hand with other 
symptoms such as anxiety, sadness, anger, powerlessness, perceived injustice and 
personal worthlessness. The contribution music makes, as a kind of co-therapist is 
key as is the feeling of having lived insightful experiences related to pain 
messages and how to relate to pain. In the words of Marguerite Yourcenar:  
“Music transports me to a world where pain still exists but it widens, 
is more serene and becomes quieter and deeper again, like a torrent 
becoming a lake” (Yourcenar & Calatayud, 2000, p. 44) (translated by 
the author). 
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The therapeutic, individual, private and subjective experiences I have seen could 
have just been discarded as my clients’ personal experiences and left in my notes. 
But I feel the application of the GIM method in groups should be shared with 
other practitioners. What is more, I believe its usefulness needs to be proved 
through empirical analysis and scientific methodology so that it can be compared 
with other treatment options in psychology.  
In 2009 I decided to look further into this therapeutic model and started a new 
course of training, on this occasion to learn how to teach the BMGIM method to 
others so that it could be more broadly used by music therapists interested in 
working with neurotically healthy adult populations. This new challenge required 
many hours of clinical practice, commitment and responsibility and ongoing study 
of the theoretical and scientific basis of this therapeutic tool. This was when I 
came into contact with problem-based learning, Professor Tony Wigram, Aalborg 
University and its PhD programme. The problem-based learning methodology 
(PBL) used at Aalborg University`s Research School of Music Therapy has 
helped me bring together all my motivations under one single project roof. This 
approach to studying involves sharing and learning more (scientifically and 
through practice) about the usefulness of GIM therapy, whilst at the same time 
expressing doubts and solving them thanks to feedback from the group of music 
therapy experts, lecturers, students, therapists and supervisors.  
 In order to further explore how FM could be treated, I offered the Asociación 
Alavesa de Fibromialgia y Síndrome de Fatiga Crónica - ASAFIMA (Alava 
Association of Fibromyalgia and Chronic Fatigue Syndrome) 12 individual, 
sessions free-of-charge to a small group of their members who volunteered. This 
experience led to a 2009-2010 pilot study of five people who received individual 
GIM therapy for 10 sessions. After finishing treatment, these clients noticed a 
positive change in pain perception, anxiety reduction and above all increased 
psychological wellbeing. This experience thus guided me in obtaining the most 
appropriate treatment structure and objectives, relaxation techniques and music 
choice for this population group (Torres, 2010). 
In 2010, thanks to contacts at my wokplace, the Instituto Música Arte y Proceso 
and also thanks to the Conservatorio Superior de Música del Principado de 
Asturias (Asturias Music Conservatory), I was able to work with the Unidad del 
Dolor del Hospital de Cabueñes (Pain Unit at Cabueñes Hospital) and the Liga 
Reumatológica de Asturias (LAR Asturias Rheumatology Association) to 
research the usefulness of the GIM method on people suffering from 
fibromyalgia. To do so, a randomised experimental study (with pretest, posttest 
and follow-up) was designed and changes in the following variables were 
observed: subjective wellbeing, impact of FM on functional capacity and health, 
pain, anxiety, depression and anger. These changes were compared with a control 
group. On this occasion Group Music and Imagery (GrpMI) was the clinical 
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method used. During therapy, GrpMI participants were able to: 1) listen to and 
express their emotional pain; 2) release pain-related blocked or repressed 
emotions; 3) comprehend their influence when facing day-to-day situations 
(including the illness) and 4) develop resources and change attitudes, such as 
coping, communication, setting limits, delegating and acknowledgement of self-
worth (Torres, 2015). Progress as a whole was favourable amongst those 
receiving GrpMI treatment and better than individuals in the control group who 
did not receive treatment. 
Gradually, the question of whether the effectiveness of the GIM method as a 
complementary therapy could be assessed empirically using quantitative 
methodology became the research project presented in this thesis.  
Personal rationale 
I approach FM therapy with profound respect for the experience of a disease that 
causes so much suffering to those who have received this diagnosis. The way this 
illness is experienced is different to the way it is conceptualised. Hence, a 
difference must be made between pain (the subjective perception of the 
physiological components of pain) and suffering (the negative emotional response 
to pain) and, in addition to this, an individual’s behaviour when facing pain, 
which may be more or less adaptive (Gatchel, Peng, Peters, Fuchs, & Turk, 2007). 
“Pain really affects all systems and all responses to it promote 
protection and cure. However, when the majority of us think of pain, 
we remember an unpleasant experience and this makes us react and try 
to face up to the situation” (Butler & Moseley, 2010, p. 9). 
Every individual experience of pain modulates information and perception of 
symptoms and subsequent disability (Gatchel et al., 2007). This subjective 
perception may be regulated by the person’s genetic makeup and influenced by 
their life experiences, current mental state and socio-cultural surroundings 
(Gatchel, 2004; Turk & Monarch, 2002). However no single one of these factors 
alone is able to appropriately explain chronic pain. Hence, any therapy needs to 
take into consideration all these different aspects of the disease (Miró Martínez, 
2003). 
This biopsychosocial approach is especially relevant in the case of FM since 
fibromyalgia symptoms include continuous, widespread difficult-to-pinpoint pain 
and also: 
“A significant drop in the frequency and type of everyday activities, 
lengthy periods of rest, physical limitations, absence from work, 
problems sleeping and tiredness, family problems, fewer social 
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contacts, excess use of medicines and visits to the doctor and 
psychological changes such as anxiety, depression and irritability” 
(Lledó, Pastor & López-Roig, 2012, p. 4) (translated by the author). 
In current FM diagnosis in addition to pain, other related symptoms and frequent 
comorbidity with other diseases are considered (Fitzcharles et al., 2013; Wolfe et 
al., 2010) and a comprehensive psychological treatment is recommended together 
with other treatments as part of an overall coping strategy for FM. This 
recommendation should facilitate an understanding of psychic functioning, 
influence and even modify the latter with therapy, guide the person and aid in 
self-care.  
GIM therapy, as a humanistic and person-centred approach can provide help, 
support and guidance when expressing pain/suffering-related sensations, emotions 
and thoughts and a realisation of associated behaviour and thought.  
“Any strategy for pain control is useful, adaptive and necessary and 
especially so when it leads to long term overall improvement in 
personal functioning. However attempts in vain at controlling pain 
become problematic if they end up dominating the life of the patient, if 
they lead to additional, unwanted problems and when they separate the 
individual from the things that are important in his/her life” (González 
Menéndez, Fernández García & Torres Viejo, 2010, p. 1002) 
(translated by the author).  
GIM therapy influences the bodily state by helping the individual concentrate 
their attention on bodily sensations, develop relaxation skills and strategies and 
promote acceptance of their own perceptions. Through image creation, it also 
develops attention, openness and awareness of other elements that may be 
influencing pain as well as other psychological and social symptoms. The GIM 
method is supported by the therapist who is listening, giving space to a client’s 
subjective complaints and trying to understand the malaise and its symbolic 
significance in a similar way to the biopsychosocial model and psychoanalytical 
theories (Velasco, Ruiz, & Álvarez-Dardet, 2006). Memories, associations and 
conflicts frequently appear in GIM sessions possibly being expressed via the body 
and revealed through the images and sensations felt when listening to music and 
understood during the session’s final, verbal part. In this way GIM encourages an 
individual to comprehend, integrate and cope with them, by promoting a new way 
of seeing them and by stimulating his/her own resources.  
Group treatment (GrpMI) has the advantage of reaching a larger number of people 
who may share both characteristics and resources. Thus group treatment can 
reduce clients’ feelings of inadequacy and isolation. A group approach allows 
some matters to be dealt with more quickly; encourages empathy and 
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identification processes between members of the group; facilitates expression and 
elaboration of painful conflicts and helps treat relational difficulties. The group 
experience has therapeutic effects, enabling recognition, expression and sharing of 
unexpressed or unresolved distress and suffering which on many occasions is 
thought to be related to the physical symptoms these patients show (De Felipe 
García-Bardón, Oñoro Carrascal, & Antón Monllor, 2007). 
In any event it decisively allows the building of a framework which provides: 1) 
sustained, structured care to deal with the true suffering that patients are going 
through; 2) a therapeutic approach where clients are helped to better understand 
how adverse psychological and relational mechanisms are expressed somatically 
and 3) coping and conflict-resolution strategies and an increase in general quality 
of life (Camino Vallhonrat, Jiménez Rico, Castro-Palomino i Serra, & Fábregas, 
2009). 
As a therapist I feel the motivation, trust and enthusiasm offered by the non-
invasive, complementary GIM therapeutic model, a model with the potential to 
transform and the structure to make it possible to face the overwhelming chaos of 
uncertainty, thus accepting what is impossible and living what is possible (Fiorini, 
2006). 
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CHAPTER 2. LITERATURE REVIEW 
This chapter provides a review of the literature on two central themes of this 
study, namely fibromyalgia (FM) and the method of Guided Imagery and Music 
(GIM). It is divided into various sections. The first section describes the search 
strategies used for reviewing the literature. This is followed by a section providing 
a conceptual and historical explanation of FM including its definition, prevalence 
in the Spanish population, criteria for diagnosis, aetiology, description of the main 
symptoms, psychological variables associated with the illness and the variables 
used in this study. A third section covers the different treatment possibilities 
available for FM. Special attention is given to describing and presenting pieces of 
research related to the treatment being used here, especially those looking into 
music, music therapy, relaxation and guided imagery. The fourth section describes 
the GIM method and how it has been adapted for groups (GrpMI). This chapter 
closes up with a fifth section describing research in which GIM or GrpMI as the 
treatment model has been used where changes in FM, other similar pathologies 
and/or the variables analysed in this study here have been demonstrated. 
2.1. DESCRIPTION OF RESEARCH STRATEGIES 
Thanks to the remote access that the Music Therapy Department offers its 
students, the electronic databases at Aalborg University library were used for 
reviewing literature. Priority was given to specialist medical and psychology 
databases such as PsycINFO and MEDline, together with other more general ones 
such as Scopus. EBSCO was also consulted when searching for references to 
articles on music, health and music therapy. A database that proved especially 
useful was the one created by Lars Ole Bonde for the Centre for Music and Health 
(Norwegian Academy of Music) in Oslo. 
When systematically searching these data bases keywords were introduced such 
as fibromyalgia, together with anxiety, depression, quality of life and chronic 
pain. These words were also combined with music, relaxation, guided imagery 
and guided imagery and music, GIM and BMGIM 
Articles on FM in the adult population were included and those on FM in 
paediatrics, children, teenagers and the elderly were excluded. Articles written in 
both Spanish and English were consulted. No time limit was put on this review 
although preference was given to articles and research published during the last 
twenty years. 
Special attention was given to articles describing original results of clinical and 
experimental research, articles carrying out systematic reviews and meta-analysis. 
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Similarly, special attention was given to articles published in specialized music 
therapy and GIM journals such as the Journal of Music Therapy, the Nordic 
Journal of Music Therapy and the Journal of the Association of Music and 
Imagery. Doctoral theses were also consulted.  
Other documents which proved to be useful for advice and guidance were those 
recommended at the doctoral courses organised by Aalborg University’s 
Department of Music Therapy and by the supervisors, especially those that have 
been useful for integrating, understanding and developing appropriate research 
methodology.  
Books describing the therapeutic models used with different groups were also 
consulted, especially those used with FM and pain groups, for example 
Explicando el dolor (Butler & Moseley, 2010). Similarly books such as Guided 
Imagery and Music, The Bonny Method and Beyond (Bruscia & Grocke, 2002), 
were also consulted as a way of getting information about how the GIM method is 
defined and put into practice. 
2.2.  FIBROMYALGIA 
Much and varied research work has been put into trying to provide a clear 
definition of fibromyalgia, its origin, characteristic symptoms and recommended 
treatment. 
Fibromyalgia was recognised as a disease by the World Health Organisation in 
1993 (WHO; ICD-10; code M79.0). Initially it was defined using diagnostic 
criteria that concentrated on pain and tender points at certain sites around the body 
on digital palpation (Wolfe et al., 1990), but more recently there has been a 
redefinition with more symptoms being included (Wolfe et al., 2010). A person 
with FM experiences continued widespread pain that cannot be precisely located 
and for which there is no pathological explanation. Other symptoms include joint 
stiffness, fatigue, sleep problems, and emotional and cognitive imbalance. 
This variety of symptoms with no known direct cause means that the disease 
confounds specialists, patients and their relatives alike. The relevance of FM, the 
way it affects the daily lives of patients and the numerous specialists involved in 
its diagnosis and treatment makes it a major health problem (Montoya et al., 
2010). It is an illness that can be very incapacitating, affecting the biological, 
psychological and social spheres of a person’s life (Collado et al., 2002; Rivera, 
Alegre, Nishishinyac, & Pereda, 2006). As such, the importance of offering 
interdisciplinary treatment is currently being explored.  
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2.2.1. THE HISTORY OF FIBROMYALGIA 
Fibromyalgia comes from the Latin word fibro (fibrous tissues) and from the 
Greek myo (muscle) and algia (pain). These terms refer to two of the illness’s 
main characteristics: myalgia, referring to the extension of widespread muscular 
pain and fibro referring to the tender points where the fibrous muscular tissue 
connects to the bone (Goldenberg, 2003). 
Descriptions similar to those for FM can be found in the mid 19th century, a 
period when similar disorders were called soft tissue rheumatism (Frioriep, 1843, 
quoted in Villanueva et al., 2004). In 1904 Sir William Gowers described a 
muscular rheumatism condition with areas sensitive to pressure, feelings of 
fatigue and sleep disorders and called it fibrositis. He believed the condition was 
due to inflammation of the muscle tissue (García, Cuscó, & Poca, 2006; 
Villanueva et al., 2004). In 1976 Doctor Hench used the term fibromyalgia to 
refer to muscular pain without inflammation. From this moment onwards 
fibrositis was no longer used (the ending algia refers to pain, whereas itis suggests 
inflammation). The studies of Smythe & Moldofsky (1977) who described 
chronic pain of musculoskeletal origin, with the existence of specific pain points 
associated to sleep disorders, helped extend the use of the term fibromyalgia. 
During rheumatology examinations Yunus, Masi, Calabro, Miller & Feigenbaum 
(1981) described other fibromyalgia-related clinical manifestations such as 
stiffness, fatigue, anxiety, insomnia, headaches, irritable bowel syndrome, 
swelling and numbness as well as widespread musculoskeletal pain and the 
presence of multiple tender points.  
Major progress was made in 1990 when the American College of Rheumatology 
(ACR) accepted the term fibromyalgia and a series of classification criteria were 
laid down identifying FM as a musculoskeletal disorder with widespread pain in 
combination with tenderness at 11 or more of 18 specific tender point sites (Wolfe 
et al., 1990). The 1992 Copenhagen Declaration recommended that since they 
operate as a standardisation protocol the criteria set out by the ACR should be 
accepted for research purposes. They even added to the characteristics mentioned 
by the ACR and pointed out that the pain experienced by FM sufferers also means 
that they experience depression and anxiety (Csillag, 1992). 
Fibromyalgia was finally recognised as a human disease when, in 1993, the World 
Health Organization (WHO, 1993) included the term fibromyalgia in its list of 
diseases, coded under M79.0 in CIE-10. In 1994 the International Association for 
the Study of Pain (IAPS) classified it with code X33.X8a in its taxonomy of pain 
syndromes (Merskey & Bogduk, 1994).  
In 1994, due to their common clinical characteristics and response to serotonergic 
and noradrenergic agents, Yunus included FM within the dysfunctional syndrome 
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together with other pathologies such as irritable bowel syndrome, chronic fatigue 
syndrome, restless leg syndrome and tension headache syndrome, putting forward 
as a hypothesis the existence of a neuroendocrine-immune dysfunction as the link 
between all of them (Villanueva et al., 2004; Yunus, 1994). Currently Yunus 
(2007, 2008) and others include FM in the Central Sensitivity Syndrome (CSS), a 
syndrome that embraces a group of pathologies with a series of common 
characteristics but each has their own, specific diagnostic specificities and their 
origin in hypersensitivity to stimuli of the central nervous system. These 
pathologies involve other genetic, immunological, endocrine, sleep-related, stress 
and physical trauma (Fitzcharles & Yunus, 2012). 
Throughout history FM has been considered from perspectives other than the 
biomedical one. In 1869, the American doctor, Beard used the term neurasthenia 
to refer to people experiencing loss of strength, chronic fatigue or tiredness. In the 
19th century neurasthenia was described using terms such as physical and mental 
weakness, headaches, sleep disorders, back pain, hyperesthesia, muscle weakness, 
dyspepsia and various sexual disorders (Quintner & Cohen, 1999). Another term, 
psychogenic rheumatism considered these symptoms the outward expression of 
neurotic disorders (García, Cuscó et al., 2006; Martinez-Lavin, 2012). 
Patients have also been described as having histeria characteristics, such as 
egocentricity, histrionics, emotional lability, reduced or fake emotions, 
eroticization of social relations, frigidness, emotional dependence and intolerance 
of personal rejections as well as excess energy spent on trying to find approval, 
attention and praise from others (Peñacoba, 2009). According to Barrera 
Villalpando, Aguirre González, Cortés Sotres & Guerrero Manning (2005) people 
with FM show high levels of neuroticism, anxiety and depression and have learnt 
hysteria personality traits. 
In 1999, Wessely, Nimnuan & Sharpe included this pathology under the general 
term functional somatic syndromes and underscored the close association between 
the somatic and emotional distress symptoms of FM, with all of them sharing a 
series of common elements (Nimnuan, Rabe-Hesketh, Wessely, & Hotopf, 2001; 
Wessely et al., 1999). What is common to all these syndromes and especially to 
fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome is that all of 
their symptoms have no known organic cause, there is a high degree of 
overlapping of symptoms in the same patient, a greater prevalence of 
psychological disorders than in the general population, resistance to medical and 
palliative treatment, sporadic outbreaks, difficulty in diagnosis and a combination 
of biological, psychological and social factors influencing both the origin and the 
symptoms of the illness (Cuevas Toro, 2010; Nimnuan et al., 2001). 
A study by Mcbeth & Silman (2001) seem to provide evidence that FM has a 
strong psychological component and meets the characteristics defined in the term 
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somatisation (expression of emotional and social distress through physical 
symptoms), which contributes to the person developing widespread chronic pain. 
Reports from these same authors show that previous disease and behaviour with 
somatic symptoms before suffering FM are significant predictors for developing 
widespread chronic pain. And yet if the somatisation characteristics are absent, 
patients do not experience widespread chronic pain. According to Winfield (1999) 
there is a connection between somatisation, dysfunctional chronic pain behaviour 
and the type and amount of pain the individual informs of since in some people 
emotional stress is expressed through somatic symptoms (including widespread 
pain) rather than an emotional disorder or distress. However, the presence of 
somatisation and other psychological factors does not negate the presence of 
elements such as fatigue and pain and Winfield highlights how important it is to 
consider other variables (Winfield, 2001). 
Some authors consider this varied symptomatology under the category of 
somatoform disorders, meaning unexplained somatic symptoms lasting for at least 
6 months which lead to significant deterioration in a person’s daily functional 
ability. No general medical condition can explain the nature and number of 
symptoms or the patient`s anxiety and concern, which cannot be attribute to the 
presence of any other mental disorder. Emotional and psychosocial conflicts play 
an important role in the onset, severity, exacerbation or maintenance of physical 
symptoms (Häuser, Kosseva, Üceyler, Klose, & Sommer, 2011). According to the 
new DSM-V (2013) criteria, where this term is replaced by Somatic Symptom 
Disorder, all FM patients may meet the criteria set out namely: (1) excessive and 
disproportionate thoughts regarding symptoms; (2) high levels of health or 
symptom anxiety; and (3) excessive time and energy spent on these symptoms or 
health problems. And yet Wolfe, Walitt, Katz & Häuser (2014) point out, that 
given how difficult it is to guarantee the objectiveness of terms such as 
disproportionate or excessive, the reliability and validity of DSM-V criteria with 
this population is very low. 
Today both patients and researchers agree that a biopsychosocial approach should 
be taken to FM in which both biological and psychosocial factors are important to 
the predisposition, exacerbation and maintenance of FM symptoms (Häuser & 
Henningsen, 2014). These authors consider a multidimensional diagnosis more 
appropriate in which somatic and psychological complaints, psychosocial stress, 
incapacity and subjective beliefs on the cause of the disease are all taken into 
consideration. 
2.2.2. PREVALENCE AND IMPACT OF FIBROMYALGIA IN SPAIN 
Different studies maintain that FM represents the most widespread form of 
chronic osteo-muscular pain in the population and is more frequent in women and 
generally in middle age. In Spain estimated prevalence is 2.37% of the general 
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population over the age of 20 (Mas, Carmona, Valverde, & Ribas, 2008; 
Valverde, Juan, Ribas, & Carmona, 2001). 
90% of patients with FM remain undiagnosed and an average of between two and 
seven years may pass between the appearance of symptoms and diagnosis 
(Vázquez Gallego & Solana Galdámez, 2004). 
FM appears in all age groups with a maximum prevalence in the 40-49 age group 
(almost 5%) although average age at which symptoms are felt is 44.7 (EPISER, 
2001). With 90% of patients diagnosed with FM being women, it is more frequent 
amongst women than men. Prevalence amongst women is 4.2% and 0.2% in men 
(Valverde et al., 2001). It is more frequent in rural (4.1%) than urban (1.7%) 
environments. Years of education correlates inversely with FM frequency and the 
illness is more prevalent amongst people without studies (4.8%) or with only 
basic education (3%), going down to 0.6% amongst the population with a 
university education. As far as work goes, there is a greater prevalence amongst 
the unemployed and housewives in comparison to the general population (Mas et 
al., 2008). In a 2006 study, Lera describes, in a sample of 83 women with FM, a 
high percentage (66%) of women with elementary studies, a smaller percentage of 
women with secondary education and only a very small number with a university 
degree. The majority of the sample worked in unskilled jobs requiring much 
physical effort (59%), 15% was self-employed and 20% had never been in 
employment. The study by De Felipe García-Bardón, Castel-Bernal & Vidal-
Fuentes (2006) found that 30% were housewives, 20% worked outside the house 
and 50% were disabled. The study by Mas et al. (2008) also underscored 
prevalence in the Spanish population of FM patients on sick leave from work, 
unemployed and housewives. 
Amongst people suffering from rheumatoid illness in the general population, the 
two pathologies associated with the greatest consumption of chronic care are 
fibromyalgia (87%) and rheumatoid arthritis (82%) (Valverde et al., 2001). FM 
and lumbago were the rheumatic complaints, which led to worst quality of life 
due to emotional limitation. Several studies, such as the one by Junyent Priu, 
Benavides, Borrel Muñoz, Sisó Almirall & Herrero Camp (2005) highlighted the 
high comorbidity of FM with other illnesses. In this study, of 130 women with 
FM who had used primary healthcare services 56% had rheumatologic, 55% 
psychiatric and 36% digestive diseases.  
An FM patient is one of the most costly patients to the health service, consuming 
triple the health resources of any other chronic patient, has a greater number of 
specialist and GP appointments, larger number of admittances through A&E and 
more hospital stays (Castilla Plaza & López Sanz, 2007; Pastor Mira, Lledó 
Boyer, López-Roig, Pons Calatayud, & Martín-Aragón Gelabert, 2010; Sicras-
Mainar, Blanca-Tamayo, Navarro-Artieda, & Rejas-Gutiérrez, 2009).  
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2.2.3. DIAGNOSIS 
As has already been mentioned previously, FM is diagnosed using two criteria 
determined by the ACR in 1990 (Wolfe et al., 1990).  
1. History of widespread pain. Pain is considered widespread when all of
the following are present: pain in the left side of the body, pain in the
right side of the body, pain above the waist, and pain below the waist. In
addition, axial skeletal pain (cervical spine or anterior chest or thoracic
spine or low back) must be present. This symptom should be present for
at least 3 months.
2. Pain, on digital palpation, must be present in at least 11 of 18 sites.
Digital palpation should be performed with an approximate force of 4 kg,
which is basically, when the examiner’s nails have changed colour. For a
tender point to be considered positive the subject must state that the
palpation was painful.
Figure 1. Tender points in fibromyalgia. 
Source: Fibromialgia. Ministerio de Sanidad, Política Social e Igualdad, 2012, Madrid: 
Ministerio de Sanidad, Política Social e Igualdad, (p. 31) 
However, in the light of evidence that when fibromyalgia was diagnosed in 
primary care, these tender points were not being used, Wolfe et at., (2010) 
proposed new diagnostic criteria for FM and developed two assessment scales that 
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did not need tender point location and were based on the two variables which best 
diagnose fibromyalgia: widespread pain and symptom severity.  
1. The Widespread Pain Index (WPI) assesses the presence of localised 
pain in different areas of the body. The patient scores between 0 and 9 
for the pain levels he/she had in these areas during the previous week.  
2. The Symptom Severity Scale records the presence and intensity of 
fatigue, tiredness on waking, cognitive symptoms and somatic symptoms 
during the previous week. Replies are given on a Likert scale of between 
0 (asymptomatic) and 3 (many symptoms). 
According to this form of measurement, for FM to be diagnosed, the 3 following 
criteria must be met: 1) Widespread Pain Index ≥ 7 and Symptom Severity Scale ≥ 5 
or Widespread Pain Index ≥ 3-6 and Symptom Severity Scale ≥ 9; 2) Symptoms 
must have been present at a similar level for at least 3 months; and 3) the patient 
has no other pathology that can explain this pain. This change in criteria 
eliminates dependence on detecting and examining tender points and makes the 
broad spectrum of symptoms that a person suffering from fibromyalgia may have 
the protagonist (Wolfe et al., 2010).  
Wolfe et al. (1990) Wolfe et al. (2010) 
 History of widespread pain. 
 
 Pain in 11 of 18 tender point sites on 
digital palpation. 
 
 
 
 Symptoms have been present for at least 
3 months. 
 Widespread pain index (WPI) > 7 and 
FM symptom severity (SS) score > 5 
       or 
 Widespread pain index (WPI) > 3-6 and 
FM symptom severity (SS) score > 9. 
 Symtoms have been present at a similar 
level at least 3 months. 
 The patient does not have a disorder that 
would otherwise explain the pain. 
Figure 2: Comparison of ACR criteria for diagnosing FM in 1990 and 2010. 
Source: Wolfe et al. (1990) The American College of Rheumatology 1990 criteria for the 
classification of fibromyalgia. Arthritis & Rheumatism, 33(2), 160-172; Wolfe et al. (2010) 
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia 
and measurement of symptom severity. Arthritis care & research, 62(5), 600-610. Inspired 
by García Fontanals, 2013, p. 57.  
2.2.3.1 Differential diagnosis 
FM may be accompanied by a large number of related disorders and this can 
make diagnosis difficult. 25% of FM patients have inflammatory disorders such 
as rheumatoid arthritis, ankylosing spondylitis or lupus (Crauw, 2009). According 
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to Villanueva et al. (2004) some diseases that should form part of the differential 
diagnosis are:  
 
Rheumatic diseases Polymyositis and dermatomyositis, rheumatic 
polymyalgia, lupus, rheumatoid arthritis, Sjögren’s 
syndrome. 
Muscular diseases Inflammatory myopathies, myopathies of metabolic 
origin 
Endocrine-metabolic diseases Hypothyroidism hyperthyroidism, 
hyperparathyroidism, adrenal insufficiciency, 
osteomalacia 
Infectious diseases Lyme disease, postviral syndrome 
Neurological diseases Parkinson’s disease, myasthenia gravis, myasthenia-
type syndromes 
Neoplasic diseases  
Psychiatric diseases Major depressive disorder, somatisation disorder 
Chronic fatigue syndrome  
Myofascial syndrome  
Figure 3. Diseases that form a part of fibromyalgia’s differential diagnosis. 
Source: Villanueva, V. L., Valía, J. C., Cerdá, G., Monsalve, V., Bayona, M. J., & Andrés, 
J. D. (2004). Fibromialgia: diagnóstico y tratamiento. El estado de la cuestión. Revista de 
la Sociedad Española del Dolor, 11(7), 50-63. 
2.2.3.2 Principal measurement tools 
When assessing the impact FM has on a patient all the different aspects of the 
illness must be considered. The majority of studies include one or several pain 
scales, one or more health questionnaires and a means of quantifying 
hyperalgesia. The following tools have been used to assess different FM 
symptoms amongst the Spanish population: 
1) For pain: the Visual Analogue Scale (VAS), the McGill Pain Questionnaire 
(MPQ; Melzack, 1975), the Multidimensional Pain Inventory (MPI; Kerns, Turk, 
& Rudy, 1985) and the Brief Pain Inventory (BPI; Cleeland & Ryan, 1994) 
together with other, non-specific tools such as the SF-36 (Ware Jr & Sherbourne, 
1992).  
2) For tenderness/hypersensitivity during examination: the ACR’s tender point 
count and, to a lesser extent, specifically designed dolorimeters.  
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3) For general life quality, functional ability and overall health: The Fibromyalgia
Impact Questionnaire (FIQ; Burckhardt, Clark, & Bennett, 1991), Short Form 36 
(SF-36; Ware Jr & Sherbourne, 1992), and the EuroQol 5D Health Questionnaire 
(Group, 1990). 
4) For the different symptoms, tests were used to assess:
a) Depression using the Beck Depression Inventory (BDI: Beck. Ward.
Mendelson, Mock, & Erbaugh 1961) and the Center for Epidemiological
Studies Depression Scale (CES-D; Radloff, 1977).
b) Anxiety using the State-Trait Anxiety Inventory (STAI; Spielberger,
Gorsuch, & Lushene, 1982) or the Hospital Anxiety and Depression
Scale (HADS; Zigmond & Snaith, 1983).
5) Other means of measurement were also used such as the Chronic Pain Coping
Inventory (CPCI; Jensen, Turner, Romano, & Strom, 1995) to measure coping 
strategies, the Arthiritis Self-Efficacy Scale (ASES; Lorig, Chastain, Ung, Shorr, 
& Holman, 1989) to measure the ability to solve or manage illness-related issues 
and the Chronic Pain Self-Efficacy Scale (CPSS; Anderson, Dowds, Pelletz, 
Edwards, & Peeters-Asdourian, 1995) for patients with chronic pain (de España 
G., 2012; Rivera, Alegre, Ballina et al., 2006). 
2.2.3.3 Benefits and drawbacks of diagnosis 
Giving an FM diagnosis is controversial and some authors prefer not to do so. 
They argue that making a diagnosis of FM has a harmful effect on the person, by 
medicalising the person and creating a patient, where previously there was none 
(Hadler, 2003). For these authors diagnosing FM is like creating a iatrogenic 
condition which reaffirms painful conduct, magnifies the disease and is 
detrimental to both patient and health system. 
However FM diagnosis does not determine subsequent adverse effects to the 
patient’s clinical condition but rather the contrary, it seems to improve some 
health-perception related issues (White, Nielson, Harth, Ostbye, & Speechley, 
2002). Furthermore there seems to be more advantages than drawbacks to an FM 
diagnosis since it 1) leads to greater understanding with the patient; 2) removes 
any doubts he/she may have regarding other, more serious diagnoses and helps the 
individual realise that their problems are shared by others; 3) prevents the patient 
from going on a search for meaning for their symptoms, reduces consumption of 
health resources and the risks of iatrogenia; 4) adds a new dimension to other 
illnesses by providing valuable information on managing other systemic processes 
(Rivera, 2004) and 5) allows fears, complaints and expectations to be shared with 
other people who also have the disease (Andreu & Sanz, 2005). Van Houdenhove 
(2003) points out that the aim of the FM label is not to dehumanize patient 
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suffering into an illness construct. He reiterates the importance of person-centred 
care and of carrying out a broad diagnostic assessment that includes biomedical 
aspects as well as psychological and social issues. Attentive listening and an 
unbiased therapeutic alliance of trust and empathy can be extraordinary powerful 
tools. Good differential diagnosis should be coupled with patient education so that 
psychosocial factors do not develop or strengthen maladaptive behaviour to the 
disease (Goldenberg, 2009; Kasper, 2009). 
Some studies describe how individuals see many different specialists (Muro 
Gastañaga, 2007; Valverde, Markez, & Visiers, 2010), and that final diagnosis 
actually produces some relief (Tobo Medina, 2007) which then becomes 
frustration due to the lack of effective treatment and due to the rejection that FM 
provokes in certain professionals. This feeling of frustration and of being 
abandoned by health professionals is repeatedly expressed (De Felipe García-
Bardón, 2012). After FM diagnosis, expenditure on healthcare decreases 
(Annemans et al., 2008; Hughes, Martínez, Myon, Taïeb & Wessely, 2006), 
statistically significant improvement in health satisfaction can be observed and, 
provided FM cases have received early diagnosis, fewer symptoms are reported 
(White et al., 2002).  
2.2.4. AETIOLOGY 
Despite many explanatory models coming from different specialities, the cause of 
fibromyalgia remains unknown. Today it is accepted that biological, 
psychological and socio-cultural imbalances all have an impact on the 
development and perpetuation of this disease. 
Different medical specialists have suggested a whole range of anomalies which 
may impact on the disease, such as: disturbed sleep (the appearance of alpha 
waves during non REM sleep) (Moldofsky, 1986); imbalance in growth hormones 
(Bennett, 2002) influencing homeostasis and muscle recovery which requires 
deep sleep to recover (Moldofsky, 1993); muscular disorders (muscle hypoxy and 
a reduction in high energy phosphates); immunological (De Meirleir et al., 2000) 
or viral (Douche-Aouric et al. 2003; Lombardi et al., 2009) upsets, hyperactivity 
in cortisol-producing hormones (Neeck & Riedel, 1994); neurohormonal 
dysfunction, especially of the hormones produced by the hypothalamic, pituitary 
and adrenal system related to the stress response (Crofford & Demitrack, 1996) 
and genetic predisposition (Neumann & Buskila, 2003) (cited in Hidalgo, 2011). 
Pain processing theories have generated much research into the multiple systems 
involved in pain regulation, from the existence of a dysfunctional response to 
stress (Okifuji, Turk, & Marcus, 1999) and further to an increase in central 
sensitivity (Yunnus, 2007). 
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Van Houdenhove, van Den Eede & Luyten (2009) emphasise that the mechanisms 
involved in the cause and development (aetiopathogenesis) of fibromyalgia are 
not just central sensitivity but also a dysfunctional response to stress based on the 
relation between adverse life experiences, the systems involved in responding to 
stress, pain processing mechanisms and genetic predisposition.  
As has already been described in previous pages, the world of psychology has 
also attempted to locate a specific pathological origin for FM (major depression, 
somatisation disorder). Within this line of research there are studies underlining 
that many patients have depression (Arnold et al., 2008; Nicholas, Coulston, 
Asghari, & Malhi, 2009; Pae et al., 2008) and that depression is related to pain 
and FM; or the existence of high vulnerability to stress (Hudson, Arnold, Keck, 
Auchenbach, & Pope, 2004; Winfield, 2000); since there is evidence that stress is 
a significant predictor of pain behaviour in people with fibromyalgia (Thieme, 
Spies, Sinha, Turk, & Flor, 2005). White, Carette, Harth & Teasell (2000) talk of 
post-traumatic stress and state that 50% of people with FM have suffered an event 
that triggered the diagnosis, normally some kind of physical trauma (traffic 
accident, infection, major surgery) and in general post-traumatic stress situations 
as well as physical and psychological events (Goldberg, 1999; White et al., 2000). 
Sufficient empirical evidence has been found to support the idea that 
psychological problems are present in FM, even though they may not be equally 
severe in all affected people. There is currently a great deal of experimental work 
assessing FM adaptive modulating variables such as coping strategies and other 
emotional factors (van Houdenhove, Egle, & Luyten, 2005). 
2.2.4.1 The Biopsychosocial Model 
This approach is a dynamic model in which initial biological (such as genetic 
predisposition) and psychosocial factors (such as adverse experiences in 
childhood) predispose a person to the disease. As a result, the person may notice 
the presence of certain symptoms such as moderate pain or fatigue. Some people 
find that adaptive and coping mechanisms activate regulatory responses both to 
physiological and psychological reactions, but in others this adaptive system fails 
either because of excessive reactivity of the central nervous system, excessive 
stressors or other affective, cognitive and environmental factors (such as a lack of 
social support) or the interaction of all of these, thus generating a dysfunctional 
response (Okifuji et al., 1999; Lledó et al., 2012). Some authors highlight that 
these deregulatory responses are triggered subsequent to an additional physical or 
emotional event (such as for example an accident, whiplash, an increase in 
responsibilities or loss of a loved one). This kind of response may become chronic 
and so symptoms persist or even worsen under the influence of a series of both 
affective (anxiety, depression) cognitive (excessive worry and catastrophic 
thinking), behavioural (hypervigilance, hyperactivity) and social (lack of 
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understanding of the environment) factors (van Houdenhove et al., 2005; van 
Houdenhove, Kempke, & Luyten, 2010). 
Figure 4. The biopsychosocial model of fibromyalgia. 
Source: van Houdenhove, B., & Luyten, P. (2008). Customizing treatment of chronic 
fatigue syndrome and fibromyalgia: the role of perpetuating factors. Psychosomatics, 
49(6), 470-477. 
2.2.5. MOST FREQUENT CLINICAL SYMPTOMS 
According to Rivera, Alegre, Ballina et al. (2006) pain and fatigue are the two of 
all the many symptoms that these patients have, which the lives of FM sufferers 
primarily are centred on. Ortega Pardo (2012) combined the results of three 
studies (Bjorkegren, Wallander, Johansson, & Svardsudd, 2009; Casanueva, 2007, 
Choy et al., 2010) to highlight the most frequent symptoms (present in more than 
50% of the sample) such as: disturbed sleep (insomnia, light sleep, frequent 
arousal, teeth grinding and non-restorative sleep); morning or after-rest stiffness; 
involuntary movements of the extremities (paroxysmal movements), especially in 
legs (restless leg syndrome); arthralgia; paraesthesia; tension headaches; difficulty 
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concentrating and difficulty remembering things (bad memory); and 
psychological distress, with close association to anxiety, mood swings, dysthymic 
symptoms and depression. In addition to these, other symptoms are mentioned 
such as: irritable bowel (dyspepsia, flatulence, nausea, constipation diarrhoea, 
pseudo-obstructive symptoms, etc); genitourinary symptoms (dysmenorrhoea, 
premenstrual syndrome and irritable bladder); Raynaud’s disease, vegetative and 
functional symptoms (cold extremities, dry mouth, hyperhidrosis, orthostatic 
dysfunction and involuntary trembling) and intolerance to many medicines 
(Martínez, González, & Crespo, 2003; Villanueva et al., 2004). These symptoms 
tend to come and go and do not necessarily all occur at the same time. They may 
appear gradually or suddenly (Rivera, Alegre, Ballina, et al., 2006). 
 
Figure 5. Symptoms generally associated to fibromyalgia. 
Source: Ortega Pardo, J. (2012). Tratamiento cognitivo-conductual protocolizado y en 
grupo, para la fibromialgia: Aplicación en contexto hospitalario (Doctoral dissertation, 
Universidad Nacional de Educación a Distancia) (p.13). 
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2.2.5.1 Pain 
Patients describe pain especially in the area around the spine, as continuous 
although with oscillations over time; worse in the morning, partial improvement 
during the day and renewed worsening in the afternoon/evening. Factors that most 
frequently worsen pain include, body posture, physical burden, emotional triggers 
and changes in the weather. Pain acuteness is a significant characteristic and 
patients frequently explain that pain is acute and excruciating, using both sensory 
adjectives (tightness, stiffness) and emotional ones (depressing, exhausting) to 
describe a characteristic pattern of chronic pain. Choy et al. (2010), Casanueva 
(2007) and Björkegren et al. (2009), give figures of 65%, 90.78% and 93.4% 
respectively for patients with pain symptoms (quoted in Ortega Pardo, 2012). 
Pain is considered complex, subjective and therefore also an emotional experience 
(IASP; 1994; Merskey & Bogduk, 1994) resulting from an interaction between 
physiological, behavioural, cognitive, emotional and social processes (Miró 
Martínez, 2003; Renn & Dorsey, 2005).  
Butler & Moseley (2010) consider many factors that influence pain, all of which 
contribute to the way it is experienced. 
Figure 6. Factors contributing to the pain experience. 
Source: Butler, D. S., & Moseley, G. L. (2010). Explain Pain. Noiggroup Publications. 
Australia (p. 97). 
In addition to the distress, impairment and suffering generally associated to 
painful experiences, chronic pain usually affects emotional stability, daily flow of 
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life, and quality of life. The impact of pain varies considerably from patient to 
patient and it is now recognised that these differences can be explained to a large 
extent by factors such as, beliefs regarding illness, emotional regulation, self-
efficiency, coping strategies and social support (Gatchel et al., 2007; Turk & 
Okifuji, 2002). Additionally high anxiety, stress or depression levels are related to 
each other and influence an individual’s pain response (Miró Martínez, 2003).  
From a psychoanalytical viewpoint pain appears at the conceptual frontier-line 
that exists between what is physical and what is emotional and where a sensation 
of pain is revived by the memory of the mental representation of injury. The way 
pain is represented depends upon the sensory, emotional and associational tributes 
it is given (De Felipe García-Bardón, 2012) and to recover from this pain it is 
necessary to evoke and express these experiences. 
2.2.5.2 Fatigue 
Fatigue is present in a high percentage of patients and may manifest as one or 
two-day periods of complete exhaustion or, more frequently, on-going fatigue. 
Some patients suffer continuous severe fatigue rather than pain and meet the 
diagnostic criteria of chronic fatigue syndrome. Björkegren et al. (2009) and 
Casanueva (2007) mention chronic fatigue in over 90% of patients whilst Choy et 
al. (2010) put this figure at 56% (Ortega Pardo, 2012). 
Many factors correlate with fatigue levels including pain, disturbed sleep, 
symptoms of depression and positive or negative interpersonal experiences 
(Kurtze & Svebak, 2001; Nicassio, Moxham, Schuman, & Gevirtz, 2002; Parrish, 
Zautra, & Davis, 2008) (in Ortega Pardo, 2012). 
2.2.5.3 Disturbed sleep 
Disturbed sleep is the third most common symptom and correlates with the degree 
of severity of fibromyalgia. It may precede the onset of pain and it most 
commonly affects falling and staying asleep, with frequent arousals and non-
restorative sleep. A large number of painful muscle twitches also occur during 
sleep. Biggatit, Henández, Cronan and Rand (2008) corroborate the existence of 
disturbed sleep and furthermore point out that disturbed sleep predicts pain level 
and pain predicts levels of physical functioning, with physical functioning 
predicting depression. So, a lack of nighttime rest may correlate to the presence of 
emotional distress, anxiety and depression, and hinder recovery from negative or 
stressful experiences (Hamilton et al., 2008). 
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2.2.6. RELATED PSYCHOLOGICAL SYMPTOMS  
The majority of research studies note that FM patients have significantly more 
psychological problems than healthy control groups or patients with chronic pain 
disorders and structural diseases like rheumatoid arthritis (Peñacoba, 2009; 
Yunus, Celiker, & Aldag, 2004). Some of these studies point out that people with 
FM have more: 1) depression and anxiety symptoms (Gormsen, Rosenberg, Bach 
& Jensen, 2010); 2) psychosocial problems and psychiatric disorders such as 
depression, anxiety, somatisation, phobia and panic attacks (De Felipe García-
Bardón et al., 2006); and 3) post-traumatic stress disorders and personality 
disorders (Rivera, Alegre, Nishishinyac, et al., 2006). In general, FM patients 
suffer from more emotional disorders, have limited strategies for coping with 
pain, smaller social circles and more negative social ties than the rest of the 
population (Nicassio, 2001).  
Epstein, Kay, Clauw, Heaton & Klein (1999) concluded that psychological 
variables such as anxiety and depression can adversely affect perception of illness 
severity, functional ability and perception and tolerance of pain. Their results 
showed that FM patients in their sample had a) greater levels of depression (both 
in the present and throughout their lives) and panic attacks; b) in general showed 
greater prevalence of psychiatric disorders, c) their degree of psychopathology 
was greater than those suffering other debilitating diseases, c) functional 
incapacity was shown to be severe in comparison to other chronic disorders; d) 
current emotional states of subjects correlated with physical wellbeing, with those 
people with higher levels of anxiety and depression functioning worse and e) 
subjects also exhibited higher levels of hypochondria and neuroticism. 
2.2.6.1 Anxiety 
Anxiety is the psychological factor which is earliest and best identified as a 
response to a painful experience (Alda, García Campayo, Pascual, & Olmedo, 
2003). It is a characteristic FM symptom.  
Anxiety may play a key role in perpetuating FM since it produces muscle tension, 
an increase in susceptibility to and a reduction in tolerance of pain as well as 
perpetuation of painful feelings, once the stimulus ceases (Alda et al., 2003), more 
tender points, hyperventilation and, in the case of fear of pain, an increase in 
avoidance behaviour and exhaustion (van Houdenhove & Egle, 2004). 
Furthermore, the time and difficulty involved in obtaining a correct diagnosis may 
produce a great deal of distress, an increase in attention to physical symptoms and 
a tremendous medical pilgrimage in the search for alternatives or solutions to 
improve health.  
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2.2.6.2 Depression 
Pain influences depression levels and depression also acts reciprocally by pre 
and/or intermorbidly partially or severely determining pain levels (Tennen, 
Affleck & Zautra, 2006). Depressive disorders are the most frequent comorbid 
psychiatric conditions in fibromyalgia patients with a prevalence rate of between 
20 and 80% (Fietta, Fietta & Manganelli, 2007), followed by depressive 
symptoms with a prevalence level of 40% (Kato, Sullivan, Evengård, & Pedersen, 
2006). They are associated with greater pain perception, lower quality of life and 
more serious life events (Aguglia, Salvi, Maina, Rossetto, & Aguglia, 2011). 
Different explanations have been put forward for this and can be summarised as: 
1) depression precedes the onset of chronic pain and fibromyalgia; 2) depression
is a consequence of chronic pain; 3) depressive episodes before the appearance of 
chronic pain and/or FM predispose an individual to new depressive episodes 
during the disease; 4) psychological factors such as coping strategies mediate 
between depression and pain and 5) depression and chronic pain share common 
characteristics but are different diseases (Blackburn‐Munro & Blackburn‐Munro, 
2001). 
For some authors the mechanisms behind depression and anxiety development 
may be different for people with FM than for those with neuropathic pain 
(Gormsen et al., 2010). For example, Palomino, Nicassio, Greenberg & Medina 
(2007) conclude that the cognitive significance given to having FM plays a 
greater role in predicting depressive symptomatology than stress factors related to 
disease, pain or disability.  
2.2.6.3 Anger 
Just like depression and anxiety, anger is a pain-related emotion and may increase 
pain perception, trigger physiological responses and muscle tension. A study by 
van Middendorp et al. (2010), suggests that anger and a general tendency to 
restrain anger is a predictor of greater pain in the day-to-day lives of FM patients. 
Thus psychological treatment might want to concentrate on healthier ways of 
anger expression and in this way alleviate FM symptoms. In this study, carried out 
on 62 women with FM and 59 without, state anger predicted (with statistical 
significance) greater pain at the end of the day in half the patients but less pain in 
a quarter of patients. Trait anger control was found to be related to more pain with 
lowest pain levels recorded in patients with high trait anger expression, i.e. those 
patients able to express (anger-out) their anger.  
Camino Vallhonrat et al. (2009) applied the STAXI-2 test at a two-group sample 
with a total of 20 patients. She showed the importance of anger in FM when 
scores obtained for experience, expression and control of anger at the pretest 
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evaluation showed results, that the authors interpreted as a tendency to control 
anger (and the high levels of anger felt) for prolonged periods of time - without 
the ability to express it, thus stimulating somatisation.  
A study by Burns, Quartana & Bruehl (2008) alludes to models that suggest that 
anger control during a challenging event may increase pain later. According to 
these authors, and following Wegner’s model (1994), efforts to suppress anger 
expression or components of anger expression may make this anger more 
accessible and relevant to the conscience and therefore more impulses, feelings 
and thoughts related to this unwanted anger can surface and exacerbate feelings of 
frustration, irritation and annoyance. 
The study of Sayar, Gulec & Topbas (2004) also showed tha t  women wi th  
FM (n = 50) have high anger scores in comparison with healthy women (n = 42) 
and rheumatoid arthritis patients (n = 20) and show positive correlation to chronic 
pain. However, the study seems to indicate that whilst FM patients internalise and 
repress their anger, rheumatoid arthritis sufferers are more prone to trait anger and 
express this anger more easily. 
2.2.6.4 Cognitive aspects 
Several studies demonstrate that the relationship between cognitive and affective 
dimensions can activate chronic pain states even without the presence of physical 
factors. 
One of the most studied factors is the perception of self-efficacy in pain control 
and acceptance (Martín-Aragón et al., 2000). The study by Pastor Mira et al. 
(2010) demonstrates that pain acuteness, tiredness and disturbed sleep do not 
explain medicine consumption. What does explain medicine consumption is the 
patient`s perception of self-efficacy for managing pain symptoms.  
Several pieces of research emphasise the relationship between pain, FM and 
cognitive distortion or misconceptions of oneself or one’s personal situation (De 
Felipe García-Bardón et al., 2006), as well as the use of maladaptive or negative 
coping strategies such as catastrophic thinking (Gónzalez et. al., 2009) and 
passive behaviour (Cuevas Toro, 2010; Lundberg, Anderberg, & Gerdle, 2009; 
Ramírez Maestre, Esteve Zaragoza, & López Martínez, 2001). So, people with 
fibromyalgia use negative coping strategies such as directing their attention at 
pain, closely watching any change, remaining still, anticipating future problems or 
confronting major challenges. And yet Govillard Garmendia (2011) highlights in 
a study that people with FM use significantly more positive coping strategies such 
as distraction through thought (64.3%), activity (57.1%), the setting of small 
challenges (42.1 %) and positive thinking-visualisation (43.6%) than healthy 
people.  
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2.2.7. QUALITY OF LIFE AND SUBJECTIVE WELLBEING 
According to the World Health Organisation’s definition, quality of life is 
individual perception of one’s life situation within a cultural context and a 
specific value system that includes aims, expectations, standards and concerns 
(WHO QoL, 1995) and is influenced or affected by health (Ortega Pardo, 2012; 
Tander et al., 2008).  
García Martín (2002) quotes Lawton (1983) when mentioning the four sectors of 
quality of life: 
“Behavioural competence refers amongst other things to adequate 
health and functional ability, social behaviours and cognition. 
Psychological wellbeing includes coherence between desired aims and 
those that have been obtained in life, contentment and optimum 
affective levels. As for perceived quality of life this includes 
individual satisfaction with oneself, family, friends, work, activities 
and place of residence. And finally objective environment 
encompasses all the physical characteristics of the surroundings where 
a person leads their life” (García Martín, 2002; p. 4) (translated by the 
author). 
 
Figure 7. Quality of life sectors. 
Source: García Martín, M. Á. (2002). El bienestar subjetivo. Escritos de psicología, (6), 
18-39 (p. 4) 
There is almost unanimous agreement that people with FM suffer a severe 
worsening of physical, psychological and social wellbeing (Hoffman & Dukes, 
2008; Ortega Pardo, 2012). Tander et al. (2008) point out that the negative impact 
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of FM on quality of life is similar to that of rheumatoid arthritis and yet these two 
diseases have different effects on a person’s mental state and physical and social 
functioning, with psychological functioning being far more deteriorated in people 
with FM. 
The quality of life and health impact variable is a key factor for determining 
effectiveness of FM treatments and assessing specific FM disorders such as 
physical ability, influence on working life, pain, fatigue, tiredness, stiffness, 
perception of wellbeing, anxiety and depression (mainly recorded using the 
Fibromyalgia Impact Questionnaire, FIQ). Factors that influence qualities of life 
include sleep quality (Theadom, Cropley, & Humphrey, 2007), pain intensity 
(Jensen et al., 2010); anxiety symptoms, depression and coping strategies 
(Campós & Vázquez, 2013) and tiredness (Ubago Linares et al., 2008). 
Moving on to examine subjective wellbeing, the majority of authors explore 
satisfaction with life and emotions; -both positive (for example: joy, pride, 
ecstasy) and negative (blame and shame, sadness, anxiety, depression, stress). 
Others broaden this idea to include acceptance, personal development and 
adaptation and integration into social surroundings (García-Martín, 2002). 
Vinaccia & Orozco (2005) underscore the importance of physical wellbeing, 
determined by functional activity, strength or fatigue, sleep and rest, pain and 
other symptoms; psychological wellbeing, related to fear, anxiety, depression, 
cognition and distress generated by disease and its treatment; social wellbeing, i.e. 
emotional functions and relations, intimacy, appearance, entertainment, isolation, 
work, economic situation and family suffering and spiritual wellbeing which 
includes the meaning of illness, hope, transcendence, uncertainty, religiousness 
and inner strength. The concept of personal wellbeing depends to a large extent on 
a person’s value and belief systems, cultural context and personal history and 
these authors highlight the influence of all this on the perpetuation, recovery or 
loss of health amongst people with chronic diseases. Specifically, people with FM 
have greater feelings of being a victim or a burden, less feeling of happiness, 
positivity and of being understood by society, healthcare professionals or work 
colleagues and a reduced perception of their quality of life (Govillard Garmendia, 
2011). 
2.2.8. IS FIBROMYALGIA A UNIFORM CONDITION OR ARE THERE 
SUBGROUPS? 
The FM population shares similar symptoms and conditions but has significant 
internal differences as well, mainly to do with perceptions of pain control, anxiety 
and depression and catastrophic thinking.  
Turk, Okifugi, Sinclair & Starz (1998) made an attempt to classify the FM 
population into subgroups and by applying the Multidimensional Pain Inventory 
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(Kerns et al., 1985) divided FM patients into three groups by psychosocial 
profiles. 1) The largest dysfunctional group contained people with high pain 
intensity, high pain interference, high psychological stress, low activity levels and 
low control perception. 2) The interpersonal stress group had, in addition to the 
previous characteristics, a low perception of support and high perception of 
punishment for pain from their surrounding environment. 3) A coping profile 
group, characterised by high perception of social support, low pain intensity and 
low pain interference, high activity levels, low distress and high perception of 
control. Turk (2005) proposed that: 
“This lack of efficacy of chronic pain treatment could be attributed to 
the prescription of similar treatments to patients with different 
characteristics, and that subdivision of patients into more 
homogeneous subgroups with similar adjustment styles could help to 
tailor different interventions to different patient profiles, and 
consequently improve treatment outcomes” (López-Chicheri, 2012, p. 4). 
Giesecke et al. (2003) differentiated three subgroups of patients with FM in which 
three symptoms were considered: hyperalgesia (pain sensitivity), degree of 
anxiety/depression and catastrophic thinking. Of these subgroups, group I 
represents the typical FM patient who goes to primary healthcare services, has 
moderate anxiety/depression symptoms, does not experience too much 
catastrophic thinking, has internal locus of control, low pain sensitivity and 
responds well to treatment. Group II has high anxiety and depression levels, an 
external locus of control, higher values of pain sensitivity and more years with 
symptoms of important social, cognitive and behavioural consequences. Group III 
is the group with most intense pain, normal depression and anxiety levels, an 
internal locus of control and no catastrophic thinking. In other words they are 
patients who respond and cope with the situation better than the other two groups 
and the prospect of obtaining improvement through pharmacological treatment 
(with antidepressants and analgesics) is good. In Consenso Interdisciplinar de la 
Fibromialgia (Interdisciplinary Consensus on Fibromyalgia) (Montoya et al., 
2010) support from Giesecke et al. (2003) classification and include biological 
and cognitive aspects, to better adapt it to clinical reality. 
In the study of De Souza et al. (2009), using the Fibromyalgia Impact 
Questionnaire (FIQ, Burckhardt et al., 1991) two groups was differentiated. 
Group I had high pain scale scores, stiffness and fatigue and low anxiety and 
depression levels (even lower than the control group) and group II experienced 
high levels of pain and fatigue (no different to group I), more stiffness and 
significantly greater anxiety and depression. Additionally, this study examined the 
groups with regard to demographic variables (age, years with symptoms, years 
since diagnosis, employment situation), pain level (pain tolerance by immersion 
in cold water), the number of pain points, restrictions to daily activities and social 
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support, without finding any significant differences. However group II scored 
significantly higher in catastrophic thinking, interference or impact of pain on 
day-to-day activities and emotional distress as well as significantly lower scores 
in self-control.  
Calandre et al. (2011) replicated in the study of De Souza et al. (2009) in Spain 
with a larger sample size (n = 421). The results of the study place 82.2% of people 
with FM in group II (high pain levels, fatigue, tiredness in the morning, anxiety 
and depression). 
2.2.9. SUMMARY 
Although FM has been recognised as a disease by the World Health Organisation 
since 1993 (WHO, 1993), its unknown origin, difficult diagnosis and high overlap 
with other medical and psychological symptoms and diseases, means that it is still 
not clearly differentiated. The disease’s most relevant characteristics are pain, 
disturbed sleep, fatigue and a depressed state of mind.  
Affecting 3-4%, the incidence of FM in the population is very high. It affects 
mainly women and has a high economic cost in terms of absenteeism, disability, 
number of specialist consultations and medicines consumed. 
The main psychological symptoms linked to FM are anxiety and depression 
(although there is no conclusion as to whether these two are the cause or 
consequence of the disease), stress and lower coping skills and strategies. Some 
studies hint at the possibility of considering the existence of FM sub-groups with 
different depression and/or anxiety symptoms, pain levels and coping strategies.  
Since many factors influence the origin, progression and chronification of FM, a 
comprehensive treatment approach is necessary in order to treat all affected 
systems. 
2.3. TREATMENT FOR FIBROMYALGIA 
Since FM is considered a chronic illness, treatment is not aimed at curing the 
condition but rather preventing some symptoms and alleviating others. Since this 
disorder has such a variety of symptoms and is comorbid with other psychological 
and physical disorders, many different kinds of treatment have been tried and an 
interdisciplinary approach is advisable. In addition to drug treatment, the most 
commonly-used treatments today are: patient education and information, exercise 
and psychological therapy. 
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The next section describes some of these treatments. After a brief reference to 
drug treatment, a second section explains two psychotherapeutic modes of 
treatment: cognitive-behavioural therapy and psychoanalysis. Finally, treatment 
using music and music therapy is taken up. Treatment using relaxation and guided 
imagery are dealt with separately.  
2.3.1. DRUG TREATMENT 
There are currently no drugs or combination of drugs (including hormone therapy) 
that have proved to be effective in treating FM symptoms as a whole (Abeles, 
Solitar, Pillinger, & Abeles, 2008). The drugs that are most widely used and have 
given best results include analgesics such as tramadol; antidepressants (including 
tricyclic antidepressants) and, more recently, anticonvulsants, such as gabapentin 
and pregabalin. Not all patients benefit from treatment with these drugs and their 
effects are limited in time (Goldenberg, 2007; López-Chicheri, 2012). 
Treatment exclusively with drugs has not proven to be the most effective. What is 
more, continued or excessive drug consumption may have negative effects on the 
body’s organism, increase dependency on health services and interfere in the 
incorporation of other more adaptive actions for the pain problem (Pastor Mira et 
al., 2003; Pastor Mira et al., 2010). 
Moix Queraltó (2005) states that: 
“Patients show greater improvement when, in addition to medical 
treatment, they receive psychological treatment, than when only 
medical treatment is given. The people treated in this joint way have 
greater reduction of anxiety, depressive feelings, the medication they 
need, problems produced by pain and even acuteness of pain” (De 
Felipe García-Bardón, 2012, p.25) (translated by the author). 
2.3.2. PSYCHOLOGICAL TREATMENT 
The aim of the majority of psychological treatment today is to help the patient 
control emotional aspects such as anxiety and depression together with cognitive, 
behavioural and social aspects that may be aggravating their symptoms. Equally, 
psychology aims to help patients modify their beliefs regarding the illness and 
learn coping techniques so that they can adequately respond to pain and other FM 
manifestations (Peñacoba, 2009).  
Rossy et al. (1999) compared the efficacy of drug and non-drug treatments on FM 
by evaluating 40 studies. They concluded that the optimum way of treating FM 
was an approach that included non-drug treatment, especially physical exercise 
and cognitive-behavioural therapies. Sim & Adams (2002) also reviewed non-
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drug treatment of FM in 25 studies. The treatments evaluated were exercise, 
education, relaxation, cognitive-behavioural therapy, acupuncture and 
hydrotherapy. The inferior quality of the studies with small samples and follow-
up of less than 16 weeks meant they had difficulty drawing conclusions on 
whether one kind of treatment was better than another. Hassett & Gevirtz (2009) 
insist on the advisability of offering treatment where behavioural, cognitive and 
affective dimensions are all covered and suggest using the acronym Express as a 
strategy in the therapeutic approach. 
”Ex is for Exercise. (…) P is for Psychiatric comorbidity since both 
depression and anxiety disorders are common in chronic pain conditions 
and contribute significantly to pain and disability. R is for Regaining 
function which in FM often involves helping patients with activity pacing 
so that they do not do too much one day when they feel good and do too 
little on days that they feel bad. E is for Education (…) S is for Sleep 
hygiene which is necessary for many who have developed counter-
productive habits. The final S is for Stress management which includes 
any number of elements including CBT, relaxation techniques, 
hydrotherapy and gentle exercise to name just a few” (Hassett & Gevirtz, 
2009; p. 9). 
In the meta-analysis of Glombiewski et al. (2010) 23 research studies including 30 
conditions for psychological treatment for FM were studied by analysing results 
in: pain, sleep, depression, catastrophic thinking and functional state. The analysis 
showed that psychological treatment for FM is promising and its effects can be 
equated, in the short term to drug treatment and other treatments for pain. The 
treatments studied used relaxation strategies, education, meditation and cognitive-
behavioural treatment. 
2.3.2.1 Cognitive-behavioural treatment  
Several studies have looked into the effects of cognitive-behavioural treatment 
strategies on patients with FM and have found evidence of its efficacy. The basis 
of cognitive-behavioural therapy is that both thought and behaviour can affect a 
person’s symptoms and may hinder their recovery. Therapy consists of reducing 
unhealthy thoughts and helping the patient to develop coping strategies, not just 
for their illness but for day-to-day life events and interpersonal relations (Morris, 
Bowen, & Morris, 2005). This kind of treatment incorporates different 
interventions such as self-regulation, biofeedback, coping strategies and cognitive 
restructuring.  
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Cognitive-behavioural therapy can be applied individually or in group and 
normally comprises different phases: 1) an educational phase in which patients are 
informed of the disease and means of coping with it; 2) a skills acquisition phase 
and, 3) a putting into practice phase (Govillard Garmendia, 2011). 
Several studies make clear the efficacy of this kind of treatment with FM patients 
(García, Simon, Duran, Canceller & Aneiros, 2006; Vidal Pérez, Redondo & 
Pérez Nieto, 2005) concerning improvement of depression, fatigue, pain, impact 
of FM and reduction in drug use (Anderson & Winckler, 2007; Falcao et al., 
2008) and concerning improvement of self-assessment and personal efficacy 
(Rivera, Alegre, Nishishinyac et al., 2006; Rocha Ortiz & Benito González, 2006; 
Villalobos-Pérez, Araya-Cuadra, Rivera-Porras, Jara-Parra & Zamora-Rodríguez, 
2005). Some authors demonstrate that modifying efficacy beliefs and expectations 
regarding disease control (cognitive resources) coupled with training patients to 
seek appropriate states of stress-recovery are key elements for FM patients 
positive progression (González-Menéndez et al., 2010; Menzies, Taylor, & 
Bourguignon, 2006). 
Current proposals include contextual cognitive-behavioural treatment which does 
not concentrate on avoiding/reducing symptoms but rather patients are brought to 
accept their continuing pain, something that requires an active, functioning 
individual who partakes of pleasant activities that give their life meaning, even if 
that requires experiencing painful sensations (González-Menéndez et al., 2010). 
Results from different pieces of research show that people with a greater 
acceptance of pain report less pain, anxiety, depression, and disability, greater 
activity levels and better labour status (Costa & Pinto-Gouveiam, 2011; Cuevas 
Toro, 2010; McCracken, Carson, Eccleston, & Keefe, 2004; McCracken & 
Eccleston, 2003; McCracken, Vowles, & Eccleston, 2004). 
2.3.2.2 Psychoanalysis 
Only very few studies refer specifically to psychoanalytic therapy. Treatment 
focuses on helping the patient develop the emotional content of pain and 
increasing their ability to express feelings related to painful physical and life 
experiences (De Felipe García-Bardón, 2012). Space/time is given to complaint 
and the subjective and symbolic meaning of symptoms, seeking to understand 
these meanings in relation to experience gathered and social context (Velasco et 
al., 2006). Some research points to the existence of an early traumatic experience, 
before the appearance of FM (Afari et al., 2014; Amital et al., 2006; Anderberg, 
Marteinsdottir, Theorell & Von Knorring, 2000; Goldberg, 1999), in which pain 
and pain’s mental representation are related to subjective experiences (D´Alvia, 
2002). 
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De Felipe García-Bardón evaluates the effectiveness of a psychodynamic 
approach to psychotherapy on a group of 116 individuals, in comparison to a wait 
list control group of 91 individuals. He qualitatively assesses the content of the 
group sessions and carries out a satisfaction survey before and after the 12 
sessions of treatment, carried out over a period of 3 months. In the conclusion he 
highlights that group psychotherapy was effective at improving depression, 
anxiety, psychosomatic traits, quality of life, overall health and interpersonal 
relations (De Felipe García-Bardón, 2012; De Felipe García-Bardón et al., 2007). 
2.3.3. MUSIC THERAPY AND MUSIC-BASED TREATMENT 
There are two different approaches to using music in medicine; 1) the use of pre-
recorded music in a hospital environment as a complement to the medical 
treatment offered by doctors and nurses and 2) music therapy in which treating the 
biomedical aspects of the injury or disease is combined with the treatment of its 
related psychosocial and emotional factors (Bruscia, 1998). Music can offer 
support to medical procedures thanks to its neurophysiological effects and by 
stimulating emotional processes that have a positive effect on the wellbeing and 
mood of patients (Dileo, Bradt & Murphy, 2008; Schou, 2008). 
“Music therapy can be defined as the clinical and evidence-based use of 
music and/or its elements by a qualified music therapist to accomplish 
individualized goals within a therapeutic relationship with one client or 
a group. The aim of music therapy is to develop potentials and/or 
restore impaired functions of individuals so they can achieve better 
intrapersonal and/or interpersonal integration, which may promote a 
better quality of life, through prevention, rehabilitation or treatment of 
specific problems” (Bernatzky et al., 2011; p. 1991). 
Kwan (2010) highlights four functions of music in music therapy used for treating 
patients in pain: 1) relaxation, 2) resonating synchronically 3) release, 
reorganising and restructuring and 4) reconstituting and integrating, considering 
three main categories: the client’s pain, the role of music in the healing process 
and progression of the client’s wellbeing. Kwan also highlights six main themes 
in the therapeutic relationship between client, music and music therapist: trust, 
presence, care, physical empathy and sympathetic resonance, empowerment and 
facilitation of communication and emotional expression.  
Some authors highlight how patients perceive the benefits of relaxing and 
listening to music, especially their preferred music from the past since it provides 
distraction from and reduces the feeling of pain and the negative experiences that 
go with it (Mitchell, McDonald & Brodie, 2006; Mitchel, Macdonald, Knussen & 
Serpell, 2007). Others emphasize, in addition to possible physical pain avoidance, 
the ability of music to evoke memories of oneself before the onset of pain. 
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Furthermore, music can improve mood, enrich spiritually, console, energise and 
accompany (Gold & Clare, 2013). Evidence shows that music’s intrinsic and 
extrinsic properties may have effects, especially because they stimulate cognitive 
and emotional mechanisms (Garza-Villarreal, Brattico, Vase, Østergaard & 
Vuust, 2012; Garza-Villarreal et al., 2014; Hauck, Metzner, Rohlffs, Lorenz & 
Engel, 2013; Roy, Lebuis, Hugueville, Peretz, & Rainville, 2012). Hauck et al. 
(2013) suggest that different mechanisms are activated in the pain processing 
system depending upon whether the patient’s preferred music is played (his/her 
focus of attention is transferred on to the pain stimulus) or if through interaction 
with a music therapist his/her own compositions are used, which activate the 
patient’s ability to control. 
In a meta-analysis on music therapy carried out by Dileo & Bradt (2005), the 
results concerning the effects of music therapy on pain reduction (examined 48 
studies, 43 were music medicine and only 5 music therapy studies) were 
inconsistent across specialitation involved, with a mean effect size of  r = .21, and 
the moderator analysis revealed that music therapy had much greater effect than 
music medicine intervention. Other research studies demonstrate the usefulness of 
this therapy in pain modulation and its effectiveness at reducing the amount of 
drug treatment and improving a person’s wellbeing (Bernatzky, Presch, Anderson, 
& Panksepp, 2011; Bernatzky, Strickner, Presch, Mendtner & Kullich, 2012; 
Matsota et al., 2103; Nilsson, 2008). Music therapy treatment is more effective if 
offered by a music therapist, who is able to take care of the therapeutic 
relationship and its subsequent therapeutic process (Dileo & Bradt, 2005; Dileo, 
2006), and if the chosen music specifically follows predictable, stable parameters 
of tempo, volume and smooth melodic lines (Gooding, Swezey & 
Zwischenberger, 2012). 
Pothoulaki, MacDonald & Flowers (2012) made a systematic review of studies on 
chronic disease where the link between listening to music and psychological 
variables such as restlessness, feelings of control, anxiety, depression, 
powerlessness and pain was explored. The different approaches covered in this 
review range from using music previously chosen by the patient (Yu, Liu, Li & 
Ma, 2009; Park, 2010) to studies which included instructions for muscle 
relaxation and breathing (Smith, Dauz, Clements, Werkowitch & Whitman, 2009) 
or used music and movement (Sung, Chang, Lee & Lee, 2006) or music-listening 
together with patient comments (Batt-Rawden, 2006). This treatment could be 
complementary to pharmacological treatment since it acts deep on the nervous 
system, activates self-healing mechanisms and promotes mental health. 
Furthermore, it has no side effects and can easily be included in multi-component 
treatments (Bernatzky et al., 2011). 
Only very few studies have examined the effects of music on fibromyalgia or 
chronic pain. Schorr (1993) observed in a quasi-experimental study that pain 
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perception was reduced in 30 women with rheumatoid arthritis when they listened 
to music of their own choice for 20 minutes and further observed that this effect 
persisted even 2 hours later. However the absence of a control group in the study 
reduced the capacity to say that music was the only factor causing a change in 
pain perception.  
McCaffrey & Freeman (2003) also used this hypothesis when they surmised, that 
music could alleviate the physical pain of the elderly suffering from osteoarthritis 
(n = 66), improve their motivation and mood and increase feelings of control. 
Measured through the McGill Pain Questionnaire (SF-MPQ), results showed a 
significant drop in the pain experienced by the experimental group in comparison 
with the control group. Listening to 20 minutes of relaxing music every day 
reduced the pain of chronic osteoarthritis to a greater extent than simply sitting 
and resting without listening to music.  
In the study of Kullich et al., (2003) on 65 patients with lumbar pain and a control 
group, pain reduction and a positive effect on sleep disturbance was achieved 
through an intervention in which music was listened to together with relaxation 
instructions.  
Siedliecki & Good (2006) made a randomised distribution of participants (n = 60) 
with chronic pain in two experimental groups with a control group. The two 
experimental groups listened to music for one hour over a 7-day period; for one 
group the music used was a standard selection of relaxation tracks and the other 
chose their preferred music. At posttest evaluation, both experimental groups 
showed better results than the control group with reductions in pain, depression 
and disability and improvements to patient ability perceptions. However, there 
were no significant differences between the two experimental groups.  
Guetin et al. (2012), in their study on 87 patients with chronic pain confirmed the 
efficacy of listening to pre-recorded music in significantly reducing pain and in 
reducing anxiety depression and consumption of medication.  
Onieva-Zafra, Castro-Sánchez, Matarán-Penarrocha, & Moreno-Lorenzo (2013) 
studied the effects of music on a nursing procedure and stated the effectiveness of 
listening to music to reduce pain intensity and improve depression symptoms in 
patients with FM. In this study, a randomized controlled clinical trial was carried 
out with a sample of 60 people diagnosed with FM. 30 patients were assigned to 
the music intervention group, treated with daily music-listening for four weeks, 
and 30 to the control group. Here McGill’s Pain Questionnaire (LF-MPQ), Beck’s 
Depression Inventory (BDI) and the Visual Analogue Scale (VAS) were used to 
measure outcome. Results indicated pain and depression reduction in the 
experimental group at posttest measurements and no change in the control group.  
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Garza-Villarreal et al., (2014) analysed the analgesic effects of music on pain in 
people with FM. To do so they divided 22 patients with FM into two groups; an 
experimental group that listened to self-chosen relaxing, pleasant music and a 
control group subject to pink noise. They found that listening to self-chosen, 
relaxing, pleasant, familiar music increased the mobility of patients with FM, 
suggesting that music reduces pain in these patients possibly through cognitive 
and emotional mechanisms and its use may contribute to increasing these patients’ 
functional mobility. 
No articles have been found demonstrating the efficacy of active music therapy on 
people with FM. The book by Vannay (2013) describes music therapy using 
active improvisation based on Priestley’s analytical music therapy method carried 
out in a group. Vannay (2013) highlights the positive effects on pain and 
emotional expression obtained after treatment.  
In the only study found in the literature evaluating the effect of vibroacoustics on 
pain points in people with FM, it is highlighted that although the experimental 
group’s perception of pain on tender points improved, the difference between the 
group that received vibroacoustics (with a frequency range of between 600 and 
300 Hz) and the control group was not significant (Chesky, Russell, López & 
Kondraske, 1997).  
2.3.4. RELAXATION TREATMENT 
Frequently music listening has been used together with relaxation techniques and 
has had a positive influence on affective-cognitive and sensorial processes at the 
same time as reducing the negative effects of stress on pain.  
Some studies highlight the efficacy of relaxation training in combination with 
information about the disease, group discussion and self-control techniques on 
patients with FM (Keel, Bodoky, Gerhard, & Müller, 1998), and emphasise the 
positive effects on pain variables, anxiety, depression and fatigue, increase in 
mobility and reduction in medicine intake (Persson, Veenhuizen, Zachrison, & 
Gard, 2008). 
Amongst the studies quoted by Glombiewski et al. (2010) on psychological 
treatment of FM we find: Field et al. (2002) who used Jacobson`s relaxation 
training: Rucco, Feruglio, Genco, & Mosanghini (1995) and Keel et al. (1998) 
who looked into autogenic group training, and the studies of van Santen et al. 
(2002) and Hassett et al. (2007) who used relaxation techniques combined with 
biofeedback in their study. Finally, Hammond & Freeman (2006) included 
visualisation and group discussion in the experimental group that received 
relaxation. These studies did not find any significant evidence of an impact on the 
pain of FM in comparison with multimodal treatments (see Table 2). 
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2.3.5. GUIDED IMAGERY TREATMENT 
Different pieces of research have demonstrated the positive impact of guided 
imagery treatment on people with FM in particular and on dealing with pain in 
general. Guided imagery is a dynamic, psychophysiological modality in which a 
person imagines and experiences an internal reality in the absence of external 
stimuli (Menzies & Taylor, 2004). 
In Hammer’s study (1996) on 18 subjects with dependencies, those who received 
treatment (n = 9) were given 10 weekly sessions of 30 minutes training in 
relaxation and guided visualisation whilst listening (for 8 - 10 minutes) to music 
where both music and induction images had been chosen previously. Despite the 
experimental group obtaining a reduction in stress and anxiety perception, these 
results were not found to be significant when compared to the control group. 
Fors, Sexton & Götestam (2002) carried out a study to test the efficacy of 
attention distraction by using relaxation training and instructions of pleasant 
guided images. In their randomised study with a control group, the sample of 55 
women with FM was divided up into three different groups. One group received 
training in relaxation and pleasant images with a view to distracting from pain; 
another received training and relaxation in images to focus on pain and a third, 
control group, continued with normal treatment. Results were measured daily with 
a visual analogue scale (VAS) for four weeks and significant differences in pain 
perception between the three groups were found. The group receiving distraction 
training showed significant positive effects in pain reduction using the 
visualisation of pleasant images in comparison with the control group, whilst the 
group receiving training in pain control images did not display any difference. 
Menzies et al. (2006) also studied the effects of a 6-week intervention of guided 
imagery on pain level, functional status, and self-efficacy in people  wi th  FM 
(n = 48). Participants randomized to guided imagery plus usual care intervention 
group received a set of three recorded guided imagery scripts, and were instructed 
to use at least one tape dairy for 6 weeks and report weekly frequency of use 
(dosage). Results showed FIQ scores decreased over time in the guided imagery 
group compared to the usual care group (p = .03). Ratings of self-efficacy for 
managing pain (p = .03) and other symptoms of FM also increased significantly 
over time (p = .01) in the guided imagery group compared to the usual care group. 
However, participants’ reports of pain did not change.  
Verkaik et al. (2014) also studied the effects of guided imagery on pain, 
functional ability and auto-efficacy on 65 people with FM in a randomised study 
with a control group over four weeks. The intervention consisted of two group 
sessions; one with initial information and the other at the end and a 4-week period 
between the two during which participants used a CD with relaxation techniques, 
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music, positive images and instructions for pain management. The results showed 
guided imagery had no effects on perceived pain intensity, self-efficacy or 
functional status.  
Onieva-Zafra, García & Del Valle (2015) carried out a study to assess the effects 
of guided imagery on pain and depression in a group of 60 patients with FM. The 
patients were randomly assigned a guided imagery group (n = 30) or a control 
grupo (n = 30). The effects were examined at baseline, post intervention 
(4th week), and at the end of the study (8th week). The treatment group reported 
statistically significantly lower levels of pain (p = .046), using the long-form 
McGill Pain Questionnaire (LF-MPQ), and a reduction in depression (p = .010) 
than the control group at the week 4 evaluation. A statistically significant effect of 
pain as measure by the daily VAS diary was also found in the experimental group. 
At week 8, no significant differences were found for pain.  
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2.3.6. SUMMARY 
Apart from prescribing drugs, different approaches to treating FM have been taken, 
ranging from exercise and education to psychological therapy and guidance. 
Currently an interdisciplinary approach using a combination of interventions is 
recommended.  
Psychological interventions have been shown to have positive effects on the main 
symptoms of FM (including pain, fatigue, mood, and physical function). The most 
recommended therapies today are cognitive-behavioural, since they have 
extensively shown their effectiveness in the short and medium term, especially 
those combining some kind of educational component with cognitive strategies to 
cope with stress and behavioural strategies, with relaxation being especially 
relevant. Other therapeutic approaches, including working on the subjective 
meaning of the symptoms in a group setting, have also been shown to be effective, 
even though they do not appear with such prominence in the literature. 
Very few articles in the literature refer to treatment using music therapy and yet 
several recent studies show the effect of that listening to music (either on its own or 
in combination with relaxation and/or guided imagery techniques) on improving 
FM and quality of life in both nursing and hospital settings. More controlled studies 
proving the effectiveness of music therapy are necessary if a true comparison of the 
usefulness of this treatment is to be made. 
2.4.  THE BONNY METHOD OF GUIDED IMAGERY AND MUSIC 
(GIM)  
This section provides an introduction to the different components of the original, 
individual GIM method and also describes the specific characteristics of this 
method once adapted to group use (GrpMI). Following this, there is a section on the 
qualitative and quantitative studies found in the literature relating to this research. 
No quantitative studies have been found in which the GIM or GrpMI method has 
been applied specifically to fibromyalgia patients, but both quantitative and 
qualitative studies are quoted that analyse changes in characteristic FM symptoms 
(such as mood, quality of life or pain) of other medical populations after using this 
method. 
2.4.1. DEFINITION  
The Bonny Method of Guided Imagery and Music (GIM) is a music-assisted 
integrative therapy form, which facilitates explorations of consciousness that can 
lead to transformation and the method has evolved through the research and 
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practice of Helen L. Bonny. In 1990 the Association for Music and Imagery (AMI) 
defined the GIM method as: 
“A centred, transformational therapy, which uses specifically 
programmed classical music to stimulate and support a dynamic 
unfolding of experiences in service of physical, psychological and 
spiritual wholeness (Association for Music and Imagery, 1990, p. 4). 
Bruscia (2002, p. 46) defined this therapy model in its original format as an: 
individual therapy based on the exploration of consciousness through the 
spontaneous creation of images in an expanded state of consciousness, whilst 
listening to a pre-designed selection of western classical music and interacting with 
a specialist facilitator who intervenes not to guide nor to analyse, within a client-
centred, music-supported approach and with the session structured into: an initial 
conversation, relaxation-induction, experience with images, return to a conscious 
state and postlude conversation.  
GIM therapy is recognised as a therapy that can have effects on the person as a 
whole, since it encourages clients to experience and freely express their bodily 
sensations, perceptions, emotions and thoughts by taking ownership and 
responsibility of their own story (Short, 2002). Short proposes that images 
emerging in GIM sessions can be taken as a recording of the range of physical, 
emotional, psychological and/or spiritual responses that a person experiences as a 
reaction to an event. This experience with images and their comprehension during 
verbal processing may: provide information about the person’s physical or 
emotional state, help transform internal perceptions and, as a result, cognitive 
explanations about the client and his/her illness (Short, 1991, 2002, 2003; Schou, 
2008). 
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Figure 8. Schematic diagram of the imagery generated by a physical illness. 
Source: Short, A. (2002). Guided Imagery and Music (GIM) in medical care. Guided 
Imagery and Music: The Bonny method and beyond, 151-170 (p.157). 
2.4.2. COMPONENTS OF THE GIM METHOD  
GIM cannot be carried out in individual segments: it can only be applied when all 
segments are connected in a unified process. Additionally, clients relate differently 
to different phases of the session, articulating the uniqueness in which each person 
perceives and comprehends their life and biographical context (Abbott, 2005).  
Induction and relaxation 
Depending upon the client’s needs, different forms of relaxation are used, although 
the most widely used is autogenic relaxation (Schultz & Luthe, 1959) and 
Jacobson’s progressive muscle relaxation (Jacobson, 1938). In previous sections of 
this thesis, several studies supporting the use of relaxation on its own or in 
combination with guided imagery have been mentioned. However the GIM method 
uses relaxation in preparation for music-listening and image creation.  
“In contrast, in GIM, the traveller undergoes a relaxation induction such 
as the ball of light before the music begins, in order to facilitate free 
imaging to the music. At this point, the image and music help the client 
to move beyond the relaxed feeling to a fuller exploration of more 
expanded states of consciousness, as they shift in depth and breadth 
from moment to moment” (Bruscia, 2002, p. 49). 
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Music 
Bonny (2002) and other GIM therapists have indicated that music has the potential 
to wake up, structure and transform different aspects of experiences 
instantaneously. Thus, music can 1) wake up something of the person's experience 
that perhaps needed to be awakened and expressed; 2) structure that person’s 
experiences, so that they can feel like being understood as well as accompanied by 
the music; 3) contain the experience and thanks to its structure, offer a figurative 
place in which the person feels safe whilst exploring his/her sentiments; 4) 
transform the person’s experiences enabling them to be felt like alternative 
experiences; 5) integrate these change experiences through all sensory channels and 
6) help containing pain and painful memories (Bonny, 2002; Abbott, 2005).
The music, which is chosen from a series of pieces that GIM therapists normally 
use (Bruscia & Grocke, 2002) to facilitate a broad range of emotional expression is 
not pre-determined and the choice of music may vary to adapt to the client’s energy 
(ISO principle) (Short, 1992; Wärja & Bonde, 2014), focus of intention and depth 
of music therapy work (Summer, 2002). Bonny & Savary (1994) stated: 
“Each composition is chosen with the following in mind: 1) to encourage 
visual images, 2) to raise emotional and feeling states, 3) to suggest early 
memories, 4) to create positive feedback, 5) to effect physical relaxation, 
and 6) to support spiritual experience” (translated by the author).  
Some authors (Bonny & Savary, 1994) have followed Hevner’s model (1937) to try 
to classify the music used and in this way cater for emotional expressions and 
musical criteria such as structure, predictability, complexity and dynamics. Summer 
(2002) proposed that the pieces of music used in group GIM work be classified as 
supportive, re-educative and reconstructive. Wärja & Bonde (2014) used clinical 
experience with individual patients, work with GrpMI and more specifically work 
on the Brief Music Journey (Wärja, Bergmark, & Bonde, 2012) to redefine these 
categories into 1) supportive music, 2) supportive and challenging music and 3) 
challenging music, with three subcategories in each one of them correlating the 
level of musical intensity and complexity, the music’s duration and its effect on 
emotions. 
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These relations are illustrated by Moe (2011) in Figure 8 below.  
Figure 9. Relationship between psychological stimuli and music parameters. 
Source: Moe, T. (2011). Group Guided Imagery and Music Therapy for inpatients with 
substance abuse disorder. Journal of the Association for Music & Imagery, 13 (p.84). 
Grocke (1999) in a study looking into music characteristics in key GIM moments 
noted the following: 
“The music was written in a structured form. The rhythmic features 
remained constant, and there was repetition of rhythmic motifs. The tonal 
structure was diatonic and constant and harmonic progressions were 
predictable. The melodic line was an important feature, although the 
shape of melodies differed. The main instrumental timbre differed: 
strings, woodwind, brass, human voices all played major roles but in 
different selections. There was dialogue between the instrumental parts, 
and the mood of the music was predominantly calm, with one selection 
very energetic and loud” (Grocke, 1999; 2010). 
She also describes evidence of the music influencing client imagery, as well as 
other situations in which the images seem to have a life of their own and are not at 
all influenced by the characteristics of the music.  
The choice of music may be perceived during the session as: supportive - and the 
client may receive it with joy, feeling at one with it or surrounded by it; challenging 
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- and the client may feel threatened, overwhelmed wanting to flee or succumb to it; 
as a source of vibrant energy – triggering physical sensations and responses; or as 
something that provides structure and meaning to internal chaos (Isenberg- Grzeda, 
1999; in Maack, 2012). 
Images 
Images emerge spontaneously when relaxing and listening to music and the flow of 
the music is what encourages their production. Clients are invited to freely use their 
imagination, explore any experience or image that comes to mind whilst listening to 
the music and interact with it. A client may experience a range of experiences. 
Grocke (1999, 2005) suggested a comprehensive categorization system with 15 
categories of imagery experiences: 1) visual experiences, 2) memories, 3) emotions 
and feelings, 4) body sensations, 5) body movements, 6) somatic imagery, 7) 
altered auditory experiences, 8) associations with the music and transference to the 
music, 9) abstract imagery, 10) spiritual experiences, 11) transpersonal experiences, 
12) archetypal figures, 13) dialogue, 14) aspects of the Shadow or Anima or
Animus, and 15) symbolic shapes and images. However Chou & Lin (2006) 
classified the images appearing during a study carried out with people suffering 
from depression into five categories: 1) natural environments; 2) surreal 
environments; 3) memories of past experiences; 4) experience of physical 
relaxation and 5) experiences of simply enjoying and interacting with the music. 
Images may vary as music and therapeutic process progress - on some occasions 
appearing to be superficial and on others the client getting deeply involved in them. 
Bonde (2007) also described different categories of images over the course of 28 
individual GIM sessions with people who had overcome cancer and compared them 
with those put forward by Moe (2002) in his study with psychiatric patients 
receiving group therapy. He concluded that there are similarities in the ability to: 
improve self-knowledge, foster hope and facilitate symbolic and metaphorical 
expression of aspects of one’s own life. 
This makes it important to consider the process of image-creation and the personal 
significance given to these images, valuing their metaphorical meaning through 
comprehensive verbal expression work and, with the assistance of the therapist, 
using the images as a synthesis of what is known and unknown to the client (Bonde, 
2000). 
The verbal process 
The phase before the musical experience (investigative discussion) and the 
reflection phase afterwards (cumulative discussion) are both significant and 
maximise the impact of the GIM method (Abbott, 2005), and hence  
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“Investigative Discussion accesses information such as comments about 
previous sessions (as applicable), about experiences of imagery, 
relaxation and music; current and past health status; and current feelings 
and awarenesses. Cumulative Discussion focuses on the preceding 
imagery and music experience, and on any links or insights of which the 
participant may have become aware. It also accesses further information 
about the meanings and associations for the participant, including 
cultural information” (Short, Gibb & Holmes, 2011, p. 7). 
Figure 10. Phases of a GIM session. 
Source: Short, A., Gibb, H., & Holmes, C. (2011). Integrating words, images, and text in 
BMGIM: Finding connections through semiotic intertextuality. Nordic Journal of Music 
Therapy, 20(1), 3-21 (p. 7). 
Several researchers have referred to the importance of the verbal process in 
developing, understanding and integrating the (often symbolic or metaphoric) 
imagery experiences of GIM sessions and also facilitating an understanding of what 
the person has experienced. (Bonde, 2000; Perilli, 2002; Zanders, 2008) highlight 
the relevance of both client and therapist using metaphors in GIM, because 
metaphors assist in: describing an experience, feeling more comfortable and safe 
during this experience, encouraging emotional involvement, increasing self-
understanding and inspiring transformation.  
The presence of the therapist 
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The therapist is a fundamental part of the setting, structuring it and making it safe 
for the client. Through the therapist`s way of being present, clients are able to find a 
focus, a screen for projection, an instrument that resonates their tone of voice and a 
music-adjusted way of speaking. The GIM therapist functions as a facilitator 
providing presence, structure and support in creating images (Moe, 2002), and is 
someone seeking emotional tuning with the client through music (Summer, 2009; 
Geiger, 2007). The therapist: 1) facilitates that the client is opening up to new 
experiences; 2) helps him/her face up to issues and helps assimilate the images, 
feelings, symbols and/or associations that may emerge; 3) (thanks to their physical 
proximity and quiet, concentrated demeanour) keeps the client in contact with 
reality; 4) helps the client conclude the music and image experience and 5) reviews 
and incorporates what has been relevant in the experience together with the client 
(Bonny, 2002; Grocke, 2005).  
2.4.3. GROUP MUSIC AND IMAGERY (GRPMI) 
Bruscia (2002) describes the characteristics of Group Music and Imagery (GrpMI) 
as a way of working with individuals in a group format in which each member 
spontaneously creates images whilst remaining in a relaxed state of consciousness 
and listening to one or more pieces of music without any permanent direction or 
dialogue with a guide.  
A GrpMI session is comprised of: initial conversation, relaxation-induction, 
experience with images, return to a conscious state and postlude conversation 
(Bruscia, 2002). Some adaptations have been described such as when 1) 
participants remain seated with their eyes open; 2) the relaxation exercise is shorter 
and more superficial so as not to break down all defences; 3) high level of 
specificity of image and goal; 4) short duration of music and 5) emphasis on safety, 
validation and reinforcement of efforts to create solutions during the prelude (Blake 
& Bishop, 1994). 
This adaptation of individual work into group work has been given different titles 
ranging from Group GIM, used by Summer (1988, 2009) to describing a 1981 
adaptation for treating patients in a psychiatric hospital; Music and Imagery used by 
Short (1992) in a course of treatment adapted for use with a group of elderly 
people; Modified GIM therapy for groups used by Goldberg (1994) for her 
experience with hospitalised psychotic patients and Group GIM Therapy used by 
Blake & Bishop (1994) for their treatment of clients suffering PTSD; whilst music 
reinforced relaxation and insight –oriented music and imagery was the expression 
used by Justice (1994) when referring to his group work with people suffering from 
eating disorders. Grocke & Wigram (2007; 2008) quote work by Marr (2001) with a 
church community Borczon (1997) with clients being treated for drug addiction, 
and Weiss (1994) with adolescents as examples.  
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Some authors refer to the types of musical pieces and/or programmes recommended 
for use during a group context (Summer, 2002; Wärja & Bonde, 2014). For 
Goldberg (1994) in group sessions, the music should offer greater support and 
stability than in individual sessions, thus allowing a brief experience of images 
without the revealing dynamic that is characteristic of standard GIM sessions.  
2.4.3.1 Advantages of group therapy 
Group adapted GIM treatment has some advantages since it reduces the intensity of 
the therapist´s attention, assists with better tolerance toward this kind of therapy and 
increases therapeutic improvements by connecting clients with other people 
experiencing similar problems (Short, 2002). Group work allows a) the individual 
aims of clients identified at the beginning of each session to be broached; b) a 
person’s own images to be processed and integrated and to establish connections 
with those of other members of the group; c) the facilitation of supportive 
relationships between the clients and d) encouragement of clients to take 
responsibility for themselves (Goldberg, 1994; Summer, 2002). 
In line with work by Yalom (Vinogradov & Yalom, 1996; Yalom, 2000), Summer 
(2002) suggests focus on different growth phases of a group. She points out that 1) 
initially clients need to develop feelings of trust (both towards the therapist and 
other group members) if they are to fully participate in the therapeutic process. As 
the group’s trust and cohesion increases 2) participants see themselves not only as 
individuals but as members of a group unit, and at this stage of group GIM therapy, 
it is a good idea to encourage and stimulate positive and immediate interpersonal 
interaction centred on the here and now. These interventions help group members to 
put aside their individual concerns and to discover a positive common denominator. 
Through focus and greater complexity of the kind of music used, the group will 
progressively work on more conflictive or threatening latent situations. As the 
group comes together self-understanding may arise since its members do not feel 
threatened by differences, they may learn from each other. At this stage of group 
GIM work, the focus could 3) concentrate on the psychological conflicts of one or 
several group members as emerging in the groups. At this time, the aim is to assist 
clients to look into how their internal conflicts have been represented through 
images and how these conflicts influence interpersonal relations (both within and 
outside the group).  
In 2012 De Felipe García-Bardón suggested that: 
“In a group, interaction and greater possibilities of expression assist 
conflict elaboration and group peers become therapeutic agents. Facing 
up to images, fantasies, feelings, relationships and experiences leads to 
changes in group members’ interiors” (De Felipe García-Bardón, 2012) 
(translated by the author). 
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Another way in which the group transforms into a therapeutic agent for each of its 
members is through the emotional responses offered to the images visualised by 
other members (Summer, 2002). In some group GIM treatments, such as that 
proposed by Körlin (2007), treatment is accompanied by psycho-educational 
elements to make the experience more manageable, comprehensible and significant 
for patients. Goldberg (1994) emphasized the role played by the therapist’s ability 
to provide a well-defined verbal structure to the images, so that they do not become 
threatening or overwhelming, supervising the verbal phase subsequent to the 
images so that each participant is encouraged to tell the group of their images, 
enabling each member to make connections between the images and their own life 
or current targets. In the study of Moe, Roesen & Raben (2000), participants (who 
were psychiatric patients participating in group-adapted GIM therapy) were asked 
which aspects of the therapy they found most beneficial and they highlighted the 
positive relevance of the relationship with the therapist, the feeling of personal 
responsibility and belonging to a group.  
The group may feel protected thanks to the structure, work, protection, support and 
care of the therapist. This helps group members to recognise and explore images 
that are often difficult to put into words and obtain a complete explanation of their 
story that can have an effect on improved self-image and self-confidence (Körlin, 
2005, 2007). To be offered a space to relax, concentrate, create, remember, feel and 
relate to other people fills their lives with hope, connection and meaning (Blake & 
Bishop, 1994). 
Skaggs (1997) (cited in Murphy, 2008) found that group GIM in the treatment of 
those with chemical addictions in a residential treatment programme was beneficial 
for: 1) viewing life from different perspectives, 2) accessing and building a trust in 
the inner helper; 3) taking moral and personal inventory of self in its deepest nature; 
4) resolving internal conflicts; 5) healing old hurts, 6) providing an on-going
support system independent of external sources, 7) bringing together fragmented 
pieces of life, 8) serving as a model of healthy responses and 9) changing moods. 
Similar characteristics were underlined by Murphy (2008) when emphasising the 
effects of GrpMI treatment on the psychological health of adult substance abusers, 
thanks to the fact that it offered participants the opportunity of practising new forms 
of interacting with themselves and others. This included learning to: 1) recognise 
and share feelings with others, 2) relax the body, 3) calm and concentrate the mind 
4) use internal reflection to explore personal questions related to the first three
steps, and 5) integrate new knowledge and understanding in the recovery process. 
2.5.  STUDIES USING GIM AND GRPMI 
Since there are no specific studies looking into the use of GIM or GrpMI 
methodology with FM, this section will describe some quantitative and qualitative 
research in which diseases similar to FM have been treated using the GIM or 
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GrpMI methodology that include some of the variables used in this study. Data 
from quantitative and qualitative studies show the GIM method to be effective in 
treating the emotional distress related to pain (Short, 2002) and chronic illness, 
demonstrating positive changes in mood, depression, anger, fatigue and confusion 
(Burns, 2002). 
2.5.1. QUANTITATIVE STUDIES 
Jacobi & Eisenberg (2002), in their study examining 27 patients with rheumatoid 
arthritis showed the effectiveness of the GIM method in reducing pain and 
depression after 10 individual sessions. In their work, together with other forms of 
measurement, they used the SCL-90-R psychometric scale to measure 
psychological distress and the McGill Pain Questionnaire (MPQ) to measure 
psychological reduction of pain. Results showed significant reduction in both. 
Music brought back negative images of self-esteem, relations, hurtful memories and 
catharsis. The researchers mention how important it is to activate the subconscious 
so that repressed feelings can be articulated and the energy implicit in emotional 
and psychosomatic symptoms released. They also refer to the importance of 
working on self-control and self-efficacy perceptions, because both influence 
patient belief in managing available internal resources, levels of activity/apathy and 
motivation and seek to improve patients’ cognitive coping skills, emotional coping 
and behavioural change. 
McKinney, Antoni, Kumar, Tims & McCabe (1997) noted that GIM had a positive 
influence on mood, reduced cortisol levels in healthy adults, and could have 
consequences for the health of people with chronic stress. They studied the effects 
of GIM on 28 healthy adults, who received six individual GIM sessions with pre 
and post treatment measurements, subsequent follow-up and a wait list control 
group. Results were measured using the Profile of Mood States (POMS) and an 
analysis of 15 cc of blood. A significant reduction in depression, fatigue and mood 
disorders was observed in post-treatment results as well as a significant reduction in 
the level of cortisol in the blood at follow-up. In a previous study McKinney, 
Antoni, Kumar & Kumar (1995) had also shown the effects on the depressed mood 
of a group of 8 healthy subjects after six individual GIM sessions.  
Burns (2002) researched the effects of GIM on the quality of life of cancer patients. 
In her work, Burns used a pretest posttest experimental design and follow up (at 6 
weeks) with an experimental group of four individuals receiving 10 individual GIM 
sessions and a wait list control group. The results demonstrated differences between 
the two groups and improvements in the state of mind of the experimental group. 
Moreover positive results were maintained 6 weeks later with an additional positive 
change to depression and anger measurements. Those in the experimental group 
spoke of better quality of life including factors such as physical wellbeing, 
psychosocial adaptation and spiritual wellbeing. The rating scales used were POMS 
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and Quality of Life - Cancer Scales (QOL-CA). Burns indicated that the clients 
involved, reported that they used the initial part of the session to rest and obtain 
energy from the music and images so that subsequently there would be more 
movement of images and an increase in energy at the end of the sessions. The 
second part of the session and programme was spent on expressing emotions related 
to their illness and on giving meaning to their experience. 
Bonde (2005) highlighted the quantitative (although not statistically significant) 
changes to anxiety, depression, quality of life and general attitude to life when 
pretest, posttest and follow up results were compared after applying 10 individual 
GIM sessions for 6 cancer survivors. He also suggested that 10 sessions may be 
sufficient to improve the mood and quality of life of these patients, indicating that 
this effect could be the result of the reconfiguration of metaphors and narratives in 
the therapeutic process.  
In the preliminary results of a study with psychiatric patients which used the Global 
Assessment of Function Scale (GAF), Bonde (2010) highlights that social anxiety 
was reduced in all participants and that imagery stimulated by classical music, 
including challenging features, was effective in boosting the health and quality of 
life of these patients. 
Beck (2012) examined the effects of 6 GIM sessions on adults on long-term sick 
leave for stress. The study included a control group and follow-up. She showed 
significant effects of GIM treatment compared to standard care on the 
psychological variables of mood, anxiety, sleep quality, and wellbeing and other 
physiological symptoms. A conclusion that can be drawn from convergence of 
qualitative and quantitative results is that GIM decreases bodily stress symptoms, 
increases energy and wellbeing, enhances coping with inner and outer conflicts, 
helps to overcome traumatic work experiences, provides new relational 
competencies, improves mood and gives access to hope for future work life. 
2.5.2. QUALITATIVE STUDIES  
In the study of Jackson (2011) a woman who was suffering pain as a result of 
unsuccessful back surgery, GIM played a role in helping her understand the 
meaning of an experience of chronic pain, changing her perception of pain so that 
she gradually stopped taking medication and even (by the end of the study) was just 
taking an antidepressant. The client made the link between the perception of 
physical pain and the emotional pain of the events and situations of her past, 
describing feelings of powerlessness, shame and punishment and understanding the 
influence of unresolved problems from the past on her current life.  
Worth mentioning is a one-patient study carried out by Grocke (2003) detailing the 
transformation of a 43 year old woman with rheumatoid arthritis after long term 
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treatment with GIM. Thanks to the treatment patient was able to relive painful 
events in her emotional life, find a link between the symbolism of her images and 
the manifestations of her disease and generate images in connection with her body 
and symptoms.  
In research by Bjellånes (1998) physical responses to pain perception and emotional 
responses to music were studied when relaxation techniques were taught to 12 
women with FM. The women received this treatment over 39 weeks divided into 
four periods. For 17 weeks they were trained in autogenic relaxation techniques. 
This was followed by 9 weeks of a combination of relaxation training and music. 
Afterwards, there was a 7-week intervention using the GIM methodology and 
finally, 6 weeks during which participants used these relaxation techniques with and 
without music in their daily lives but without the help of a therapist.  
Merrit (1993) describes remission of ankylosing spondylitis (a progressive, 
paralysing disease) in a 44 year-old male. A reduction in chronic pain and stiffness 
was achieved with a GIM intervention of just 2 sessions that led to the release of 
repressed thoughts and the emotions underlying them together with the appearance 
of powerful archetypical figures during the sessions. 
Logan (1998) and Burns (1999) have also described how GIM can reduce feelings 
of pain and improve mood in cancer patients (cited in Burns, 2002). 
2.5.3. SUMMARY 
GIM (and its group adaptation, GrpMI) is a method that in every session brings 
together several components influencing multiple dimensions of a person, 
including: training in relaxation techniques, cognitive and emotional stimulation 
through music, linking to and understanding the symbolic significance of image 
production and development of social inter-relational skills. All of this supported 
and influenced by the prominence of perception, meaning and relevance that each 
individual finds.  
A review of the literature on quantitative and qualitative studies of people with 
chronic pain problems, musculo-skeletal diseases or cancer confirms the usefulness 
of this method and shows that GIM treatment can offer important positive changes 
in patient mood and quality of life as well as in other aspects such as anxiety, 
depression, anger or fatigue. However, there are no references in the literature to the 
application of the GIM or GrpMI method with FM patients.  
Further research needs to be done on the usefulness of this therapy method with 
randomised control trials and larger samples and/or studies that show the 
differential efficacy of the different component parts of this method.  
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CHAPTER 3. OBJECTIVES AND 
HYPOTHESES 
Set out below is the general objective, followed by the specific objectives of this 
study and the hypotheses formulated from them. 
3.1.  OBJECTIVES 
The principal objective of this study is to evaluate the effectiveness of GrpMI 
treatment on women with fibromyalgia (FM). The more specific study objectives 
are the following: 
1. To examine the demographic and clinical profile of the sample of women
suffering from FM who took part in this research and the extent to which
their symptoms are comorbid with other illnesses.
2. To analyse the association between the different study variables.
3. To assess the effectiveness of GrpMI on the one hand, by comparing
subjects receiving treatment with a control group of similar characteristics
who do not receive treatment (intergroup analysis), and on the other hand,
by taking into consideration the development of participant according to
each of the study variables (intragroup analysis).
4. To check whether therapeutic results remain three months after the end of
treatment.
3.2. HYPOTHESES 
Based on the literature review presented in the previous chapter, the general 
hypothesis of this study is that GrpMI will significantly improve participant’s 
subjective perception of their psychological wellbeing, whereas impact of FM on 
functional capacity and health, pain perception, anxiety and depression will 
decrease significantly, as well as their experience, expression and control of anger.  
9 hypotheses are formulated in relation to the specific objectives. One refers to the 
first objective (hypothesis 1) another to the second objective (hypothesis 2), 6 to the 
third objective (hypotheses 3-8) and a final hypothesis relates to the fourth objective 
(hypothesis 9). 
Hypothesis 1: The women in the sample will show higher levels of impact of FM 
on functional capacity and health, pain, anxiety, depressive symptoms, and anger 
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than the general population, whereas the subjective psychological wellbeing of the 
sample will be lower than amongst women who do not suffer FM. 
Hypothesis 2: A significant positive correlation will be found between the impact 
of FM on functional capacity and health, pain perception and the different 
indicators of psychological distress evaluated (anxiety, depression and anger), 
whereas the relationship between all these variables and the indicators of subjective 
psychological wellbeing will be negative.  
Hypothesis 3: GrpMI will significantly increase the subjective psychological 
wellbeing of the women receiving treatment.  
Hypothesis 4: After treatment, there will be a significant reduction of the impact 
FM has on functional capacity and health of the women receiving treatment. 
Hypothesis 5: As a result of treatment, women taking part in the study will 
experience a significant decrease in pain perception as expressed in current pain 
intensity. 
Hypothesis 6: After treatment, state and trait anxiety will be significantly reduced 
in the group receiving treatment.  
Hypothesis 7: After treatment, the affective component of state and trait depression 
will be significantly reduced in those women receiving treatment.  
Hypothesis 8: After treatment, women will see a significant decrease in their 
experience, expression and control of anger. 
Hypothesis 9: The effects of GrpMI therapy on people with FM will remain three 
months after the end of treatment. 
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CHAPTER 4. METHOD 
This chapter describes the method used in this study to assess the effectiveness of 
GrpMI treatment in women with FM. The research design used in the study 
consisted of pretest-posttest and follow-up measurement with treatment and control 
groups, comprising a sample of 70 women with FM. 
The first section explains the design and procedure used in the research study. The 
second section describes the participants and sample selection. The third section 
describes the tools used for measurement and the fourth section describes the 
application, aims and structure of the treatment. The fifth section presents the data 
analysis process used explaining the characteristics of the process. Finally, there is a 
reference to how ethical aspects are dealt with. 
4.1. STUDY DESIGN  
The research design used in the study consisted of repeated pretest-posttest and 3-
month follow-up measurements of treatment and control groups (see  
Figure 11). 
Figure 11. Design and procedure used in the research study. 
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Six measurement tools were used during the pretest procedure to measure the 
dependent variables that, according to the hypotheses, would benefit from the 
treatment. Also an ad hoc questionnaire was designed to determine a number of 
different demographic variables on FM comorbidity and medication. The researcher 
applied all measurement tools.  
During 2012 and 2013, participants subsequently received continued and systematic 
group treatment in 12 sessions of GrpMI, as shown in Figure 12. The researcher, 
who is a GIM therapist with the necessary credentials to use this therapy method, 
also performed the treatment. The therapeutic treatment was performed once a week 
with 8 subjects in each group. The sessions took place at the premises of the 
associations (Pamplona, Bilbao and Valladolid). 
Figure 12. Participating associations and dates of GrpMI treatment (2012-2013). 
Notes: AFINA: Asociación de Fibromialgia de Navarra; AVAFAS: Asociación Vasca de 
Fibromialgia y Fatiga Crónica; AFICRO: Asociación de enfermos de Fibromialgia y Fatiga 
Crónica de Valladolid y provincia.  
4.2. PARTICIPANTS 
The study sample consisted of 70 women aged between 35 and 65 diagnosed with 
FM. Participants in the study were recruited from three Spanish FM associations: 
the Fibromyalgia Association of Navarra (AFINA), the Basque Association of 
Fibromyalgia and Chronic Fatigue (AVAFAS) and the Association of Fibromyalgia 
and Chronic Fatigue Patients of Valladolid and Province (AFICRO-VALL). 
In order to estimate a sample size, a power analysis was performed with the 
statistical package G*Power 3.1.3. An a priori analysis was carried out (using 
ANCOVA with one covariate and two groups), in which alpha level was set to 0.05. 
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If a medium effect were assumed (f = 0.25), the total sample size to achieve the 
recommended minimum power of 0.80 (Cohen, 1988) would be 128, whereas if a 
large effect was assumed (f = 0.40) 52 participants would be sufficient to achieve 
the same power. 
Of the 70 women participants, 40 were allocated to the experiment group and 30 to 
the control group. 
4.2.1. INCLUSION AND EXCLUSION CRITERIA 
To be included in the sample, the subjects were required: a) to be women aged 
between 35 and 65, with a diagnosis of FM from a consultant using ACR criteria 
(1990); b) to volunteer to participate in the study, filling out the Informed Consent 
Form and c) not to have been diagnosed with serious dementia, schizophrenia, 
paranoia, major depression or mental disability (according to DSM IV criteria in 
effect at the time of the study). 
4.2.2. SAMPLE SELECTION PROCEDURE 
The following procedure was used to create the sample:  
1. Contact was made with several FM associations.
2. The secretary (or equivalent in the association) prepared a list of possible
candidates, based on the established criteria. These people were entirely
unknown to the researcher.
3. An information sheet was sent to each person on this list (see Appendix A)
with the objectives and conditions of the study. Those expressing their
curiosity, interest or motivation, could confirm their wish to participate by
contacting the secretary. The secretary listed their names, ages and
telephone numbers and sent the final list to the researcher. The researcher
contacted each of them by phone to arrange a group appointment for an
information session.
4. In the information session the candidates were informed of the study
procedure and objectives and the proposed treatment model. Candidates
wishing to commit to the trial signed a Participant Consent Form (see
Appendix B).
5. The candidates were then given a new appointment to perform the pretest
measurement and complete the questionnaire on demographic data, co-
morbidity and medication.
6. Once the pretest measurement tools had been completed, the women were
randomly assigned to one of the two groups (control/experiment). Simple
randomisation was carried out for this purpose, using the SPSS21 statistics
packet for Windows. Each subject was randomly allocated a number from
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0 to 70. This procedure was conducted separately for each participating 
FM association.  
7. Finally, participants were told by telephone of the two groups to which 
they had been assigned. A date and time for the first session was agreed 
with the members of the experimental group. Members of the control 
group were asked to attend a future posttest measurement session (to be 
held approximately 12 weeks after the treatment). 
4.2.3.  SAMPLE DESCRIPTION 
Of the 70 participants, 29 came from AFINA (Pamplona), 24 from AVAFAS 
(Bilbao) and the remaining 17 from AFICRO-Vall (Valladolid). As Table 6 shows, 
56 participants completed the pre-post test phase and 49 completed the entire 
process, including the 3-month follow-up phase. Of those who failed to complete 
the experiment, 10 were from the control group and 11 from the experimental 
group. 
Table 6. Participants from the sample in experimental and control groups broken 
down by membership of the different Spanish associations. 
Association/group Randomization (n = 70) 
Pre-post 
(n= 56) 
Follow-up 
(n = 49) 
Experimental 40 33 29 
     AFINA/1 8 8 7 
     AFINA/2 8 6 5 
     AVAFAS/3 8 6 4 
     AVAFAS/4 8 6 6 
     AFICRO/5 8 7 7 
Control 30 23 20 
     AFINA 13 11 11 
     AVAFAS 8 5 3 
     AFICRO 9 7 6 
F (1,38) = 0.075, p > .0.5 
Notes: AFINA: Asociación de Fibromialgia de Navarra; AVAFAS: Asociación Vasca de 
Fibromialgia y Fatiga Crónica; AFICRO: Asociación de enfermos de Fibromialgia y Fatiga 
Crónica de Valladolid y provincia  
It was decided to include all members of the experimental group in the analysis, 
even those who had not attended all sessions. The maximum number of sessions not 
attended by any participant was four. Seven women abandoned treatment, due to: a) 
scheduling problems; b) one women said she had already addressed the goals of this 
therapy in other previous sessions and c) one woman said the therapy caused 
adverse effects, making her feel more tired than before. The experimental group 
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was therefore reduced to 33 individuals in the posttest phase. With regard to the 
follow-up assessment; four women did not complete the assessment tools. 
From the control group, two individuals were excluded from the sample in the 
pretest phase because they had psychiatric disorders (schizophrenia combined with 
limited intellectual capacity and bipolar disorder, respectively). Five people did not 
complete the tools in the posttest assessment while three people did not complete 
them at the 3-month follow-up. The control group was therefore reduced to 20 
individuals (see Figure 13). 
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Figure 13. Flow chart of participation in the study. 
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4.3. MEASUREMENT 
Six measurement tools with suitable psychometric guarantees were used to measure 
the dependent variables. In addition, a further two tools were used, one to collect 
demographic data on the sample and another specific tool for the GrpMI treatment, 
the Individual Assessment Questionnaire, which was completed only by women 
taking part in the treatment. The aim of the questionnaire was to evaluate patients’ 
subjective perception of the treatment after completing it. 
The tools used for the experimental measurement are described below. 
4.3.1. QUESTIONNAIRE OF DEMOGRAPHIC DATA 
Demographic information on the participants was collected using a questionnaire 
designed specifically for this study. The questionnaire covered: 1) general 
information on age, marital status, children, education attained and employment 
status, 2) information on diagnosis, time since diagnosis and any associated 
diagnoses and 3) medication being taken (Appendix C). 
4.3.2. PSYCHOLOGICAL WELLBEING SCALE (PWS; SÁNCHEZ-
CÁNOVAS, 1998/2007) 
The PWS consists of 65 items intended to measure psychological wellbeing. The 
subject uses a scale from 1 to 5 to say to what extent s/he agrees with phrases such 
as “I am excited” o “I feel everything is going well for me”. The higher the score, 
the higher the subjective perception of wellbeing. The PWS contains subscales on 
subjective psychological wellbeing (30 items), material wellbeing (10 items), 
wellbeing at work (10 items) and wellbeing in relations with partner (15 items). 
This study only used the first of these subscales (subjective psychological wellbeing 
(30 items)), which addresses happiness, i.e. a positive mood. 
Internal consistency of the test is very high for subjective psychological wellbeing 
(Cronbach's alpha = .95). Criterion validity studies confirm similar correlations 
(r = .89) with the Oxford Happiness Inventory. 
4.3.3. FIBROMYALGIA IMPACT QUESTIONNAIRE (FIQ; BURCKHARDT, 
CLARK & BENNETT, 1991) 
The FIQ consists of 10 items. Its purpose is to measure the impact of FM on 
functional capacity and health, taking into consideration the physical and 
psychological variables most frequently affected. The first item, relating to the 
physical function, consists of 10 questions related to the subject’s capacity to 
perform everyday activities (such as “doing the shopping” or “climbing the stairs”). 
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 These were measured using a Likert-type scale from 0 (always) to 3 (never) during 
the week prior to the measurement. Item 2 measures general wellbeing. The subject 
was asked how many days she had felt well over the last week. Item 3 measure the 
impact on work and the degree to which the pain and symptoms (of FM) interfere in 
the performance of everyday work. Specifically, subjects were asked how many 
days they were unable to perform their usual work (including housework) because 
of FM. Items 4 to 10 used a Likert-type scale from 0 to 10 to measure the subjective 
perception of different FM-related symptoms (perception of pain, fatigue, tiredness 
in the morning, rigidity/stiffness, anxiety and depression). The FIQ has a score 
range of 0 to 100; the higher the score the higher the FM impact. The following cut-
off points are used: minor impact: FIQ - total ≤ 50; moderate impact: 50 < FIQ – total ≤ 70 
and severe impact: FIQ – total > 70 (Casanueva, 2007). 
Burckhardt et al. (1991) concluded that the original American version was 
adequately reliable and valid and could be used in both clinical practice and in FM 
research. This present research uses the updated harmonised Spanish adaptation, 
created with involvement of the research groups behind each of the four previous 
Spanish-language versions of the FIQ (Esteve-Vives, Rivera, Salvat, Gracia & 
Alegre, 2007). Although Esteve-Vives et al. (2007) cannot be considered a proper 
validation study, a criterion validity study of this Spanish adaptation of the FIQ 
showed a good correlation with semi-objective and subjective indices of FM 
severity – .57 and .76, respectively (p < .001). It is therefore considered that the 
proposed questionnaire may be of interest in measuring FM patients in Spain. 
4.3.4. MCGILL PAIN QUESTIONNAIRE (MPQ; MELZACK, 1975) 
The MPQ identifies sensory and sentimental components of pain and is used for 
measuring quantitative and qualitative pain-related aspects. The MPQ has been 
found to offer adequate psychometric guarantees (Melzack, 1975), and the 
preliminary analyses carried out with the Spanish adaptation indicate very similar 
reliability and validity results to the original (Lázaro, Bosch, Torrubia, & Baños, 
1994). 
We have used two scales from this tool. The first is the scale of Present Pain 
Intensity (PPI), where the measurement procedure uses a descriptive score on a 
scale with five possible response categories (“minor”, “moderate”, “strong”, “very 
strong”, and “unbearable”). The second is the Visual Analogue Scale (VAS) in 
which each participant is asked to score the intensity of the pain they are currently 
feeling on a Likert scale from 0 to 10 (where 0 indicates “no pain” and 10 the 
“worst pain imaginable”).  
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4.3.5. STATE-TRAIT ANXIETY INVENTORY (STAI; SPIELBERGER, 
GORSUCH & LUSHENE, 1970/1982) 
The STAI is a self-reported assessment consisting of 20 items related to state 
anxiety (a transitory emotional state, characterised by subjective feelings, 
consciously perceived, of tension and apprehension, and by hyperactivity of the 
autonomic nervous system), and another 20 related to trait anxiety (stable anxious 
predisposition to perceive situations as threatening). Subjects score how they feel 
right now (state scale), and how they generally feel most of the time (trait scale); 
the answers are scored on a Likert scale from 0 to 3. For each scale, the score 
ranges from 0 to 60. The higher the score, the higher the manifestation of the aspect 
in question (state anxiety or trait anxiety). Psychopathological scores are not 
proposed, although some authors have proposed a percentile of > 75 (De Felipe 
García-Bardón, 2012).  
The validation of the Spanish version, developed on the basis of work by Bermúdez 
(1978a, 1978b) suggests that the averages and reliability (Cronbach’s alpha and 
test-retest correlation) are similar to the original, which ranges from .82 to .92. The 
concurrent validity in the original studies (relating STAI with other measures of 
anxiety) ranges from .52 to .80 in the case of female university students. A recent 
study (Guillén-Riquelme & Buela-Casal, 2011) shows that the Spanish adaptation 
of the STAI retains adequate levels of psychometric properties. Moreover, it has 
proved sensitive to an increase in stress-provoking stimuli in the environment. 
4.3.6. STATE-TRAIT DEPRESSION QUESTIONNAIRE (ST/DEP; 
SPIELBERGER, BUELA-CASAL & AGUDELO, 2008) 
The ST/DEP is a questionnaire consisting of 20 questions on a Likert scales (1 to 
4). The aim of this is to identify the degree of impact (state) and frequency (trait) of 
the emotional component of depression. Each scale contains 5 items for assessing 
dysthymia or negative impact, and another 5 for measuring euthymia or positive 
impact (these items have an inverse score). In the state scale, subjects are asked to 
circle the option that is closest to how they feel at this time (answers indicate 
intensity: “not at all”, “somewhat”, “quite a bit” or “a lot”). For the trait scale, they 
are presented with the same statements, but asked to circle the option that comes 
closest to how they generally feel most of the time (in this case the answers reflect 
frequency: “hardly ever”, “sometimes”, “often” or “nearly always”). The scores 
range from 10 to 40 for each scale. The higher the score, the higher the level of 
state/trait depression. Scores above the 75th percentile indicate the existence of 
depression (Buela-Casal & Agudelo, 2008). 
In terms of psychometric guarantees, the internal consistency figures obtained by 
the authors with a sample of university students, adolescents, general populace and 
a clinical sample gave alpha coefficient values of between .83 and .87 for the state 
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scale and between .79 and .84 for the trait scale. Convergent validity was tested 
with the Basic Depression Questionnaire (Cuestionario Básico de Depresión or 
CBD, Peñate Castro, 2001), giving a correlation of .64 for state depression and .64 
for trait depression. 
4.3.7. STATE-TRAIT ANGER EXPRESSION INVENTORY (STAXI-2; 
SPIELBERGER, 1999/2006) 
The STAXI-2 is used to measure the experience, expression and control of anger. It 
can be used to obtain an anger expression inventory (AEI) showing the general 
frequency with which the subject expresses anger either internally or externally. It 
consists of 49 questions on Likert scales (from 0 to 3) divided into three separate 
sections: state anger, trait anger and expression-control. The state anger section 
contains three sub-scales (feeling, verbal expression and physical expression) and 
includes feelings or actions such as “I am furious”, “I feel like breaking things”, 
etc., reflecting how the subject feels at that moment. The trait anger section 
contains two sub-scales (temperament and reaction) and includes items such “I have 
an irritable character”, “I get angry very easily”, etc. Subjects have to answer how 
they normally feel. The third section, consisting of two sub-scales, expression and 
control, lists feelings subjects might have or actions they might do when they get 
angry. These 24 items are used to obtain four scales: internal expression, external 
expression, internal control and external control. The higher the score, the higher 
the degree of state anger, trait anger or anger expression. Individuals scoring above 
the 75th percentile are likely to experience and/or express angry feelings that 
interfere with optimal functioning (Spielberger, 1988, 1999). 
The authors of the Spanish adaptation report a test-retest correlation of .71 and a 
Cronbach’s alpha coefficient of .89 for the state anger scale, .82 for the trait anger 
scale, and .69 for the anger expression inventory. Validation studies have shown 
construct validity. Correlations between trait anger and the hostility index in the 
Buss-Durkee Inventory were .66 for female university students and .73 for female 
army recruits.
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4.3.8. INDIVIDUAL TREATMENT EVALUATION QUESTIONNAIRE 
The posttest phase used the same instruments as in the pretest phase. In addition, 
participants in the experimental group completed an ad hoc treatment evaluation 
questionnaire, based on other questionnaires used in GIM (Bruscia, 2000; 
Meadows, 2000; Moe et al., 2000) (Appendix D). The purpose of the questionnaire 
was to ascertain the opinions and subjective perceptions of change of participants in 
the experimental group, and how useful they felt the GrpMI treatment had been for 
them. 
It included questions about their perception of change in their self-perception with 
regard to: 1) the most frequent FM-related symptoms (pain, fatigue, sleep, 
concentration and mood), and 2) changes in everyday life (at work, in relations with 
their partners, children, in their social lives and in their perception of themselves or 
self-worth, and whether they felt that these changes were related to the GrpMI 
treatment. In these sections, subjects were asked for yes or no answers, and then 
they were given the option of making a short comment or of qualifying their 
answer. In other sections, the women were asked to give their opinions on 3) the 
usefulness of the treatment, 4) the different phases of the sessions and their 
relevance to the treatment process: significant images (their own or those of other 
participants) music and subjects, 5) group relations and 6) relations with the 
therapist. Finally, 7) they were asked for their suggestions and proposed changes, 
and 8) whether they would like to have the option of continuing with the treatment, 
as a further measure of their satisfaction with the treatment.  
4.4. INTERVENTION 
The treatment used in this experimental study consisted of 12 weekly sessions of 
GrpMI, each two hours in long. Each group consisted of 8 individuals. 
The sessions took place in a specially prepared room (with soundproofing, warmth, 
comfort and spaciousness). There were two separate areas in the room: one with 
chairs for the verbal sections of the session and another for the musical listening 
and image section with mattresses where the women could lie down. Subjects were 
offered a choice between sitting or lying down during the music-listening, 
depending on their individual movement restrictions and/or limitations due to pain. 
A CD player, sheets of A4 paper and crayons (for drawing the mandala) were also 
provided. 
GrpMI treatment requires and works with an open attitude for verbal participation 
and acceptance of the images that arise spontaneously during the musical listening, 
as well as subsequent recounting of the experience. The experience with imageries 
can include physical sensations, emotions, memories and/or thoughts. These may be 
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associated with the given theme of the session or with other matters. In the 
subsequent conversation, patients are encouraged to consider and interpret these 
images and relate them to their own everyday life. All members participate actively 
at all phases of the session.  
The structure of each of the sessions (see Figure 14) follows the sequence proposed 
by Grocke & Wigram (2007; 2008). This consists of: 
1. Dialogue between therapist and participants, during which each
participant remembers significant aspects of the previous session and
significant changes since then and suggests a theme to be addressed in the
session. After this verbal introduction, the therapist agrees on a common
theme to be shared by the group. The therapist also asks how each
participant is feeling in terms of pain, tension and/or emotional state/mood.
Taking these answers into consideration, the therapist selects music to
facilitate an experience with self-generating images.
2. Relaxation and induction, guided by the therapist. The relaxation is
adapted to the participants’ stated needs. Among other methods it may use
relaxation focusing on breathing or progressive muscle relaxation or colour
or light sensations enveloping the body. After this relaxation, participants
are invited to listen to music, while considering the theme of the session.
Participants are expected to allow images and/or sensations to emerge with
the help of the music, experiencing them fully without trying to change or
retain any of them.
3. Active listening to a selection of music adapted from programmes used in
individual GIM therapy (Bonde, 2010; Bruscia & Grocke, 2002). As
shown in Table 8 the duration of the musical selection ranged from 6.36
minutes to 18.30 minutes. In some selections, subjects listened to a single
piece and in others up to three separate pieces consecutively. As mentioned
above, in this form of treatment, there is no dialogue either with the
therapist or among participants during the musical listening. Nonetheless,
the therapist observes the participants and can provide help if required.
4. Creative drawing (mandala); after the musical listening has ended,
participants are invited to draw a creative picture graphically and
symbolically expressing what they consider to be most important or
significant about the session, using circles as references on a piece of blank
paper and crayons. Once the drawing is finished, individuals are asked to
give their mandala a title, consisting of a single word or short phrase.
5. Dialogue between participants and the therapist addressing their
experience with the music, the images and how they were expressed in the
drawing (mandala) and discussing the most significant aspects of this
experience. They also discuss how it relates to the goal of the session
and/or with each participant's everyday life. The therapist may intervene
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on occasions with guidance and summaries that will help internalise 
perceptions and strengthen positive internal skills and strengths.  
Figure 14. Structure of the GrpMI sessions and function of the therapist. 
Adapted from Wärja & Bonde (2014). Music as Co-Therapist: Towards a Taxonomy of 
Music in Therapeutic Music and Imagery Work. Music and Medicine, 6(2), 16-27. 
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Table 8. Table of musical selections used in GrpMI treatment. 
Session Pieces used in each of the five GrpMI treatment groups 
1º 
 (2) Beethoven: Piano Concerto nº 5 (adagio); (6:36)
 Secret Garden: Song from secret garden & Serenade to spring; (6:51)
 Kobialka: The water is wide; (6:09)
 Haydn: Cello concerto in C Major (adagio); (9.45)
2º 
 Kostia & Arkenstone: The cello`s song & Morricone: Gabriel’s Oboe;
(10:49)
 (3) Haydn: Cello concert in C (adagio); (9:45)
 Secret Garden: Sigma Chaconne, Song from secret garden & Serenade to
spring; (13:30)
3º  (3) Secret Garden: Sigma Chaconne, Song from secret garden & Serenadeto spring; (13:30)
 (2) Debussy: Dances sacred and profane; (10:30)
4º 
 Kobialka: The water is wide & Will mountain theme (11:49)
 (2) Elgar: Enigma Variations (8 and 9) & Schumann: Fünf Stücke; (10:22)
 Debussy: Prelude to the afternoon of a faun & Vaughan -Williams:
Fantasia on Greensleeves; (15:00)
 Dvorak: Serenade in E (larghetto); & Warlock: Capriol in suit, pieds en
l´air; (9:00)
5º 
 Strauss: Hero`s Journey & Dvorak Czech Suite, 4th movement; (13:48)
 Brahms: Violin concert (adagio) & Bach: Concerto for 2 violins and strings
(largo); (16:29)
 Bach: Prelude in B minor & Bach: Air on G; (10:01)
 Bach: Prelude in B minor, Bach: Chorale from the Easter Cantata & Bach:
Air in G; (arr. Stokowski); (14:33)
 Bach: Concerto for 2 violins and strings (largo); (7:38)
6º 
 Vaughan - Williams: The lark ascending; (15:05)
 Dvorak: Serenade in E (larghetto) & Warlock: Capriol in suit, pieds en
l´air; (9:00)
 (2) Vaughan - Williams: Rhosymedre, Prelude; Belioz: L´enfance du Christ
& Canteloube: Songs of the Auvergne; (18:31)
 Brahms: 4th symphony (andante moderato); (12:40)
7º 
 Kostia & Arkenstone: The cello`s song; (7:12)
 Debussy: Prelude to afternoon of faun & Vaughan – Williams: Fantasia on
Greensleeves; (15:00)
 Beethoven: Piano Concerto nº 5(adagio) & Vivaldi: Gloria et in terra pax;
(12:22)
 Mahler: 5th symphony, adagietto & Corelli: Concerto Grosso nº8 in g
minor (adagio); (14:10)
 Vaughan - Williams: Rhosymedre, Prelude; Belioz: L´enfance du Christ &
Canteloube: Songs of the Auvergne; (18:31)
(n): number of groups for which the music was used. 
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8º  Brahms: 4th symphony (andante moderato) ;(12:40)
 Lloyd Weber: Alice, Morricone: Childhood & Kobialka: Awakenings Bach
(11:26)
 Elgar: Serenade for strings (larghetto), Walton: Touch her soft lips &
Massenet: Sous les tilleuls (12:50)
 Brahms: Violin concert (adagio) & Bach: Concert for 2 violins and strings
(largo) (16:29)
 Chopin: Piano Concerto nº1 in E major, Romance (larghetto) & Mozart:
Vesperae solennes de confessore (laudate dominum) (14:26)
9º  Orff: Carmina Burana Excerpts; (10:00)
 Beethoven: 9th symphony (adagio molto); (16:03)
 Nusrat Fateh Ali Khan: III movement, Hope (The prayer cycle) & Zimmer:
New we are free (Gladiator); (10:52)
 Brahms: 4th symphony (andante moderato); (12:40)
 Bach: Prelude in Eb & Dvorak: Czech Suite, romance; (10:01)
10º 
 Brahms: Violin concert (adagio) & Bach: Concerto for 2 violins and strings
(largo); (16:29)
 Bach: Prelude in B minor, Bach: Chorale from the Easter Cantata & Bach:
Air in G; (arr. Stokowski); (14:33)
 Strauss: Hero`s Journey & Dvorak: Czech Suite, 4th movement; (13:48)
 Vivaldi: Trio in C (larghetto), Vivaldi: Guitar Concert in D & Boccherini:
Cello Concert nº 7 in G (adagio); (16:03)
 Mahler: Symphony 5, in C minor, Adagietto & Corelli: Adagio, Concerto
grosso; (14:18)
11º 
 Beethoven: 9th symphony (adagio molto); (16:02)
 Brahms: Violin concert (adagio) & Bach: Concerto for 2 violins and strings
(largo); (16:29)
 Brahms: 4th symphony (andante moderato); (12:40)
 Elgar: Enigma Variations 8 and 9; Barber: Adagio for Strings & Schumann:
Fünf Stücke; (18:01)
 Elgar: Dream children, nº 1 G; andante & Fauré: Pavana op. 50; (10:09)
12º  (3) Wagner: Lohengrin (prelude to Act I); (9:50) Elgar: Enigma Variations (8 and 9) & Schumann: Fünf Stücke; (10:28)
 Bach: Prelude in Eb & Dvorak: Czech Suite, romance; (10:01)
(n): number of groups for which the music was used. 
Treatment objectives  
The treatment uses the condition of listening to classical music in a state of 
relaxation to provoke images and feelings that enable subjects to experience 
wellbeing, self-knowledge and creativity. The aims of the sessions were: 1) to 
increase the subjects’ ability to relax, and increase their bodily awareness; 2) to 
improve pain management and acceptance of the illness; 3) to increase expression 
of their feelings (pain, depression, anxiety and anger), understanding of their 
personal significance and relationship with symptoms; 4) to increase the ability to 
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look after and be responsible for themselves and 5) to facilitate, increase and 
improve interpersonal relationships. 
Monitoring of the process 
Throughout the process, the GrpMI treatment was continually monitored and 
evaluated using observational techniques. The purpose was to consider and adapt 
the process and the attention to each individual member of the group and the group 
dynamic as a whole. This made it possible to observe any progress or regression in 
the group, encourage dialogue and integration of the different themes that arose in 
the sessions and to identify specific targets for individual and collective work at the 
different stages. 
The following techniques were used for recording the process: 1) a session log, 
describing the musical selections, the most significant forms of behaviour observed, 
the focus of the individual themes and the common focus, the themes expressed 
verbally at the beginning and end of each session and the conclusions arising  from 
each  session; 2) an archive of creative drawings/mandalas and their titles; and 3) a 
record of level of pain and tiredness before and after the session, with each 
participant being asked  to score their perception  of present pain and tiredness on a 
scale of 0 to 10 (where 0 is “no pain” and 10 “the worst pain possible”). 
4.5. DATA ANALYSIS 
4.5.1. STATISTICAL ANALYSES 
Statistical analyses of this study were made using the SPSS 21 statistics program 
for Windows. 
Firstly, the basic assumptions required for using parametric tests were verified 
(normality, homogeneity of variance and independence). The Kolmogorov-
Smirnoff test showed that the assumption of normality was not met in the following 
variables: pain intensity index, D (56) = 0,230, p = .000, pain intensity on visual 
analogue scale, D (56) = 0,180, p = .000, state anger, D (56) = 0,241, p = .000 and 
trait anger, D (56) = 0,167, p = .000. As a result, in analysing these variables the 
corresponding non-parametric tests were used.  
Different types of analyses were performed with the data obtained by the 
participants in the pretest, posttest and follow-up measurements, as described 
below: 
1. Descriptive analyses (mean scores and standard deviations in quantitative
variables, and frequencies/percentages in qualitative variables).
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2. In addition, the following analyses were used to characterise the sample
(demographic variables, FM-associated diagnoses, medication) and verify
the homogeneity of the experimental and control groups in these variables
and the study variables: a) for qualitative variables, the chi-square test and
Fisher’s exact test; and b) for quantitative variables, Student’s t test –for
normally distributed variables–, and the Mann-Whitney U test (with its z
values) for variables that did not meet the assumption of normality.
Bonferroni correction was used when pair-wise comparisons were
performed. In all cases it was decided to use the r to estimate effect size, as
being more recommendable in the case of non-parametric tests (Field,
2013). 
3. Spearman's Correlation Coefficients were calculated to explore the
relations between the variables used for the experimental assessment.
4. To compare the experimental and control groups in the different study
variables (intergroup comparison) at posttest and at the 3-month follow-up,
covariance analyses (ANCOVA) were used for variables that met the
assumption of normality, and a non-parametric analysis of covariance
(Quade's test) for all others. In all cases the pretest score for each test was
used as a covariable to minimise the effect of pre-treatment differences.
5. To analyse intragroup differences the t-test was used for related samples in
the case of variables that met the assumption of normality. For all others
the Wilcoxon signed-rank test for related samples was used (the non-
parametric equivalent).
6. Finally, the Reliable Change Index (RCI) was used for determining
clinically significant changes in each of the participants in the study, in
order to overcome the limitations of statistical significance in the clinical
area by virtue of being based on group averages. Clinical significance
refers to the importance of the change in the patient occurring as the result
of psychotherapeutic treatment. Jacobson and Truax (1991) propose RCI
as a procedure for determining clinically significant changes that provide
an additional means of analysis to comparisons of group averages. The
RCI for each individual is calculated based on pre-treatment scores (Xpre),
post-treatment scores (Xpost) and standard error between the differences in
the two scores (Sdiff), so that:
RCI ൌ Xpost	– 	XpreSdiff
The cut-off points are established in 4 categories: recovered (>1.96), 
improved (1 - 1.96), unchanged (0.1 – 1) and deteriorated (< 0). When a 
person has a score of over 1.96 it is reasonable to assume that they have 
recovered (Ogles, Lumen and Bonesteel, 2001).  
The term recovered is used because it is faithful to the original 
terminology. It does not suggest that the patient is considered to have 
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definitively recovered from this chronic illness (FM), but refers to an 
absence of the symptom during that period of time.  
4.5.2. MISSING VALUES  
The following process was used to deal with missing values in the statistical 
analyses: 
 Participant 14. Posttest material PWS and all follow-up analysis were
missing. The missing value was replaced using the average posttest score
for this variable in the experimental group, and the individual was included
only in the pre-post analyses.
 Participant 35.STAI, ST/DEP and STAXI in posttest were missing. The
missing values were replaced using the control group's posttest average,
and the individual was included in all analyses.
 Participants 20 and 24 missed the follow-up, and were therefore included
only in the pre-post analyses.
 Finally, Participant 37 missed the entire pretest measurement and was
therefore excluded from the analyses.
4.6. ETHICAL ASPECTS 
This research was passed by the Ethical Committee of the School of Humanities of 
the University of Aalborg, (Denmark) (Human Research Ethics Boards), as shown 
in Appendix E. 
CHAPTER 5. RESULTS 
The results of this research study are presented in six sections. The first section 
offers a detailed description of participants’ demographic characteristics, 
comorbidity (diagnoses associated with FM) and medication. The second section 
analyses the pretest scores obtained in the different study variables by the subjects. 
The aim of these two sections is twofold: a) to characterise the sample in as much 
detail as possible, and b) to ensure the homogeneity of the experimental and control 
conditions with regard to these variables. The third section sets out the results of the 
correlational analyses showing the relations between the different study variables. 
The fourth sections presents the results of the comparative analysis of the two 
groups (intergroup analyses) and the intragroup comparison for the different 
assessments (pretest, posttest and follow-up). The fifth section shows the results for 
clinical change in each individual subject. The sixth and last section describes the 
results of the assessment questionnaire, showing the change perceived by 
participants receiving GrpMI treatment. 
5.1. DEMOGRAPHIC CHARACTERISTICS, COMORBIDITY AND 
MEDICATION OF PARTICIPANTS 
As Table 9 shows, the mean age of the women taking part in the study was 51.34. 
On average 10.6 years had elapsed since they were diagnosed as having FM.  
As can be seen in Figure 15, 48.2% of participants had completed their education 
up to secondary level, 42% to primary level and only 8.7% had completed tertiary 
education. As for their working status, Figure 16 shows that 23.6% of those 
sampled had had a disability or a not fit for work certificate, 21.8% were working 
outside the home and the same proportion were unemployed. Only 12.7% of 
participants described themselves as unremunerated housewives. With regard to 
marital status (see Figure 17), 69.6% were married, 14.3% single, 10.7% separated 
or divorced and 4.3% widowed. 85.5% of the participants have a child (M = 1.72, 
SD = 0.74, range 1 - 4). There was no difference in the number of children between 
the experimental group (M = 1.68, SD = 0.67) and the control group (M = 1.79, 
SD = 0.86), t (45) = -0.50, p = .621. Similarly, there were no statistically significant 
differences in the other variables between the two groups assessed.  
However, there were differences, albeit not statistically significant, both in the level 
of education and in employment situation. The proportion of women with primary 
studies was bigger in the experimental group. Similarly, a larger percentage in the 
experimental group was unemployed or had a disability or not fit for work 
certificate.  
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Figure 15. Educational attainment of total participants in the study (%). 
Figure 16. Labour status of total participants in the study (%). 
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Figure 17. Marital status of total participants in the study (%). 
5.1.1. PARTICIPANT COMORBIDITY 
As Table 10 shows, 79.6% of participants have at least one FM-associated 
diagnosis. Here, there is a significant difference between the experimental group 
and the control group (93.8% and 59.1% respectively; p = .004). Based on the 
Relative Risk (RR), the probability of the participants in the experimental group 
having at least one FM-associated diagnosis is therefore 1.59 times bigger than 
those in the control group.  
By categories, the most common diagnoses are osteo-articular disorders (53.7%), 
chronic fatigue syndrome (24.1%) and chronic dysthymia and depression (20.4%). 
The only significant difference between experimental and control groups by 
diagnostic category can be seen in the case of osteo-articular disorders, χ2 = 4.49, 
p = .034, RR = 1.83.  
Table 10. Diagnostics associated with fibromyalgia in participants in the study. 
Experimental
(n = 32) 
Control 
(n = 22) 
Total 
(n = 54) 
n % n % n % P 
Participants with other diagnoses 30 93.8 13 59.1 43 79.6 .004 b 
Diagnostic categories 
 Osteo-articular disorders 21 65.6 8 36.4 29 53.7 .034 a
 Chronic fatigue syndrome 8 25.0 5 22.7 13 24.1 NS a
 Chronic dysthymia and depression 9 28.1 2 9.1 11 20.4 NS b
 Anxiety 4 12.9 2 9.1 6 11.3 NS b 
 Endocrine diseases 2 6.2 4 18.2 6 11.1 NS b 
 Cardiac disorders 3 9.4 0 0.0 3 5.6 NS b 
 Cancer 2 6.2 0 0.0 2 3.7 NS b 
 Irritable bowel syndrome 2 6.2 0 0.0 2 3.7 NS b 
 Myalgic encephalomyelitis 1 3.1 0 0 1 1.9 NS b 
a Chi-square 
b Fisher´s exact test 
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5.1.1.1 Multi-comorbidity or polypathology 
At the same time, it is worth noting that 35.2% of participants have two or more 
FM-associated diagnoses (see Figure 18), with no significant differences between 
the experimental and control groups, χ 2 (1) = 2.53, p = .112. 
When there are two or more associated diagnoses, the most frequent case is that the 
same participant presents diagnoses of osteo-articular disorders and chronic 
dysthymia/depression (42% of participants with 2, 3 or 4 associated diagnoses). 
Figure 18. Percentage of participants in the study with FM-associated diagnoses. 
5.1.2. MEDICATION USED BY PARTICIPANTS 
As can be seen in Table 11, 92.5% of participants are on some form of medication. 
The most common are analgesics (57.7%) and anti-depressants (52.8%). No 
significant differences were found between the two groups in this regard. 
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Table 11. Medication used by participants in the study.  
Experimental
(n = 31)
Control
(n = 22)
Total
(n = 53)
n % N % n % p  
Participants on medication 29 93.5 20 90.9 49 92.5 NS b
Type of medication
 Analgesics 17 56.7 13 59.1 30 57.7 NS a
 Anti-depressants 19 61.3 9 40.9 28 52.8 NS a
 Anti-inflammatories 9 29.0 8 36.4 17 32.1 NS a
 Anxiolytics 10 32.3 5 22.7 15 28.3 NS a
 Neuropathic pain 8 25.8 4 18.2 12 22.6 NS b
 Hypnotics 5 16.1 6 27.3 11 20.8 NS b
 Muscle relaxant 4 12.9 2 9.1 6 11.3 NS b
Thyroid diseases 0 0.0 2 9.1 2 3.8 NS b
 Local anaesthetics 1 3.2 0 0 1 1.9 NS b
a Chi-square  
b Fisher ´s exact test 
It is worth noting that 69.8% of participants are habitually using pharmaceuticals 
from two or more of the above categories (see Figure 19), with no significant 
difference in this regard between experimental and control groups, χ 2(1) = 0.68, 
p = .409. 
Among those taking two or more types of medication, the most common 
combination was analgesics and anti-depressants (34% of cases). 
Figure 19. Percentage of participants from the different categories listed in table 12. 
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5.2. PARTICIPANT CHARACTERISTICS IN RELATION TO 
STUDY VARIABLES 
Table 12 shows the pretest scores obtained by participants in the different study 
variables. Comparing the total scores with the percentiles for normative samples 
used for Spanish adaptation and typing of different instruments (reference tables for 
the general adult female population), one is struck by the low score in subjective 
psychological wellbeing (15th percentile) and the high scores in state depression 
(90th percentile) and trait depression (90th percentile) and trait anxiety (80th 
percentile).
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The scores obtained by the experimental group in impact of FM on functional 
capacity and health (M = 74.79) indicate severe impact (> 70; in a range of 0 to 
100). However, the control group had a lower mean (M = 66.70), in a moderate 
level, (FIQ between 50 < 70, in a range of 0 to 100). 100), showing significant 
differences for this variable between the experimental and control groups, t 
(54) = 2.16, p = .035, albeit the effect size is small (r =.28). 
A comparison between the scores for the sample used in this study (see Table 13), 
and the population reference tables used for adaptation (50 women and 4 men, with 
an average age of 44.2, diagnosed with FM following the criteria of the ACR shows 
no significant differences. 
Table 13. Comparison between scores of the sample and those of the reference 
population used for Spanish adaptation of questionnaire to assess overall FM 
impact (FIQ), present pain intensity (PPI), and pain intensity recorded on a visual 
analogue scale (VAS). 
Reference population Total sample 
(n = 56) 
Variable N M SD M SD r 
FIQ 54 70.50 11.80 71.46 14.23 .04 
PPI 279 2.80 1.23 2.79 1.00 .00 
VAS 279 5.32 2.54 6.54 2.02 .24 
M = mean pre-test; SD = standard deviation 
Effect size r = .10 (small), r = .30, (medium), r = .50 (large) 
Notes: FIQ: Fibromyalgia Impact Questionnaire; PPI: Present Pain Intensity; VAS: Visual 
Analogue Scale 
The scores for pain intensity show an above-average perception of present pain, at 
M = 6.54 on a scale of 0 to 10 on the visual analogue scale (VAS), and M = 2.79 in 
present pain intensity on a scale of 0 to 5. The Spanish adaptation of the MPQ does 
not have reference scales, but if it is compared to the reference group of 273 
patients with chronic pain or acute pain, it can be seen (Table 13), that the average 
score obtained by the participants in this study is practically the same as that of the 
reference group for present pain intensity whereas for pain intensity measured on 
the visual analogue scale it is somewhat higher (M = 6.54) than the reference group 
(M = 5.32), albeit the effect size is small (r = .24).  
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5.3. CORRELATIONS BETWEEN DIFFERENT STUDY 
VARIABLES  
This section discusses the correlational analyses performed to highlight any relation 
between the different variables assessed in the pretest phase. The results of 
Spearman's correlation analyses conducted with the variables used for the 
experimental assessment are shown in Table 14. 
The psychological wellbeing variable shows significant negative relations with 
impact of FM on functional capacity and health, and with the different variables 
indicating psychological distress such as pain (present pain intensity and pain 
intensity measured on a visual analogue scale); anxiety (state and trait), depression 
(state and trait), and experience, expression and control of anger. In the case of the 
correlation between subjective wellbeing and the anger expression index, the result 
is negative, though not significant.  
There is a significant positive correlation between the impact of FM on functional 
capacity and health, perception of pain, and the different indicators of psychological 
distress (anxiety, depression and anger). Only the correlations between state of 
health and functional capacity with trait anger and the anger expression index were 
not significant. The same can be said of perceived pain, where the correlation is not 
significant with trait anger and the anger expression index.  
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5.4. EFFECTIVENESS OF TREATMENT  
5.4.1. INTERGROUP ANALYSIS RESULTS 
As discussed above, in order to compare the different study variables in the 
experimental and control groups (intergroup comparison) in posttest and in the 3-
month follow-up, analyses of covariance (ANCOVAs) have been used in the case 
of variables that fulfil the assumption of normality, and a non-parametric analysis 
of covariance (Quade's test) in the others. In all cases the corresponding pretest 
score was used as a covariable to minimise the effect of pre-treatment differences.  
The results of the analyses (see Table 15) show that, following treatment, the 
members of the experiment group experienced improvements in subjective 
psychological wellbeing, with scores that were significantly higher than those of the 
control group, F (1.53) = 6.89, p = .011, who experienced deterioration; the effect 
size was medium (r = .34). Whereas in the experimental group an improvement was 
observed following treatment, the members of the control deteriorated in 
comparison to their initial situation. 
At the same time, the experimental subjects’ scores for state anxiety were 
significantly lower than those of the control group, F (1.53) = 4.71, p = .035, with a 
small-medium effect size (r = .29). The state anxiety of the experimental group 
decreased following treatment, while the anxiety of the control group increased. 
It is also worth noting the tendentially significant differences observed between the 
two conditions for a number of variables (with a small effect size in all cases). The 
experimental participants recorded tendentially lower scores than those of the 
control group in impact of FM on functional capacity and health, F (1.53) = 3.69, 
p = .060, trait anxiety, F (1.53) = 3.83, p =.056 and present pain intensity, 
F (1.54) = 4.00, p = .051. 
Finally, the score for state anger was tendentially higher than that of the control 
group, F (1.54) = 3.76, p = .058, although it is important to note that whereas the 
experimental group experienced a decrease in state anger after treatment, the 
control subjects remained unchanged from the pretest situation. 
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With regard to the differences between groups at the 3-month follow-up (see Table 
16), the results of the analysis of covariance show significant differences between 
experimental and control subjects only in state anger, F (1.47) = 5.65, p = .022, 
with a medium effect size (r = .35). Although members of the experimental group 
had a slightly higher state of anger in the follow-up assessment (M = 20.76) than the 
control group (M = 20.05), this level was below the one recorded in the pretest 
assessment, whereas in the control group, state anger increased between pretest and 
follow-up. 
 Ta
bl
e 
16
. M
ea
n 
an
d 
st
an
da
rd
 d
ev
ia
tio
ns
 in
 e
xp
er
im
en
ta
l a
nd
 c
on
tro
l s
ub
je
ct
s 
in
 p
re
te
st
 a
nd
 f
ol
lo
w
-u
p,
 a
nd
 r
es
ul
ts
 o
f 
an
al
ys
es
 o
f 
co
va
ria
nc
e 
in
 fo
llo
w
-u
p,
 ta
ki
ng
 p
re
te
st
 sc
or
es
 a
s a
 c
ov
ar
ia
bl
e.
 
 
Pr
et
es
t 
Fo
llo
w
-u
p 
 
 
 
 
 
 
Ex
pe
rim
en
ta
l 
(n
 =
 2
9)
 
  
C
on
tro
l 
(n
 =
 2
0)
 
 
Ex
pe
rim
en
ta
l 
(n
 =
 2
9)
 
C
on
tro
l 
(n
 =
 2
0)
 
  
A
nc
ov
a 
Fo
llo
w
-u
p.
Q
ua
de
  
Te
st
a  
 
 
V
ar
ia
bl
es
 
M
 
SD
 
 
M
 
SD
 
M
 
SD
 
M
 
SD
 
 
F 
(1
,4
6)
 
F 
(1
,4
7)
 
p 
r 
PW
S 
75
.8
3 
23
.1
7 
 
80
.7
0 
16
.0
9 
79
.4
8 
24
.8
1 
79
.4
0 
18
.3
2 
 
0.
83
 
 
N
S 
.1
3 
FI
Q
 
73
.2
8 
13
.9
0 
 
67
.9
5 
13
.6
5 
64
.1
0 
17
.7
0 
67
.7
0 
17
.1
6 
 
1.
93
 
 
N
S 
.2
0 
PP
I 
2.
86
 
1.
06
 
2.
65
 
0.
99
 
2.
52
 
1.
06
 
2.
40
 
1.
05
 
0.
00
 
N
S 
.0
0 
V
A
S 
6.
83
 
1.
98
 
6.
30
 
2.
20
 
5.
76
 
2.
97
 
5.
70
 
2.
25
 
0.
04
 
N
S 
.0
3 
ST
A
I-
S 
30
.0
3 
12
.2
8 
 
25
.4
0 
10
.1
3 
26
.8
6 
13
.3
6 
29
.6
0 
12
.3
9 
 
2.
02
 
 
N
S 
.2
0 
ST
A
I-
T 
36
.9
0 
10
.8
1 
 
35
.0
0 
7.
76
 
32
.4
5 
11
.8
3 
32
.0
5 
10
.7
7 
 
0.
10
 
 
N
S 
.0
4 
 S
T/
D
EP
-S
 
26
.8
3 
8.
38
 
23
.6
5 
6.
37
 
24
.5
9 
8.
10
 
24
.5
5 
5.
66
 
1.
26
 
 
N
S 
.1
6 
 S
T/
D
EP
-T
 
28
.0
7 
7.
66
 
 
25
.2
0 
5.
29
 
25
.0
0 
7.
93
 
25
.0
5 
6.
42
 
 
2.
59
 
 
N
S 
.2
3 
ST
A
X
I-
S 
 
25
.8
3 
13
.3
2 
18
.4
5 
6.
73
 
20
.7
6 
7.
03
 
20
.0
5 
4.
57
 
5.
65
* 
.0
22
.3
5 
ST
A
X
I-
T 
23
.1
4 
6.
87
 
20
.1
0 
4.
59
 
21
.0
0 
9.
84
 
20
.8
0 
7.
03
 
1.
84
 
N
S 
.2
0 
A
EI
 
31
.0
7 
11
.5
1 
27
.2
5 
9.
80
 
31
.3
4 
10
.0
5 
27
.4
0 
9.
57
 
0.
81
 
 
N
S 
.1
3 
a.
 n
on
 p
ar
am
et
ric
 a
na
ly
si
s o
f c
ov
ar
ia
nc
e 
+ 
p 
< 
.1
0 
* 
p 
< 
.0
5 
Ef
fe
ct
 si
ze
 r 
= 
.1
0 
(s
m
al
l) 
r =
 .3
0 
(m
ed
iu
m
) r
 =
 .5
0 
(la
rg
e)
 
N
ot
es
: P
W
S:
 P
sy
ch
ol
og
ic
al
 W
el
lb
ei
ng
 S
ca
le
 ; 
FI
Q
: F
ib
ro
m
ya
lg
ia
 Im
pa
ct
 Q
ue
st
io
nn
ai
re
; P
PI
: P
re
se
nt
 P
ai
n 
In
te
ns
ity
; V
A
S:
 V
is
ua
l A
na
lo
gu
e 
Sc
al
e;
 
ST
A
I S
-T
: S
ta
te
 /T
ra
it 
A
nx
ie
ty
 In
ve
nt
or
y;
 S
T/
D
EP
 S
-T
: S
ta
te
 /T
ra
it 
D
ep
re
ss
io
n 
In
ve
nt
or
y;
 S
TA
X
I-
2 
S-
T:
 S
ta
te
 /T
ra
it 
A
ng
er
 E
xp
re
ss
io
n 
In
ve
nt
or
y;
 
A
EI
: A
ng
er
 E
xp
re
ss
io
n 
In
de
x 
 
5.4.1.1 Intergroup trends in the different study variables. 
Figure 20. Trends in experimental group and control group in subjective perception 
of psychological wellbeing. 
Figure 21. Trends in experimental group and control group in impact of FM on 
functional capacity and health. 
Pretest Postest Follow‐up
PWS Exp 75,83 82,86 79,48
PWS Cont 80,70 78,00 79,40
74,00
76,00
78,00
80,00
82,00
84,00
PWS
Pretest Postest Follow‐up
FIQ Exp 73,28 63,86 64,10
FIQ Cont 67,95 67,50 67,70
60,00
62,00
64,00
66,00
68,00
70,00
72,00
74,00
FIQ
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Figure 22. Trends in experimental group and control group in intensity of perceived 
pain in present situation. 
Figure 23. Trends in experimental group and control group in state anxiety and trait 
anxiety. 
Pretest Postest Follow‐up
PPI‐Exp 2,86 2,34 2,52
PPI‐Cont 2,65 2,65 2,40
VAS‐Exp 6,83 5,24 5,76
VAS‐Cont 6,30 5,90 5,70
2,00
3,00
4,00
5,00
6,00
7,00
8,00
PAIN  (PPI / VAS)
Pretest Postest Follow‐up
STAI‐S Exp 30,03 23,31 26,86
STAI‐S Cont 25,40 25,80 29,60
STAI‐T Exp 36,90 29,52 32,45
STAI‐T Cont 35,00 31,55 32,05
15,00
20,00
25,00
30,00
35,00
40,00
STAI‐ S / T
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Figure 24. Trends in experimental group and control group in state depression and 
trait depression. 
Figure 25. Trends in experimental group and control group in state anger and trait 
anger. 
Pretest Postest Follow‐up
STAXI‐S Exp 25,83 20,38 21
STAXI‐S Cont 18,45 17,8 20,8
STAXI‐T Exp 23,14 20,72 20,76
STAXI‐T Cont 20,1 18,45 20,05
16
18
20
22
24
26
28
STAXI S  / T
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5.4.2. INTRAGROUP ANALYSIS RESULTS 
5.4.2.1 Trends in experimental group. 
As Table 17 shows, there was a statistically significant increase in subjective 
psychological wellbeing following treatment (pre-post) t (28) = 2.14, p = .041, and 
an equally significant reduction in impact of FM on functional capacity and health, 
t(28) = -2.80, p = .009, state anxiety, t (28) = -2.50, p = .018, trait anxiety, t (28) = -3.83, 
p = .001, state depression, t (28) = -2.48, p = .020, trait depression, t (28) = -3.61, 
p = .001, present pain intensity, z = 2.30, p = .021, pain intensity on visual analogue 
scale, z = 3.45, p = .001, state anger, z = 2.37, p = .018, and trait anger, z = 2.20, 
p = .028. In all cases, the effect size is medium-large.  
In the 3-month follow-up assessment (post-follow up) the results remain 
unchanged, with a significant increase only in state anxiety, t (28) = 2.22, p = .035, 
and trait anxiety, t (28) = 2.17, p = .039, with a medium effect size in both cases.  
Between the pretest and follow-up, there are significant differences in impact of FM 
on functional capacity and health t (28) = -2.71, p = .011, trait anxiety, t (28) = -2.15, 
p = .041, trait depression, t (28) = -3.07, p = .005, present pain intensity, z = 2.00, 
p = .045, pain intensity on visual analogue scale, z = 2.61, p = .009, state anger, 
z = 2.14, p = .032, and trait anger, z = 2.00, p = .045. In all cases there are 
significant reductions in the scores for these variables, with a medium-large effect 
size.  
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Trends in experimental group for study variables. 
Figure 26. Trends in experimental 
group for perception of subjective 
psychological wellbeing. 
Figure 27. Trends in experimental 
group for impact of FM on functional 
capacity and health. 
Figure 28. Trends in experimental 
group for perceived present pain 
intensity. 
Figure 29. Trends in experimental 
group for state anxiety and trait 
anxiety. 
Figure 30. Trends in experimental 
group for state depression and trait 
depression. 
Figure 31. Trends in experimental 
group for state anger and trait anger. 
Pretest Postest Follow‐up
STAXI‐S 25,83 20,38 21,00
STAXI‐T 23,14 20,72 20,76
16,00
18,00
20,00
22,00
24,00
26,00
28,00
STAXI
Experimental Group
5.4.2.2 Trends in control group. 
Table 18 shows the scores obtained by the control group in the pretest, posttest and 
3-month follow-up assessments. Between the pretest and posttest scores, there is a 
significant reduction only in the scores for trait anxiety, t (19) = -3.07, p = .006, and 
trait depression, t (19) = -2.82, p = .011, with a large effect size in both cases.  
Between the posttest and the follow-up assessment, the score for trait depression 
rises significantly, t (19) = 3.10, p = .006, to practically the same level as in the 
pretest assessment. State anger also rises significantly, z = -2.63, p = .009, with 
even higher scores than those observed in the pretest assessment (in both cases the 
effect size is large). Indeed, when one compares the results obtained in the pretest 
and follow-up assessments no significant changes are observed, except for state 
anger, where there is a statistically significant increase, z = -2.14, p = .003, r = -.48.  
In general terms, these results show that the mere passage of time does not have any 
effect, other than a significant increase in state anger. 
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Trends in control group for the different study variables. 
Figure 32. Trends in control group 
for perception of subjective 
psychological wellbeing 
Figure 33. Trends in control group 
for impact of FM on functional 
capacity and health. 
Figure 34. Trends in experimental 
group for perceived present pain 
intensity. 
Figure 35. Trends in control group 
for state anxiety and trait anxiety. 
Figure 36. Trends in control group 
for state depression and trait 
depression. 
Figure 37. Trends in control group 
for state anger and trait anger. 
5.5. CLINICALLY SIGNIFICANT CHANGE 
As discussed above, this study uses the Reliable Change Index (RCI) to determine 
clinically significant changes for each of the participants in the study. This helps 
overcome the limitations that statistical significance exposes in the clinical area 
because it is based on group means. 
5.5.1. RELIABLE CHANGE INDEX IN PARTICIPANTS IN THE 
EXPERIMENTAL GROUP 
Table 19 shows the results obtained by each of the participants in the experimental 
group for some of the key measurements in the study, (perception of subjective 
wellbeing, impact of FM on functional capacity and health, intensity of pain and 
state of anxiety, depression and anger) and changes in these figures.  
One indicator of a clinically significant change between pretest and posttest 
assessments could be when a subject has registered an improvement and/or 
recovery in at least three of the six variables considered without experiencing any 
deterioration. Participants who do not have two or more deteriorations in the 
follow-up assessment could also be considered to have maintained the improvement 
attained in the posttest assessment. 
Between the pretest and the posttest, one can see that 21.2% (7 subjects, coded 2, 3, 
15, 20, 21, 26 and 70) registered an improvement or recovery in three or more of 
the six variables, without experiencing any deterioration. Other participants also 
achieved the same number of improvements or recoveries, but experienced a 
deterioration in one (8 subjects, 24.2%, coded 1, 4, 5, 11, 16, 19, 32, 7 and 57) two 
(3 subjects, 9.1%, coded 6, 7 and 22) or even three variables (1 subject, 3%, code 
13). Of the seven subjects who met the criteria for clinically significant change 
between pretest and posttest, three did not complete the follow-up assessment, and 
the rest registered a deterioration during this period in three or more of the 
‘recovered’ or ‘improved’ variables. 
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Table 19. Reliable Change Index (RCI) in the experimental group. 
Pre-post Post-Follow up 
P. PWS FIQ VAS STAI-S ST/DEP-S STAXI-S PWS FIQ VAS 
STAI-
S 
ST/DEP-
S STAXI-S
1  I R R R I D D S D D D D 
2 R R R R R S --- --- --- --- --- --- 
3  S I S I S I D D S D D D 
4 R R I R I D D D D D D D 
5  S R I I S D D D D S D D 
6 I I D I D S D S I R I S 
7  I D R R S D D D D D D D 
8 D D I D D D S D D D D S 
11  S D S R I R D S D D D D 
12 D S I D D D D S I R I S 
13  R R I D D D D D D D I D 
14 D R D R D S --- --- --- --- --- --- 
15  I R I I S S D D D D D D 
16 D I I I I R D S I S D I 
17  I D D D R D D D D D D S 
19 S D I R I S D R D D D D 
20  R R I R R S --- --- --- --- --- --- 
21 R R R R R R S R D D S D 
22  S D D R R R D D S D D S 
24 D I D I S D --- --- --- --- --- --- 
25  D D D D D D I R D S S D 
26 R R S R R R D D D D D D 
27  D I D D S D D S I D S R 
29 S I I S S S D D D D R D 
30  S S D D D D D D D S S D 
32 D S S R R R R D D D D S 
57  S R I S I D D D D D S D 
58 S S I D I D S D S D D S 
59  S D I D D I R R D I R S 
64 I S S D I D D S D D S S 
65  D I D S I D S D D D S D 
68 I D D D D S S S D D S D 
70  S R R R R R D D D D D D 
Recovered (R) > 1.96; Improved (I) 1 – 1.96; / Same (S) 0 – 0.99; Deteriorated (D) < 0. 
PWS: Psychological Wellbeing Scale; FIQ: Fibromyalgia Impact Questionnaire; VAS: 
Visual Analogue Scale; STAI-S: State Anxiety; ST/DEP-S: State Depression; STAXI S: 
State Anger 
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5.5.2. RELIABLE CHANGE INDEX IN PARTICIPANTS IN THE CONTROL 
GROUP 
In the case of the control subjects (see Table 20) two participants (8.7%) achieved 
three or more improvements between the pretest and posttest, but during the same 
time deteriorated in some of the other variables (Subjects 44 and 46). These 
participants deteriorated significantly in the follow-up assessment (six 
deteriorations in the case of Subject 44 and five in the case of Subject 46). 
Table 20. Reliable Change Index (RCI) in the control group. 
Pre-Posttest  Post-Follow up 
Su
b PSW FIQ VAS 
STAI-
S 
ST/DEP-
S 
STAXI-
S PSW FIQ VAS 
STAI
-S 
ST/DEP
-S 
STAXI-
S 
33  D S S R S I --- --- --- --- --- --- 
34 D D D I D I --- --- --- --- --- --- 
35  S D D S S D R D D D D D 
36 D D D D R R D S S I D D 
38  S R S D D S S S D S D D 
42 D D D D D D D D S D D D 
43  S S D D D D I D S R I D 
44 R R I I R D D D D D D D 
45  D D D D D D D S S D D D 
46 R D D R R I D D D S D D 
48  D D D S S D R S S R D D 
49 D S I S R D I S D D D D 
50  S D D D D R D D S D R D 
51 D S D D S D I I S D D D 
52  S R D S D D D D D D D I 
53 I D D D S D S D D R S D 
54  D S D R D D R D D D I D 
55 D S D D D D --- --- --- --- --- --- 
56  D D D D D D R S D R S D 
60 D S I I D D D R D D D D 
62  D D S I I D D S S D D D 
66 S S S D D D S D D D D D 
67  D S R S I D S S D D D D 
Notes: Recovered (R) >1.96; Improved (I) 1 – 1.96; Same (S) 0 – 0.99; Deteriorated (D) < 0. 
PWS: Psychological Wellbeing Scale; FIQ: Fibromyalgia Impact Questionnaire; VAS: 
Visual Analogue Scale; STAI-S: State Anxiety; ST/DEP-S: State Depression; STAXI S: 
State Anger. 
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5.5.3. COMPARISON BETWEEN THE TWO CONDITIONS 
As indicated in the previous section, in the posttest assessment 19 participants from 
the experimental group (57.6%) achieved the category of improved and/or 
recovered in at least three of the six study variables, as opposed to only 2 
participants (8.7%) from the control group. This difference is statistically 
significant, χ2 (1) = 13.82, p = .000, RR = 6.44 (see Figure 38). 
Figure 38. Comparison between experimental and control groups according to the 
number of variables recovered and/or improved by its participant on the posttest 
RCI. 
It is also interesting to compare for each variable the percentages of experimental 
and control participants who improved or recovered, showed no change and 
deteriorated in the posttest assessment. As can be seen in Table 21, compared to the 
control participants a significantly higher percentage of experimental subjects 
registered improvements or recovery in impact of FM on functional capacity and 
health, χ2 (1) = 11.27, p = .001, RR = 4.46, subjective psychological wellbeing, 
χ2 (1) = 4.61, p = .032, RR = 3.00, state anxiety, χ2 (1) = 4.01, p = .045, RR = 1.93, 
and pain intensity on visual analogue scale, χ2 (1) = 7.84, p = .005, RR = 3.18. The 
percentages of improvement or recovery in state depression and state anger are also 
higher in the case of the experimental participants, albeit not to a statistically 
significant degree. In similar terms, it is worth noting that the percentages of 
experimental subjects registering deterioration in the different variables were lower 
in all cases than the percentages of control participants. These differences are 
statistically significant in subjective psychological wellbeing, χ2 (1) = 6.32, p = .012, 
RR = 2.26, and pain intensity on visual analogue scale, χ2 (1) = 6.69, p = .010, RR = 2.17. 
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Table 21. Number and percentage of participants who in the pretest-posttest 
assessment showed recovery or improvement, no change, or deterioration in the 
different variables according to the Reliable Change Index (RCI). 
Experimental 
(n=33) 
 Control 
(n=23) 
n %  n % p 
PWS 
Recovery or improvement 13 39.4  3 13.0 .032 a 
Remains same 11 33.3 6 26.1 NS a 
Deteriorated 9 27.3  14 60.9 .012 a 
FIQ 
Recovery or improvement 19 57.6  3 13.0 .001 a 
Remains same 5 15.2 9 39.1 NS a 
Deteriorated 9 27.3  11 47.8 NS a
PAIN/VAS 
Recovery or improvement 18 54.5  4 17.4 .005 a 
Remains same 5 15.2 4 17.4 NS b 
Deteriorated 10 30.3  15 65.2 .010 a 
STAI-S 
Recovery or improvement 19 57.6  7 30.4 .045 a 
Remains same 3 9.1 5 21.7 NS b 
Deteriorated 11 33.3  11 47.8 NS a
ST/DEP-S 
Recovery or improvement 17 51.5 6 26.1 NS a 
Remains same 7 21.2 5 21.7 NS b 
Deteriorated 9 27.3  12 52.2 NS a
STAXI-S 
Recovery or improvement 9 27.3 5 21.7 NS a 
Remains same 8 24.2 1 4.3 NS b 
Deteriorated 16 48.5  17 73.9 NS a
a Chi-square; b Fisher´s exact test  
Notes: PWS: Psychological Wellbeing Scale; FIQ: Fibromyalgia Impact Questionnaire; AS: 
Visual Analogue Scale; STAI-S: State Anxiety; ST/DEP-S: State Depression; STAXI S: 
State Anger. 
Finally, Table 22 shows the percentages of participants who in the pretest-posttest 
assessment show a recovery or improvement in the different variables, and who 
maintain or increase it in the follow-up. Although the percentage remaining the 
same is lower in the experimental group, it is still above that of the control group, in 
which only one participant (Subject 38) shows a recovery in impact of FM on 
functional capacity and health in the pretest-posttest assessment and remains 
unchanged at three months. 
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Table 22. Number and percentage of participants who registered recoveries or 
improvements in the pretest-posttest assessment, and who maintained or increased 
on these at follow-up. 
Experimental 
(n = 29) 
Control 
(n = 20) 
N % n % p 
PWS 2 6.9 0 0.0 NS b
FIQ 5 17.2 1 5.0 NS b
VAS 3 10.3 0 0.0 NS b
STAI-S 3 10.3 0 0.0 NS b 
ST/DEP-S 2 6.9 0 0.0 NS b 
STAXI-S 4 13.8 0 0.0 NS b 
a Chi-square; b Fisher ´s exact test 
Notes: PWS: Psychological Wellbeing Scale; FIQ: Fibromyalgia Impact Questionnaire; 
VAS: Visual Analogue Scale; STAI-S: State Anxiety; ST/DEP-S: State Depression; STAXI 
S: State Anger.  
5.6. PARTICIPANT EVALUATION OF TREATMENT 
In order to evaluate the impact of the MI treatment, members of the experimental 
group completed assessment scales upon finishing the treatment. Of the 33 
participants in the experimental group, 31 filled out the scales. The following 
aspects of the scales are assessed: 1) perceived change in intensity of some of the 
symptoms most frequently associated with the disease: pain, fatigue, sleep, 
concentration and mood, and whether these changes bear any relationship with the 
treatment; 2) perceived change in everyday life: at work, in relations with partner, 
with children, in social life and in their perception of themselves or self-assessment, 
and whether these changes are related to GrpMI process. In addition, a further item 
was also assessed: 3) suggestions and interest in continuing treatment, as a measure 
of satisfaction with the treatment. 
Participants gave a positive assessment of their participation, mentioning some of 
the positive changes perceived in several areas, as Table 23 shows. 74% of 
participants say they have noticed changes in the intensity of the symptoms, 
especially highlighting perceived changes in mood (16 participants). They also 
mention changes in pain (11 participants), tiredness (12 participants), and sleep 
disorders (9 participants). A smaller number (4 participants) also mentioned 
changes in concentration (see Table 24). 18 of the participants completing the 
scales considered these changes to be related to the GrpMI treatment, highlighting a 
more positive attitude towards the disease and towards themselves (see Table 25). 
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Table 23. Percentage of changes perceived by participants in intensity of FM 
symptoms following GrpMI treatment. 
Changes of symtoms 
YES 23
NO 5
NA 3
Table 24. Changes in different FM symptoms perceived by participants following 
GrpMI treatment (percentage). 
Changes of intensity of the symtoms 
Pain 11
Fatigue 12
Sleep 9
Concentration 4
Mood 16
Table 25. Examples of participants' answers regarding perceived changes in the 
intensity of symptoms and their relation to GrpMI treatment 
Changes in intensity of symptoms and relation to GrpMI 
(5) I came out more positive; (2) coping better with situations which I hadn’t previously 
controlled; (1) less flagging and with a smile on my face.  
(3) I feel calmer. 
(1) It's helped me relax, sometimes making me feel less tired. 
(1) On some occasions it's increased the intensity of the pain, by stirring up feelings for 
example. Eventually, though, it reduces other symptoms like tiredness and improves my 
mood. 
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With regard to changes perceived in everyday life during or after the treatment, as 
can be seen in Table 26 and Table 27, 25 participants say they have seen some 
change, mostly often mentioning a change in their self-appreciation and self-
assessment (18 subjects; 58.1%), although they also mention changes in family 
relations, (16 subjects; 51.6%), relations with their partners (11 people; 35.5%) and 
in the case of 11 participants, relations with their children; 10 participants (32.3%) 
mentioned changes in their social life. Only 4 participants (12.9%) mentioned 
changes in their working life.  
All of them considered these changes to be related to the treatment, and particularly 
emphasised aspects relating to their self-assessment, where they value themselves 
more highly and, consequently, feel stronger and more secure in their relations with 
others (see Table 28).  
Table 26. Percentage of changes perceived by participants in aspects of everyday 
life after GrpMI treatment. 
Changes of daily life 
YES 25
NO 5
NA 1
Table 27. Percentage of changes in different areas of everyday life. 
Changes in daily life 
At work 4
Family life 16
Relationship with partner 11
Relationship with children 11
Social life 10
Self-esteem 18
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Table 28. Examples of answers from participants on changes perceived in everyday 
life after GrpMI, especially in the area of self-assessment. 
Answers regarding perceived changes in everyday life after GrpMI: 
Self-assessment 
(6) I value myself more; (5) and I place greater value on the things around me. (2) I enjoy 
the little things; (1) I value my own inner strength more, despite the obstacles.  
(6) I feel stronger and more secure in myself; (1) I am more capable of coping with 
problems; (1) I feel more vitality and more strength for resolving conflicts; (1) stronger in 
defending my opinion; (1) I am more secure and more comfortable.  
(3)I am calmer and more patient. 
(3) I dare to socialise more and am less reluctant to do so; I feel more comfortable in 
relations, less afraid. 
(3) I see my life with a more positive future; I live for the moment; I’m more positive, 
enjoying every situation, facing my future with the disease more positively, trying to 
understand myself; By reinforcing my self-esteem, it has opened up new paths for me 
(2) A change in my attitude towards myself: I accept what I have, without feeling guilty about 
it; (1) I love myself more; (2) I establish more limits. 
(2) I am more relaxed; I don’t feel as tired; I know how to pace myself and stop and rest. 
(2) I listen to my body and myself; (1) It has been a release of feelings. 
(1) Openness to greater creativity 
(n) number of times answered with the same or very similar words. 
In answer to an open question as to how GrpMI treatment has helped them, 
participants said it had been useful for: listening to themselves, knowing 
themselves, understand and respecting themselves more; gaining confidence, 
security and strength to express their feelings and accept their disease, finding 
empathy, support and respect within the group (see Table 29).  
Table 29. Examples of answers from participants on the usefulness of GrpMI. 
Answer on the usefulness of GrpMI 
(6) I felt encouragement and support from the group. (3) I felt listened to and loved. (4) We 
shared many common aspects, but there were also differences. (3) To learn from each of 
them. 
(5) To express and share my feelings; (3) with greater security; (3) and without shame. 
(3) To know myself a bit better, (2) and understand myself. (1) I heard myself; (1) As if had 
been born again or found the little girl that was trodden on; (1) To look inside myself and 
find memories 
(1) To look after myself more; To value what I have and to ask others for help. 
(1) To know different points of view and see connections with other aspects, and not only the 
pain.(1) To accept more (with more patience and understanding).  
(1) To find the peace I needed. (1) I came out of it relaxed, happier 
(n) number of times answered with the same or very similar words. 
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In the suggestions section, participants were asked if they would have liked to 
continue with the treatment. Of the total number who answered, 27 (87.1%) said 
they would; they suggested that the sessions should be longer (7), that the treatment 
should have lasted for more sessions (10), in order to express more intimate aspects 
or that it should have dealt in greater depth with components such as relaxation (3). 
Only 2 people expressed a preference for individual therapy. 
5.7. SUMMARY 
An analysis of the data shows that: 
The sample group comprised 56 participants, all women, with an equivalent age 
distribution (51.34 years) and an average of 10.6 years living with the disease. 
There is a predominance of married women and women with children. The majority 
have primary and secondary-level education. A much smaller percentage has 
completed tertiary education. 23.6% of the total have a disability or not fit for work 
certificate, while 21.8% work outside the home and the same percentage are 
unemployed. 
A large percentage of the women have some associated diagnosis (79.6%), the most 
common of which are osteo-articular disorders and depression. The probability of 
having an associated diagnosis is higher in the experimental group. A large 
proportion of the sample group (69.8%) habitually take medication.  
With regard to the study variables, the participants are characterised by low levels 
of subjective psychological wellbeing, high in impact of FM on functional capacity 
and health, and high levels of state and trait depression and trait anxiety. They also 
have an above-average perception of present pain intensity.  
Significant differences can be seen between the experimental and control subjects 
in impact of FM on functional capacity and health; the impact of the disease is 
higher in the experimental group.  
The correlational analyses show a significant positive correlation between in impact 
of FM on functional capacity and health, and perception of present pain intensity, 
anxiety, depression and anger. Similarly, subjective psychological wellbeing shows 
a significant negative correlation with impact of FM on functional capacity and 
health and the other variables (perception of pain, anxiety, depression and anger). 
The results of the analyses of covariance, performed to assess the effect of GrpMI 
treatment by comparing the experimental and control conditions, show positive, 
statistically significant, effects in subjective psychological wellbeing and state 
anxiety after treatment, and tendentially significant in impact of FM on functional 
capacity and health, intensity of pain, trait anxiety and state anger, comparing the 
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differences between the scores for the different study variables of the two groups 
after treatment. After three months, there were no statistically significant 
differences in these scores for any of the variables analysed, except state anger. 
For the experimental group, an analysis of intragroup differences, performed to 
assess the evolution of each of the conditions, experimental and control, in each of 
the variables assessed, showed as follows:  
 There is a statistically significant increase in perception of subjective
psychological wellbeing; i.e. participants receiving GrpMI treatment are
more satisfied and happier with their personal and material life, after the
treatment.
 There is a statistically significant reduction in the impact of FM on
functional capacity and health; i.e. participants receiving GrpMI treatment
registered an improvement in functional capacity and perception of quality
of life in relation to FM after treatment.
 There is a statistically significant reduction in the perception of pain
intensity in participants after GrpMI treatment.
 There is a statistically significant reduction in state anxiety, and a
tendentially significant reduction in trait anxiety; i.e. participants in GrpMI
treatment saw a reduction in emotional state of attention, apprehension and
hyperactivity at specific moments, and show less of a tendency to perceive
situations as threatening.
 There is a statistically significant reduction in scores for degree of
affectation (state) and frequency of occurrence (trait) of the emotional
components of depression in participants receiving GrpMI treatment.
 There is a reduction on anger both at specific moments (state) and in the
tendency to perceive situations as being annoying or frustrating (trait) after
GrpMI treatment.
On the contrary, the control group did not register statistically significant changes 
in any of the variables analysed, except in trait anxiety and trait depression. 
After three months, the experimental group continued to be better than before 
beginning treatment (pretest) in all aspects, although with no statistical significance, 
except in state anxiety, where the difference was statistically significant. The 
control group remained the same as before the experiment began, even registering 
some deterioration in some aspects.  
RCI was used to determine clinically significant changes. It showed a significantly 
higher percentage of experimental subjects registering improvement or recovery in 
at least three of the variables studied (57.6%), as compared to only 8.7% in the 
control group. The improvements, after three months, remained at 17.2% in the 
experimental group. 
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Finally, turning to the participants’ subjective assessment made after GrpMI 
treatment, it is worth noting that 51.6% perceived changes in mood, saying that the 
changes have had a (positive) influence on their everyday life, and have essentially 
improved their self-assessment (58.1%). Most of the participants attributed these 
changes to the group treatment.  
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CHAPTER 6. DISCUSSION AND 
CONCLUSIONS 
The principal objective of this study was to evaluate the effectiveness of GrpMI on 
a group of women with fibromyalgia (FM). Hence, the general hypothesis behind 
this research study was that GrpMI will improve participants’ subjective perception 
of their psychological wellbeing, whereas, impact of FM on functional capacity and 
health, pain perception, depression and anxiety will decrease significantly, as well 
as their experience, expression and control of anger. Additionally, I wanted to 
examine the demographic characteristics of the sample, to see whether correlation 
exists between study variables, and to assess whether the therapeutic results 
remained after three months.  
What follows is the discussion drawn from the specific objectives mentioned above 
and the hypotheses formulated from them (as presented in Chapter 3) and from the 
results as presented in chapter 5. Furthermore, the findings were compared with 
some of the most relevant research studies published in recent years. Finally, the 
contributions arising from this research, the limitations of the study, as well as 
recommendations for possible research based on the results of this present study are 
reported.  
6.1. DISCUSSION 
In this study it was decided to examine a group of women with FM because of the 
higher prevalence of the disease in women (EPISER, 2001).  
6.1.1. DEMOGRAPHIC, CLINICAL AND COMORBIDITY PROFILE 
The first specific aim of this study was to examine the demographic, clinical and 
comorbidity profile of the sample of women suffering from FM, who took part 
in this research.  
Women taking part in the study had a mean age of 51.34 and had been suffering 
from FM for an average of 10.6 years. As for their education; 42.9% had primary 
education; 8.9% university education and a significant 48.2% secondary education. 
23.6% had a disability or a not fit for work certificate, a similar proportion (21.3%) 
were unemployed, and only 12.7% of women stated that they were full-time 
housewives.  
These results are similar to the education profile described by other authors (Martín, 
Luque, Solé, Mengual, & Granados, 2000; Tobo Medina, 2007) in their studies. Yet 
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in this study, unlike what some others authors found (Wolfe et al., 2010), there is a 
significant percentage of women (48.2%) with secondary education. 
A comparative analysis between the two groups highlights socio-educational and 
employment profile differences between women allocated to the experimental 
group and those allocated to the control group, although these differences are not 
statistically significant. In the experimental group there is a higher percentage of 
women with primary studies (51.5%) than in the control group (30.4%) and also 
these women are in a worse employment situation than the control group as a 
whole. This poor educational and working situation of the experimental group may 
be related to the results in the impact of FM on functional capacity and health 
variable where (as reflected in the FIQ) they obtain lower scores than the control 
group. This relation is pointed out by Murray & Murray (2006), who claim that 
educational level and employment status may be predictors of the severity of FM.  
The study shows that FM is highly comorbid with: other osteo-articular diseases 
(53.7%), Chronic Fatigue Syndrome (24.1%) and endocrine diseases (11.1%). 
These results are consistent with the results of other studies (Junyent Priu et al., 
2005; Lera, 2006; Pérez-Pareja, Sesé, González-Ordi, & Palmer, 2010; Uguz et al., 
2010), who have also shown a high level of comorbidity with these and other 
diseases. In her descriptive, comparative and cross-sectional study of 190 women 
with FM, Govillard Garmendia (2011) also underscores high comorbidity with 
other diseases, pointing out the following diseases as the most frequent: Chronic 
Fatigue Syndrome (70.7%), Irritable Bowel Syndrome (61.3%), rheumatic arthritis 
(46.4%) and thyroidism (17.2%). However, she also describes the presence of other 
diseases, which our study did not find (restless leg, irritable bladder or night-time 
apnea syndromes). As has been shown in numerous studies, FM shares clinical 
manifestations with other diseases, which is precisely what makes diagnosis 
difficult (Clauw, 2009). Additionally, some of these diseases, such as Chronic 
Fatigue Syndrome and Irritable Bowel Syndrome may share common symptoms 
(Aaron et al., 2000) or have a common aetiology (Hudson, Goldenberg, Pope, 
Keck, & Schlesinger, 1992; Schur et al., 2007), which, according to several authors, 
may be related to alterations of central processing mechanisms (Aaron et al., 2000; 
Clauw et al., 1997). 
The fact that a significant percentage of participants had depression (20.4%) and 
anxiety (11.3%) disorders is in line with other studies that have underscored the 
high comorbidity of FM with both these pathologies (Sicras-Mainar et al., 2009). 
However, their unequal incidence should also be noted together with studies 
highlighting that they are independent of FM (Vallejo Pareja, Comeche Moreno, 
Ortega Pardo, Rodríguez Muñoz, & Díaz García 2009). The high percentage of 
people that were found to have a depression disorder, since this is the disorder most 
commonly associated with FM (42% of people with several associated disorders 
have depression), matches other studies, that found a high presence of depression 
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amongst people suffering from FM (Carta et al., 2006; De Felipe García-Bardón et 
al., 2006; Aguglia et al., 2011). However, fewer cases of anxiety disorders were 
found in this study (11.3%) when comparing with others studies, where between 58 
and 66% of people affected by FM had an anxiety disorder (De Felipe García-
Bardón et al., 2006). These results may be due to the fact, that the anxiety-
depressive symptomatology frequently associated with FM is not necessarily 
diagnosed as a differentiated psychiatric disorder. In fact, anxiety and depression 
symptoms, together with stressful life events and psychological trauma in 
childhood, are characteristics, commonly associated with FM and other syndromes 
with symptoms lacking an identified organic cause (Afari et al., 2014). 
Whatever the associated diseases are, the higher the level of comorbidity and the 
higher the probability of the disease becoming permanent, the more patients seek 
health services (Clauw & Crofford, 2003). This often contributes to deterioration in 
their quality of life and their level of activity. Such a high level of comorbidity 
makes it even more important to look into a coordinated, interdisciplinary approach 
to care and therapy that covers the whole range of patients’ medical, psychological 
and social conditions. 
In this study, once again differences were found between the control and 
experimental group with regard to the presence of associated diagnoses (79.6% for 
the control group and 93.8% for the experimental group); thus the latter having a 
1.59 higher probability of having some associated diagnosis. From this data we can 
deduce that the experimental group was more vulnerable than the control group at 
the beginning of the treatment, because they had a higher number of associated 
pathologies. Despite having made a random, blind allocation after having carried 
out the initial tests, the differences between the two groups emerged and seem to be 
down to chance. Or they could be down to mistakes in the design of the sample 
selection protocol, which may not have been sufficient discriminatory (because of 
the tremendous variety of FM associated symptoms and diagnoses) or not sufficient 
thorough, since no medical certification of diagnoses was asked for.  
As for medication, the majority of patients were on medication (92.5%), with 
analgesics and antidepressants being the most widely used. However, the 
percentage of women habitually taking two or more drugs (68%) was higher than 
the percentage described in other studies, in which only 18% of people suffering 
from FM were taking 2 drugs and just 10% were taking 3 (Cascada, Kasai, Inhalan 
& Schwartz, 2008). In FM treatment drugs to treat fibromyalgia are widely used 
and occasionally are the only treatment patients receive, despite the fact that no 
combination of drugs have proven effectiveness in treating all FM symptoms 
together (Abeles et al., 2008; López-Chicheri, 2012). 
The first hypothesis is formulated taking into consideration the characteristics of the 
sample, specifically with regard to the study variables: 
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Hypothesis 1. The women in the sample will show higher levels of impact of FM 
on functional capacity and health, pain, anxiety, depressive symptoms, and anger 
than the general population, whereas the subjective psychological wellbeing of the 
sample will be lower than amongst women who do not suffer FM. 
In the results of this study participants showed a lower perception of subjective 
psychological wellbeing than the general population (15th percentile on a range of 
1-100). 
Furthermore, they also displayed a severe level of functional incapacity in 
comparison to the general population (M = 71.46) (Bennett, 2005; Casanueva, 
2007), which is consistent with other studies, that emphasized moderate and high 
functional limitation levels and negative impact on health amongst people suffering 
from FM (De Felipe García-Bardón et al., 2006; Govillard Garmendia, 2011; 
Iverson, Le Page, Koehler, Shojania, & Badii 2007; Sayar et al., 2004).  
A Visual Analogue Scale (VAS) ranging between 0 and 10 produced higher than 
average pain intensity scores (M = 6.54) for these women, which is similar to the 
results given on a Perception of Pain Intensity (PPI) scale ranging from 0 to 5 (M = 
2.79). These scores are similar to those recorded for patients suffering acute or 
chronic pain. However, participants scored slightly higher on the VAS scale than 
the reference population, although the effect size is small. This difference may be 
related to the fact that the scores used for comparison with the VAS scale were 
measured on people, whose pain was principally (50.5%) related to rheumatic 
disorders. Many studies have pointed out differences in pain perception between 
people suffering from FM and those with other pain-related diseases. White et al., 
(2002) emphasize, that FM patients display higher pain intensity than those with 
rheumatoid arthritis as well as higher overall severity of FM, functional incapacity, 
fatigue and less health satisfaction. 
Furthermore, when comparing the scores from the whole of the sample with score 
ranges in the general population, the study shows high scores for state and trait 
depression (90th percentile in both). These figures confirm the symptomatic 
characteristics, which other studies on FM have shown with a prevalence of 
depression or depressive states amongst this population (Aaron et al., 1996; Bigatti 
et al., 2008; Jensen et al., 2010; Palomino et al., 2007; Rehm et al., 2010; White et 
al., 2002). 
High levels of state and trait anxiety (70th and 80th percentiles respectively) are 
consistent with other studies that mention the presence of anxiety symptoms in 
patients with FM (Aaron et al., 1996; Malt et al., 2002; Martin et al., 2000; Pagano, 
Matsutani, Ferreira, Marques, & Pereira 2004; Pérez-Pareja et al., 2004; White et 
al., 2002). High scores in trait anxiety (80th percentile) is similar to what other 
research studies have observed, when they compared 1) patients suffering pain, but 
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not from FM, using a control group (Pérez-Pareja et al., 2004), or they compared 2) 
patients with rheumatoid arthritis using healthy control groups (Besteiro González 
et al., 2008), or they compared 3) group treatment programmes for patients with FM 
(Camino Vallhonrat et al., 2009). Besteiro González et al. (2008) interpreted the 
high neuroticism scores (anxiety, hostility, depression, social anxiety and 
vulnerability) as an attempt to adapt to a chronic disease, and to a general subjective 
unease dimension to it (including moodiness, anger, annoyance, nervousness, fear 
or depression), which can lead to negative or threatening interpretations of different 
stimuli.  
Lastly, the study also finds the presence of anger experience, both in state anger 
and trait anger above 60th percentile, although this was not considered pathological 
(pathological levels are those above 75th percentile) (Miguel-Tobal et al., 2001). 
These results coincide with other studies indicating the presence of this emotion in 
people suffering from FM (Okifuji et al., 1999; Sayar et al., 2004). 
To conclude, these results allow us to confirm entirely the first hypothesis, because 
higher levels of impact of FM on functional capacity and health, pain, anxiety and 
anger, and lower subjective psychological wellbeing are observed in this group 
when comparing than with those of general population.  
However, it should be pointed out that not all people with FM show symptoms of 
anxiety, depression or anger. Some authors have actually suggested that anxiety and 
depression levels are variables that differentiate the impact of FM on functional 
capacity and health (Aaron et al., 1996; Calandre et al., 2011; De Souza et al., 2009; 
Giesecke et al., 2003). These authors defend the existence of subgroups within FM, 
considering that there are differential characteristics such as sensitivity to pain, 
anxiety and depression and cognitive coping abilities. They also reflect on applying 
different therapeutic approaches in treatment work with each subtype of FM 
patients. It has not been possible to determine, whether the diverse psychological 
symptoms are the causes or the factor that predispose or precipitate the disease or if 
they are the consequences of the disease. The presence of diverse psychological 
symptoms worsening the discomfort of people with FM, justifies following 
treatment interventions that take a biopsychosocial perspective, which concentrate 
on the person as a whole, dealing with all their dimensions. This can give back 
these people the ability to change or to adapt to the situation (Keller, Gracia, & 
Cladellas, 2011; Lledó et al., 2010). 
An analysis of the scores of the two groups shows differences between them, with a 
bigger deterioration in all variables in the experimental group, showing a significant 
difference in the score for the impact of FM on functional capacity and health (FIQ) 
for this group (M = 74.79, as opposed to M = 66.70 for the control group). These 
results are in line with the differences noted in demographic variables, where the 
experimental group was also identified as being in a worse condition. These results 
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suggest that one could relate worse levels of functional capacity to worse 
sociocultural and employment levels, something which has been mooted in other 
studies (Bergman et al., 2001; Brekke, Hjortdahl, & Kvien, 2001; Dobkin, De 
Civita, Abrahamowicz, Baron, & Bernatsky 2006). In this study such correlation 
has been worked out. 
Even though an analysis of covariance has been carried out using corresponding 
pretest scores as the covariable, this initial difference in the impact of FM on 
functional capacity and health on the two groups may have influenced the results of 
the intergroup analysis.  
6.1.2. CORRELATION BETWEEN VARIABLES 
The second specific objective of this study was to analyse the association between 
the different study variables. To do so the following hypothesis was formulated. 
Hypothesis 2: A significant positive correlation will be found between the impact 
of FM on functional capacity and health, pain perception and the different 
indicators of psychological distress evaluated (anxiety, depression and anger), 
whereas the relationship between all these variables and the indicators of 
subjective psychological wellbeing will be negative. 
The results show a statistically significant positive correlation between the impact 
of FM on functional capacity and health, pain perception and the different 
indicators of psychological distress, namely anxiety, depression and anger. In other 
words they confirm the tendency to feel more pain perception, anxiety, depression 
and anger. The higher the impact of FM on functional capacity and health, the 
higher the tendency is to feel more pain perception, anxiety, depression and anger. 
The results also confirm significant negative correlations between subjective 
psychological wellbeing and the impact of FM on functional capacity and health, 
pain, anxiety, depression and anger. In other words, when physical and 
psychological symptoms worsen there is evidence of a reduction in perception of 
quality of life and subjective psychological wellbeing. Thus, it can be concluded 
that the data corroborate virtually the whole of the second hypothesis.  
These results are consistent with other studies showing that the incapacitating 
effects or impact of FM on functional capacity and health (when measured using 
FIQ) predict a higher degree of emotional disturbance (Bigatti et al., 2008; Huber, 
Suman, Biasi, & Carli, 2008; Pagano et al., 2004; White et al., 2002), and higher 
pain intensity (Jensen et al., 2010; Perrot, Bouhassira, & Fermanian, 2010). In other 
studies the relation between these dimensions is expressed by highlighting, that 
emotional symptoms (especially anxiety and depression) predict state of health 
(Epstein et al., 1999; Lledó et al., 2010; White et al., 2002) and the impact of FM 
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on daily life (Dobkin et al., 2006; Goldenberg et al., 1994; Verbunt, Pernot, & 
Smeets, 2008; White et al., 2002).  
However, the results of this study are different to those of Jensen et al. (2010), who 
observed no relationship between symptoms of pain related to anxiety or 
depression, although this may be because the results are drawn from a study in 
which pain was induced experimentally and hence the perception of pain may not 
share the same characteristics as the perception of pain of FM. Other studies 
provide opposite results, more in line with the results of this study, where a 
relationship between pain intensity and anxiety was found (Fietta et al., 2007; 
Kurtze & Svebak, 2001; Wilson, Robinson, & Turk, 2009). 
The only area where insufficient statistical significance was found was in the 
correlation of impact of FM on functional capacity and health with trait anger and 
the anger expression index. Even so there was positive correlation between state 
anger, health, functional capacity and the remaining dimensions, namely 
depression, anxiety and pain. This means the worse a person perceives state of 
health and lower functional capacity, the higher the tendency to feel anger. 
Furthermore, when state anger increases, pain, anxiety and depression do so too. 
These results may be related to an adaptive tendency towards pain. When patients 
increase their level of attention towards bodily sensations, it may lead them to 
respond to discomfort with negative moods such as agitation, fear, anger and 
despondency (Besteiro González et al., 2008).  
6.1.3. EFFECTIVENESS OF TREATMENT 
6.1.3.1 Effectiveness of treatment after intervention 
The main aim of this study is to assess the effectiveness of GrpMI on the one 
hand, by comparing subjects receiving treatment with a control group of 
similar characteristics who do not receive treatment (intergroup analysis). On 
the other hand, by taking into consideration the development of participant 
according to each of the study variables (intragroup analysis).  
Below you find a discussion of the results obtained for this third objective 
consisting of: 1) the intergroup comparison, 2) the intragroup development of each 
variable, 3) clinical significant changes (RCI) 4) evaluation of the participants´ self-
recorded questionnaires. All these results are discussed according to each of the 
hypotheses. 
Hypothesis 3: GrpMI will significantly increase the subjective psychological 
wellbeing of the women receiving treatment. 
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Study results from the intragroup comparison indicate that the experimental group 
had a statistically significant increase (with a medium effect size) in their 
perception of subjective psychological wellbeing compared to the control group. 
Consistent with this finding, the intragroup comparison results also show (with 
statistical significance) that the experimental group had improved levels of 
subjective psychological wellbeing at the end of treatment, whilst the control group 
felt worse in comparison to their original situation. Along the same lines, results 
obtained from the Reliable Change Index (RCI) confirm that the experimental 
group had a 39.4% recovery at the end of treatment, whilst in the control group only 
13% had an increase in subjective psychological wellbeing, with 60.9% (14 out of 
23 people) declaring a worsening of this variable.  
Based on these results, hypothesis three is entirely confirmed and GrpMI treatment 
is shown to be effective at increasing the subjective wellbeing of people with FM.  
These results are similar to results from a study finding positive changes to the 
subjective wellbeing and quality of life of cancer patients after applying GIM 
(Burns, 2001) and to Jacobi & Eisenberg’s (2002) study. They used the SCL-90 
scale for measurement and also indicated an improvement of the psychological 
distress in the 27 patients with rheumatoid arthritis. 
If we compare these results with those obtained using the same assessment tool 
with FM patients receiving other treatments (in this case cognitive-behavioural 
treatment), they are consistent with the results described by Govillard Garmendia 
(2011). She found improvement in psychological wellbeing when applying 
individual treatment (n = 33) with electromyogram feedback and group treatment 
(n = 33) without biofeedback, and she found that the subjective psychological 
wellbeing of the control group (n = 22) decreased.  
Subjective wellbeing is related to an increase in positive emotions and a decrease in 
negative emotions. According to the evaluation of the participants´ self-recorded 
questionnaire, the participants refer to an increase in positive emotions (joy, 
satisfaction, affection), and a reduction in negative emotions (sadness, anxiety, 
anger, blame and shame). Furthermore, it should be pointed out that 18 participants 
noted positive change in the way they perceived themselves, which is a real relevant 
dimension, when referring to perception of wellbeing. Some studies describe the 
following issues that help increase subjective wellbeing: a) participating in a group 
and feeling the support of this group, b) keeping oneself active despite pain or 
fatigue, c) finding satisfaction in small things, d) setting priorities and rationing 
effort, e) adapting the pace of activities and f) increase in self-confidence (Juuso, 
Skär, Olsson, & Söderberg, 2011; Sallinen, Kukkurainen, & Peltokallio, 2011; 
Söderberg, Lundman, & Norberg, 1999). These many aspects, mentioned by other 
authors were also described subjectively and individually by participants in GrpMI 
treatment as being for them the most positive part of this treatment. Descriptions of 
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similar noteworthy aspects after GIM therapy have also been described in the 
literature (Blake & Bishop, 1994; Maack & Nolan, 1999; Murphy, 2008; Skaggs, 
1997).  
The GIM method focuses mainly on recognising and expressing emotions (both 
pleasant and “negative” ones) and it has been found to be more effective to express 
emotions than not expressing them, both in the case of FM and concerning other 
chronic diseases (Geenen, van Ooijen-van der Linden, Lumley, Bijlsma & van 
Middendorp, 2012; van Middendorp et al., 2008).  
Hypothesis 4: After treatment, there will be a significant reduction of the impact 
FM has on functional capacity and health of the women receiving treatment. 
The data obtained from comparing the impact of FM on functional capacity and 
health of subjects in intergroup analysis (experimental and control) show a 
tendentially significant difference between them. But it is worth noting that 
improvements were observed in FIQ scores in the experimental group with a 
difference of 11.21 between pretest and posttest scores, in comparison to virtually 
no change in the FIQ scores of the control group. If scores obtained from intragroup 
analysis are examined, there is in the experimental group a statistically significant 
reduction of the impact of FM on the functional capacity and health after receiving 
GrpMI sessions, whilst in the control group the pretest-posttest differences are not 
significant. Consistent with these results, the RCI analysis confirms a significantly 
higher percentage of experimental subjects (57.6%), who show improvement in this 
variable. In the control group, only 3 subjects (13.0%) showed improvement.  
Therefore it can be concluded that the data obtained confirm virtually the whole 
hypothesis 4 and they highlight the reduction of the impact of FM on the functional 
capacity and health of participants receiving GrpMI treatment.  
The results of this study, showing the positive effects of GrpMI treatment on the 
overall impact of FM on functional capacity and health of women with FM are 
similar to those obtained by Menzies et al. (2006), who noted a reduction in the FIQ 
scores of people suffering from FM after treatment using visualisation or guided, 
pleasant pre-recorded images, when the scores were compared with those of a 
control group. However, Verkaik et al. (2014) did not find any significant effects 
when they applied the same techniques.  
Taken together, results from this study suggest that GrpMI treatment helps reduce 
the impact of FM on functional capacity and health more significantly and 
positively than using other techniques with only one part of the components of this 
method, be it music-listening, relaxation or guided visualisation (Baranowsky et al., 
2009; Glombiewski et al., 2010; Sim & Adams, 2002).  
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Furthermore, this treatment requires the support and accompaniment of an educated 
therapist (Dileo & Bradt, 2005), and in this case results are comparable to those 
obtained from applying group cognitive-behavioural therapy (Anderson & Wincker, 
2007; Glombiewski et al., 2010). 
Hypothesis 5: As a result of treatment, women taking part in the study will 
experience a significant decrease in pain perception as expressed in current pain 
intensity. 
When results from the PPI (Present Pain Intensity) scale are used to describe pain 
perception, there is a decrease in scores given by women in the experimental group 
but not in the control group. However, no differences were found between the two 
groups in the intergroup analysis in measurements recorded on the Visual Analogue 
Scale (VAS). These results contrast with data obtained from the intragroup analysis, 
where participants receiving GrpMI (those in the experimental group) showed a 
statistically significant decrease in pain perception on both the VAS and PPI 
subscales, whilst the control group showed no significant differences between 
pretest and posttest scores on these same scales used to measure pain perception. 
Similarly the RCI analysis showed that 54.5% of participants receiving treatment 
(in the experimental group) experienced improvement or recovery in pain 
perception as opposed to 17.4% in the control group, where, in fact, 62.5% of the 
participants worsened.  
Therefore, these data confirm practically the whole of hypothesis 5. 
These results are consistent with those obtained by Jacobi & Eisenberg (2002) in 
their study of 10 sessions of individual GIM treatment given to 27 patients with 
rheumatoid arthritis, who scored significant reduction of pain perception on the PPI 
scale of the MPQ test. Other research studies have also highlighted pain reduction 
amongst people suffering from FM, when treatments using music listening (Garza-
Villarreal et al., 2104; Guétin et al., 2012; Onieva-Zafra et al., 2103), relaxation 
(Field et al. 2002; Keel et al., 1998; Kravitz et al, 2006; Rucco et al, 1995; van 
Santen et al, 2002), visualisation (Castel, Pérez, Sala, Padrol, & Rull 2007; 
Hammon & Freeman, 2006) or guided imagery (Bjellånes, 1998; Fors et al., 2002) 
are offered. In contrast, other studies did not find significant differences when 
applying treatments using only guided imagery (Menzies et al., 2006; Verkaik et al., 
2014) or relaxation (Hassett et al., 2007). 
The intragroup analysis of this study suggests that GrpMI treatment has a positive 
influence on those participants who receive it, in that it reduces pain (with a 
medium-large effect size) in a way comparable to other multi-component cognitive-
behavioural treatments. This contrasts with the results of the meta-analysis of 
Glombiewski et al. (2010), who showed a small effect size in pain reduction when 
psychological treatments were used.  
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The quality and intensity of the changes that patients experienced could be related 
to aspects underscored in other studies such as: a) changes to images of pain 
(Bjellånes, 1998); b) an increase in energy and coping capacity (Jacobi & 
Eisenberg, 2002); c) distraction from concentration on pain with greater focus on 
relaxation, active strategies and social relations (Torre et al., 2008); d) embracing 
positive pain coping strategies (Govillard Garmendia, 2011); e) pain acceptance 
(Cuevas Toro, 2010; González-Menéndez et al., 2010; McCracken & Eccleston, 
2003; McCracken, Carson et al., 2004; McCracken, Vowles et al., 2004) or f) the 
intrinsic positive factors of group psychotherapy (Anderson & Wincker, 2007).  
GrpMI therapy contributes to better pain acceptance by dealing with the many 
physiological, emotional, cognitive and behavioural variables involved in pain 
perception. GrpMI therapy can be used to incorporate positive breathing, self-
control and relaxation strategies, and it can help patients focus on pleasant images. 
It can also help in reflecting on the personal meanings given to pain and its 
relationship to other psychological and emotional states. All of these elements assist 
patients in: a) developing greater self-confidence, b) makes it possible for them to 
express and regulate emotions, and c) find an identity that is not only defined by 
pain and disease. 
Hypothesis 6: After treatment, state and trait anxiety will be significantly reduced 
in the group receiving treatment. 
When looking at the effects obtained on anxiety and comparing the experimental 
group with the control group, a statistically significant reduction of state anxiety 
was seen in the experimental group, coupled with a tendentially significant 
reduction in trait anxiety. Equally, an intragroup analysis showed that the group 
receiving treatment displayed a statistically significant reduction both in state and 
trait anxiety (with a medium-large effect size). However, in the control group there 
was no significant change to pretest and posttest results for state anxiety, although 
there was a statistically significant reduction in trait anxiety at posttest. Finally, the 
RCI analysis showed that 57.6% (19 out of 33 participants) of the experimental 
group experienced an improvement in their state anxiety after receiving treatment, 
as opposed to 30.4% (7 out of 23 subjects), who showed improvement in this 
variable in the control group. 47.8% of this same control group actually 
experiencing a worsening of this variable.  
Based on these results it can be said that the data observed confirm practically the 
whole of hypothesis 6 since state anxiety was reduced in the group receiving 
treatment (to a statistically significant level). However, the changes to trait anxiety 
were not statistically significant in the experimental group. Trait anxiety is a 
personality characteristic, which is relatively stable over time and in different 
situations, but, depending on the person’s specific situation at the precise moment 
of the test, it may be influenced by past experiences (Spielberger et al. 1970).  
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One conclusion that this study draws on anxiety is consistent with those described 
by Camino Vallhonrat et al. (2009) who, using the STAI test as a means of 
assessment, measured the effect of 10 group treatment sessions given to patients 
with FM on the anxiety variable. They considered the anxiety variable “the reactive 
response to pain, as well as a generator and intensifier of pain” (p. 207). In their 
results they indicate: 1) a high prevalence of state and trait anxiety, with the latter 
being higher at the beginning of treatment; 2) a significant reduction in state anxiety 
and a slight (non-significant) reduction in trait anxiety. These authors interpret that 
trait anxiety “is generated by structural personality aspects and by the social-family 
context that require family intervention and a longer period of treatment” (p. 214). 
Several studies of research coincide in highlighting, that GIM treatment leads to a 
positive reduction of anxiety in cancer survival patients (Bonde, 2005; Burn, 2001; 
McKinney & Clark, 2003), and in people suffering from work-related stress (Beck 
2012). Other studies also indicate how treatment, focusing on one of the 
components of GrpMI, such as relaxation (Field et al., 2002); relaxation, music and 
guided imagery (Hammer, 1996); relaxation and pleasant visualisation (Fors & 
Götestam, 2000); and music listening (Garza-Villarreal et al., 2014) also have this 
same effect of positive anxiety reduction. There are also many research studies that 
provide a reduction in anxiety after the application of a cognitive-behavioural 
programme (Camino Vallhonrat, et al., 2009; Collado et al., 2002; Comeche 
Moreno et al., 2010; Gelman, Lera, Caballero, & López, 2002; Govillard 
Garmendia, 2011; Moioli & Merayo, 2005; Vázquez-Rivera et al., 2009). 
The positive effects of treatment on state anxiety can be interpreted in different 
ways and from several perspectives. Some authors maintain that learning breathing 
and relaxation techniques can contribute to reduce hypervigilance, reduce being 
alert to and anticipating situations of pain. Other authors maintain that the use of 
distraction strategies (with or without music and images) can reduce fear and 
avoidance of certain situations. GrpMI therapy helps a person become more 
familiar with experiences of bodily tension. It incorporates relaxation strategies and, 
through the use of music, offers support, structure and containment. On the other 
hand, the use of music, by adding stronger dynamics and more tension to the music 
progressively, encourages the person to explore the imagery of uncomfortable 
situations, and invites the person to face the conflicts that lie beneath her/his 
distress. In fact, in GrpMI some participants may not feel comfortable, and may not 
experience pleasant visualisations, rather quite the opposite. At times, they may feel 
higher anxiety, stress or distress because during relaxation they are not always in 
control. With the help of music listening, thoughts and feelings that they had hoped 
to be able to ignore or to suppress, come to the surface in images. By working on 
consciousness of previous (or current), unpleasant conflicts and emotions, these 
people can: 1) improve their respect towards and conscious attention of their own 
intimate perception, 2) increase their self-assurance and self-confidence, and 3) 
reduce the impact of conflicts on the current moment. In other group therapy (such 
as brief, group psychoanalysis) the focus is on naming and expressing conflicts or 
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on a symptom’s symbolic value (De Felipe García-Bardón, 2012; De Felipe García-
Bardón et al., 2007). They have shown similar results in anxiety reduction. 
Hypothesis 7: After treatment, the affective component of state and trait 
depression will be significantly reduced in the women receiving treatment. 
When assessed through the State-Trait Depression Questionnaire (ST/DEP) tool, 
scores for affective components of depression improve both in state depression and 
trait depression after GrpMI treatment in the experimental group, although they are 
not statistically significant when compared to the control group. Thus the scores for 
the group receiving treatment (who initially had worse depression levels than the 
control group) go down in the frequency (trait) and intensity (state) of depressive 
symptoms, whilst in the control group they stay virtually the same, without any 
changes to pretest and posttest scores. Consistent with these results, when analysing 
intragroup scores, the difference in pretest and posttest scores of the experimental 
group are statistically significant. Although, there are no significant differences to 
state depression in the control group, there is a statistically significant reduction to 
trait depression in this group. The RCI analysis showed that state depression 
improved in 17 women (51%), in the experimental group, whilst in the control 
group only 6 participants (26%) underwent an improvement in mood, whoever 12 
(52.2%) were actually worsening in this dimension.  
These results mean that practically the whole hypothesis 7 is confirmed since there 
is a statistically significant reduction in state and trait depression in the 
experimental group, although this significance is not corroborated when compared 
with the control group. Even so, except for trait depression, the control group did 
not show any significant changes in this variable.  
The results of this study are consistent with others studies in which GIM treatment 
has proved to be beneficial in reducing depressive mood in people with rheumatoid 
arthritis (Jacobi & Einsenberg, 2002), cancer (Bonde, 2005), workplace stress 
(Beck, 2012), and healthy adults (McKinney et al., 1997). These results are also 
endorsed by research studies that use one or some of the parts of comprehensive 
GrpMI treatment. Onieva-Zafra et al. (2015) reports a significant reduction in 
depression after treatment using music and guided imagery. Studies that used 
meditation and mindfulness techniques also confirm a reduction in depressive 
symptoms (Astin, et al., 2003; Quintana & Rincón Fernández, 2011; Sephton et al., 
2007; Smith, Harris, & Clauw, 2011). Specifically, these kinds of studies promote 
self-observation, reflection on and acceptance of pain and promote encouragement 
of patients to observe life and symptoms from new viewpoints. So these viewpoints 
acquire higher meaning, become more comprehensible and therefore, more 
manageable (Sephton et al., 2007). GrpMI stimulates these aspects in a similar way 
by encouraging participants to surrender /let go into the musical experience and to 
allow spontaneous image creation in a non-ordinary state of consciousness.  
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As Bernardy, Füber, Köllner & Häuser (2010) and Glombiewski et al., (2010) have 
highlighted, cognitive-behavioural therapies are also effective at reducing the 
depression of people suffering FM. The treatments referred to by these authors use 
strategies, which underlie the GrpMI method, such as strengthening positive skills, 
facing up to problems and opening up to new perspectives. Authors such as 
Comeche Moreno et al., (2010), Govillard Garmendia (2011), and Moioli & 
Merayo (2005) obtain similar results for reducing affective components of 
depression as the results obtained in this study by applying group cognitive-
behavioural treatments.  
These positive changes in the reduction of affective symptoms of depression using 
GrpMI treatment suggest that a depressed mood can be improved when people who 
suffer from FM can a) find a place to be listened to, b) are given the possibility of 
expressing their mood, c) experience a series of sensations, emotions or thoughts, d) 
process them all in their own way, e) observe improvements to other symptoms of 
their disease, and f) share this experience with other people. In their subjective 
evaluation of treatment, 16 participants in this study noted a better mood and 
recovery of their desire to live, fight and lead a “normalised” life, even if the pain 
and disease did not completely disappear. This is consistent with the study of 
Palomina et al. (2007) that highlights the influence of feelings of powerlessness and 
unmanageability on depressive symptoms.  
However, the conclusions of this study on the effect of GrpMI treatment on 
depression show how difficult it is to evaluate fixed, stable conditions (trait) 
separately from specific one-off situations (state), a condition which is especially 
important to be aware off if progress should be done in ways of researching the 
differences in these conditions.  
Hypothesis 8: After treatment, women will see a significant decrease in their 
experience, expression and control of anger. 
When analysing results for anger experience, expression and control in this study, 
the experimental group showed a significant trend towards improvement in state 
anger, despite still obtaining lower scores than the control group. If we observe the 
scores of both groups before treatment, it can be seen that initially the experimental 
group was in a worse condition for state anger than the control group. However, 
posttest scores for the group receiving treatment were lower in state anger, whilst 
the scores of the control group remained the same. In other words, perception of 
stress, anger, current irritation and frustration when facing difficult obstacles, went 
down in the experimental group after GrpMI treatment. This group also improved 
in trait anger, i.e. anger outbursts were less frequent and/or intense (although not 
statistically significant) when compared with the control group. These results are 
consistent with data from intragroup analysis, where the group receiving treatment 
recorded a statistically significant reduction in their score for state and trait anger 
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after GrpMI treatment (with a medium-large effect size), whilst the control group 
hardly showed any changes to this variable. In the RCI analysis only 9 participants 
(27.3%) in the experimental group showed an improvement in their state anger, 
whilst 16 (48.5%) deteriorated. In the control group 17 of the 23 (73.9 %) people 
deteriorated in this dimension.  
After examining the results it can be concluded that practically the whole 
hypothesis 8 has been confirmed since there has been a tendency for state anger to 
decrease in the group receiving GrpMI treatment and an improvement in trait anger 
and the anger expression index (although not statistically significant) when 
compared to the control group.  
It has not been possible to compare the results of this study with other, similar ones 
applying GIM or GrpMI. Positive effects on anger-hostility (one of the six moods 
measured on the POMS scale) are found in a study by Burns (2001), who found an 
overall improvement in the mood of cancer survivors after GIM treatment. 
Wrangsjö & Körlin (1995) also noted a significant reduction in the hostility variable 
in a comparative study on the levels of psychiatric symptomology after GIM 
treatment.  
Govillard Garmendia (2011) found a decrease in anger (state, trait and anger 
expression index) after applying group cognitive-behavioural treatment and using 
STAXI as an assessment method. The study of Camino Vallhonrat et al. (2009) also 
measured this variable and described significant scoring for feelings of anger and 
frustration amongst patients with FM (trait anger), and described lower levels on 
the anger expression index at pretest. However, posttest measurements did not 
show significant reductions in anger scores.  
The positive effects of reducing state anger and, to a lesser extent reducing trait 
anger after GrpMI treatment may be related to an improvement in the tension-
release relation. It may also be related to the possibility this treatment offers of 
dealing with painful emotions via been confronted with imageries and via a wide 
variety of additional strategies such as: 1) expression of what are considered 
“negative” emotions, 2) acceptance of emotions and thoughts of anger and the 
symbolic comprehension of these thoughts, together with 3) higher security and 
strength when managing these emotions in both an intra and interpersonal way. 
This was also stated in some of the comments appearing in the self-recorded 
questionnaires filled out after GrpMI treatment had finished.  
As a conclusion, the results show the positive effect of GrpMI treatment on the 
emotional variable anger. As van Middendorp et al. (2010) say, this findings 
suggests the need to carry out further research into examining the emotion of anger 
in effective FM treatment, as anger can be another emotional indicator of physical 
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discomfort in FM. GrpMI treatment can help facilitate anger expression and anger 
regulation in a calm, symbolic way. 
6.1.3.2 Effectiveness of treatment in the follow up test 
Finally, the fourth specific objective of this study addressed a check on whether 
the therapeutic results remained three months after the end of treatment. 
Hypothesis 9: The effects of GrpMI therapy on people with FM will remain three 
months after the end of treatment. 
The results of the intergroup analysis examined three months after end of treatment 
show, that improvements in subjective wellbeing, impact of FM on functional 
capacity and health, state and trait anxiety, state and trait depression and current 
pain perception (measured on a VAS scale) were maintained, despite not being 
statistically significant. As has already been mentioned above, when referring to the 
state anger variable it did improve, the experimental group did improve, despite the 
fact that initially this group scored worse than the control group for this variable. In 
the follow up test the scores for the control group actually deteriorated, but because 
of the initial differences between the two groups the follow up results do not mirror 
these changes. 
According to the data, the results from the intragroup analysis show that the group 
which received GrpMI treatment maintained a statistically significant reduction in 
impact of FM on functional capacity and health (with a medium-large effect size), 
current pain perception, trait anxiety and trait depression and state and trait anger 
as well as in state anxiety (although in the state anxiety, it was not statistically 
significant). Subjective wellbeing also maintained its improvement (although once 
again, without statistical significance).  
However, when intragroup progression of the control group was analysed, no 
significant differences were found after three months. Hence, it can be said that 
members of the control group did not perceive changes to their state of health and 
functional capacity nor did perceive changes to their subjective wellbeing. They 
even showed a degree of worsening in some symptoms such as state anxiety (not 
statistically significant) and state anger (statistically significant) (see Table 18).  
Finally, the RCI analysis shows that only a few participants maintenance of 
recovery in the experimental group but still these scores are better than scores of the 
participants of the control. In the control group, only one participant maintained the 
recovery in impact of FM on functional capacity and health. 
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These results partially confirm hypothesis 9 since it can be seen that the 
experimental group maintains its positive increase in subjective psychological 
wellbeing and also maintains its reduction in impact of FM on functional capacity 
and health, state and trait anxiety, state and trait depression, pain perception and 
especially state anger. No members of the experimental group returned to the state 
of deterioration they were in before GrpMI treatment.  
The significant differences in state anger scores in the intergroup analysis could be 
related to the treatment process, because participants in the experimental group 
received GrpMI treatment and experienced therapeutic relationships in the group, 
which brought about changes in their symptoms. Furthermore, there were also 
changes in the relationships among the members of the group, where participants 
experienced increased feelings of being understood and supported by the other 
members, as friendships were growing. Unlike the experimental group, the 
members of the control group may have experienced frustration or feelings of 
unfairness, because they did not share feelings with other group members, nor did 
they receive treatment.  
Conclusions drawn from these results may also be influenced by the frequently 
mentioned reduction of the effect of therapy over time. Many authors recommend 
that maintenance or “booster” sessions be programmed at the end of treatment. In 
this vein, virtually all those who participated in treatment said that they would like 
to have continued with GrpMI and they expressed an interest in carrying on 
participating in these kinds of activities. They expressed these wishes although 
some studies show difficulties in getting these patients to comply with and commit 
to treatment.  
6.2. CONCLUSION 
The results of this study reveal a higher level of psychopathology in people with 
FM than will be found in the general population including: a higher perception of 
pain, anxiety, depression and anger and lower perception of subjective wellbeing. 
This confirms the heavy physical and emotional malaise suffered by people with 
FM. The women who took part in this study share psycho-socio-demographic 
characteristics of women in other research studies on the FM population. The fact, 
that this group is different to the general population, justifies that different, 
interdisciplinary treatment possibilities should be offered. 
In the study, both groups (experimental and control) had a homogenous distribution 
in age, marital status and in the amount of time they had been suffering from the 
disease. However, there were differences between subjects in the experimental 
group and those in the control group. In the experimental group (although these 
differences were not statistically significant) a greater proportion of women had 
primary studies, their employment situation was worse and they had higher 
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comorbidity with other diseases. This high level of patient diversity makes it even 
more important to take a biopsychosocial perspective on this disease and to look 
into person-centred therapy approaches that take care of the whole range of the 
patients’ medical, psychological and social symptoms. 
The results also reveal correlation between study variables, reflecting a relation 
between the impact of FM on functional capacity and health - and pain intensity, 
anxious and depressive states and anger. This relation shows that as perceived pain, 
anxiety, depression or anger increase, and subjective psychological wellbeing 
decrease. Although it is not an indication of a cause-effect relationship, the results 
show that any treatment, which work with and influence one or all of these 
emotional aspects, will also have an effect on a person´s state of health, quality of 
life and subjective wellbeing.  
As for the effectiveness of this GrpMI treatment, it should be highlighted that the 
results of this study reveal that women who received 12 treatment sessions were 
shown to have a statistically significant increase (with a medium effect size) in 
subjective wellbeing and state anxiety when compared with the control group. The 
results also demonstrated a decrease in the impact of FM on functional capacity and 
health and in trait anxiety, state anger and current pain intensity, although with 
lower statistical significance and a smaller effect size.  
The progress data recorded from each of the two groups (control and experimental) 
at different evaluation moments, reveal that the experimental group obtained a 
statistically significant positive effect in all variables after treatment, whilst the 
mean scores for the control group remained virtually unchanged at posttest 
evaluation. Furthermore, when comparing treatment effects on the individual 
clinical progress of each participant (RCI), 19 participants (57%) in the 
experimental group showed improvement in at least three variables after GrpMI 
treatment whilst just 2 participants (8.7%) in the control group obtained 
improvement in at least three variables, at the same time as the same participants 
felt worse in at least one other variable. 
At the follow-up test the positive effects of GrpMI treatment were maintained, 
although it was not found to be statistically significant at the intergroup analysis. 
However if reflecting on the intragroup analysis, differences in the experimental 
group between pretest and follow-up test are significant in the impact of FM on 
functional capacity and health, pain intensity, trait anxiety, and depression and in 
state and trait anger. In other words, improvements in the experimental group are 
maintained after three months. On the other hand, there are no significant changes 
between pretest and follow-up test for the control group – even if there were 
worsening of some variables, such as with state anger. The RCI analysis shows a 
low percentage of maintenance/perpetuation at follow up test for the experimental 
group, although the level is still higher than that of the control group, and there are 
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no variables returning to pretest - levels. The general tendency that benefits are 
reduced over time makes it advisable that treatment is offered for a longer period, 
even if the treatment consists only of booster sessions, to secure the maintenance of 
the benefits. 
The positive changes observed in the participants can be interpreted to be due to the 
positive effect of GrpMI treatment and not due the passing of time or due to other 
reasons. Nevertheless, the therapeutic improvement might simply be due to the 
beneficial results of taking part in treatment. Authors such as Allen, Escobar, Leher, 
Gara & Woolfolk (2002) hypothesize that expectations of improvement and 
attention from a healthcare professional or the stimulus of returning to healthy 
functioning may be the elements that positively influence the outcome of treatment 
for people with disorders that have multiple, unexplained physical symptoms 
(Sánchez-García, 2014). Undoubtedly, having regular group meetings with a 
specific aim enables cohesion and interpersonal support and this, in its turn, helps to 
reduce the social isolation, and the tendency to a passive lifestyle that many people 
suffering from FM present. They claim that pain is what limits them in this way 
(Quintana & Rincón Fernández, 2011). Thus the task of encouraging and 
motivating this population to continually and systematically participate in 
programmes, treatment and sessions that encourage social interaction, is very 
important.  
Group psychotherapy models mostly achieve positive psychological and functional 
effects (Anderson & Winkler, 2007) because group work facilitates emotional 
expression and sharing of feelings and thoughts and allows participants to observe 
and practice different illness coping strategies (Anderson & Winkler, 2007). It also 
alleviates feelings of desperation, powerlessness, depression and anxiety, fostering 
a reduction in physical discomfort (Allen et al., 2002; Sánchez-García, 2014). The 
women who received GrpMI treatment emphasized the positive effects of this 
group relationship in the answers to the self-reported questionnaires. 
The conclusions of this study coincide with data published on the effectiveness of 
the GIM and/or GrpMI methods, when used with medical patients suffering from 
pain. These methods are shown to be more effective than treatment focussing 
exclusively on just one of the elements in the methods as relaxation, guided 
imagery or music. The effects are comparable to other multi-component cognitive-
behavioural group therapies.  
The study validates the benefits of the therapeutic care that GrpMI offers - a method 
that simultaneously deals with the different areas of needs of the person as a whole, 
and respects the person’s state of being and respects the personal definitions. The 
study encourages a search for new, individual perspectives in treatment of FM 
patients and GrpMI should be considered as an alternative, complementary therapy 
in treatment of people suffering from FM.  
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6.3. CONTRIBUTIONS AND LIMITATIONS OF THE STUDY 
6.3.1. CONTRIBUTIONS 
Data from this empirical study provide evidence of how GrpMI treatment fosters 
positive changes in the different symptoms from which people with FM suffer. 
GrpMI reduces perceived pain perception; intensity or state anxiety, intensity of the 
affective components of depression, and the experience, expression and control of 
anger. GrpMI also increases the subjective wellbeing, functional capacity and 
health of the women with FM participating in the study. Thus it provides empirical 
evidence, that this kind of treatment can be considered beneficial when dealing with 
FM, and that short and medium term effects of this treatment are comparable to 
those of other psychological treatments. 
This medium-sized study (70 participants) used quantitative methodology and a 
controlled, randomised design with a control group. The variables were evaluated 
with proven, valid and reliable tools, and measurements were scored at three 
different moments. This means the study has objective elements that can be 
compared with similar pieces of research. It also means that the work of music 
therapists and more specifically GrpMI therapists, has gained clinical relevance and 
specificity amongst the healthcare community, even if these methods still are quite 
unknown and even if they first now are emerging as a form of treatment in the 
healthcare system. This study can be used as an example and as a means to 
motivation for further research studies in this field for music therapists and GIM 
therapists interested in FM and in other populations of similar characteristics.  
The study illustrates the correlation between the impact of FM on functional 
capacity and health (and hence its impact on quality of life), and the malaise caused 
by variables such as pain, anxiety, depression and (with a less statistical 
significance) anger. Opposite, subjective wellbeing is negatively influenced by the 
symptoms analysed in the study, namely: impact of FM on functional capacity and 
health, intensity of perceived pain, anxiety, depression and anger. This corroborates 
the results of other studies, which suggest a link between the mutual influence of 
physical and emotional factors on illnesses such as FM, where a range of medical 
and psychological disorders come together. 
The demographic characteristics of a sample of 70 women with FM have been 
described in line with those indicated in other, similar studies focussing on this 
population. The results show how women with FM, despite sharing some 
characteristics, present at the same much variety in their perception of intensity, 
quantity and degree of their wide range of symptoms. This corroborates the 
difficulty of diagnoses and of choice of treatment.  
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The positive results in this study with GrpMI treatment helps to contribute to a 
broader perspective on FM. This method is based on a humanistic, person-centred 
approach it considers the person from a biopsychosocial perspective. The method 
focuses on the internal strengths of the patient and the capacity to accept her 
responsibility for change. In this perspective the patient is taken care of in a global 
context in which the patient is able to cope with, adapt to or to modify the effects of 
the disease, because she encounters a professional care setting, that offers respect 
and recognition to the individual and to the group as well as care and improvement 
strategies. So, bearing in mind the conclusions of this study, GrpMI therapy can be 
considered a recommended, effective therapy alternative, which can be used in 
treatment of FM patients in different contexts such as in the health system or in 
addition to those commonly offered by associations of patients and their families. 
The conclusions of this study show how favourable results can be achieved, when a 
comprehensive therapeutic treatment is applied such as GrpMI, in which relaxation, 
music and images are used together. GrpMI includes a therapist who can 1) provide 
support as a specialised therapist, 2) do psycho-education about the disease for the 
patient, and 3) work from an emphasize on the influence of both emotional, 
cognitive and social factors on the appearance and perpetuation of symptoms. Thus, 
this study demonstrates the effectiveness of a treatment that aims at developing 
acceptance of and adaptation to pain in addition to broaching other psychological 
aspects, with the support and structure of music as a co-therapist. 
6.3.2. LIMITATIONS 
Despite all the positive results and arguments stated above, this study does have its 
limitations, some of which will be presented below. 
The study results may have been influenced and therefore limited by the protocol 
followed during sample selection. The sample of women was taken from members 
of FM associations, who were contacted by letter. Just by joining an association a 
person demonstrates an active, responsible and constructive attitude towards the 
disease, possibly different to those who do not join an association. Furthermore, 
since participants were informed about the study by letter, their decision to 
participate was an active one. Their motivation to take part may have been driven 
by positive (or negative) expectations, making the experimental group different to 
the whole FM population in Spain. Other women suffering from FM may only use 
hospital or medical settings to cope with their disease or, once they have received 
diagnosis, may withdraw from any kind of clinical contact. A lack of comparison 
with other women, who do not belong to an association, may limit the scope of the 
results and any generalisation of them amongst the whole population affected by 
FM. Additionally, although inclusion criteria were clearly explained, the women, 
who accepted to take part in the study, were referred by the association’s secretary, 
without the researcher asking for any verified, broader, external information about 
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diagnosis or symptom development. Sample inclusion and exclusion criteria would 
have been more thorough, had a more detailed inclusion protocol of the women’s 
clinical characteristics been followed, or had the selection criteria been coordinated 
with medical staff or somebody from an interdisciplinary team in charge of 
diagnosing and monitoring the disease. This would have produced more solid 
clinical and follow-up information.  
I would like to underscore though, that given the variety of health professionals 
who diagnose the disease of FM, and given the flexibility in the way criteria 
established by the ARC are used, even though these criteria are regulated in 
protocols for action, diagnosing FM always has been and still is controversial. The 
clinical manifestations of FM are multiform and varied and a bias concerning 
diagnosis and treatment exists. It was decided to treat a sample exclusively of 
women, because FM appears mainly in women, but this could represent an 
inequality bias with the population as a whole. Equally, the age range covered by 
the sample (which is the range in which there is greatest prevalence of people with 
FM), may have influenced the increased chronic nature and severity of FM 
symptoms, which in its turn could have influenced the higher scores that were 
found, when characterising the sample. Higher symptom chronicity may also have 
influenced the effects of GrpMI treatment. In future research it could be worth 
bearing in mind the possible variability in the effects of the treatment if GrpMI is 
offered to a population without such deeply-rooted dysfunctional physical, 
emotional, behavioural and cognitive responses to the disease.  
Differences in some of the demographic characteristics in the two sample groups 
(even though they were not statistically significant) may be a limitation for the 
generalisation of these results in such a diverse population as the FM population. 
This is especially true for the FM population, in which socio-cultural and 
employment situations have been shown to influence symptoms (Bergman et al., 
2001; Brekke et al., 2001). In future studies it would be helpful to ensure that these 
demographic variables are less different by using samples with similar 
characteristics, which can confirm or disprove the results obtained. 
Furthermore, despite the fact that at pretest assessment the only statistically 
significant differences between the experimental and control groups in the study 
variables were in impact of FM on functional capacity and health (with higher 
scores found in the experimental group), the experimental group also scored higher 
than the control group in all the other study variables assessed. To minimise these 
pre-treatment differences an analysis of covariance was used (with the pretest score 
as the covariable) during intergroup comparison. These pretest differences may 
explain the low levels of significance found in the results of the intergroup analysis 
carried out after the intervention (especially if intragroup analyses reveal very 
positive progress of virtually all the variables assessed in the experimental group, 
with statistically significant differences and medium-large effect size).  
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These basic differences between the experimental and the control groups may be 
due to: a lack of thoroughness during the selection process and/or the variety of 
diagnostic criteria mentioned in the previous paragraph. It may simply also be due 
to the many, diverse and non-uniform symptoms of FM, that make it very difficult 
to be clear about pre-treatment or pre-psychological assessment, which will be 
influenced by the individual symptomatic circumstances of people with FM. In this 
sense, if a person-centred treatment model, coupled with a biopsychosocial 
understanding of the disease, was truly the approach applied, the diagnosis process 
would take into consideration the person’s overall state of health, and it would 
make it possible to pinpoint subgroups that could benefit from specific kinds of 
interventions. This has already been suggested by several studies (Glombiewski et 
al., 2010; Goldemberg, Burckhardt, & Crofford, 2004; Hardy-Pickering, Adams, 
Sim, Roe, & Wallymahmed, 2007; Lemstra & Olszynski, 2005; Montoya et al., 
2010). Some of the intergroup differences could have possibly been avoided, if the 
following procedures had been carried out: 1) initial selection following 
classification criteria more in line with the variability of FM symptoms where the 
existence of subgroups were taken into consideration as suggested by Giesecke et 
al. (2003) in the Interdisciplinary Consensus Document for the Treatment of 
Fibromyalgia (Montoya et al., 2010); 2) randomisation after a correction of the 
pretest assessment tools and after the establishment of well-defined cut-off points. 
If this approach had been carried out, treatment could have been modified or even 
offered according to the specific characteristics of each FM subgroup with a greater 
precision in planning the objectives of GrpMI treatment. 
Another limitation to the study is the fact that self-reported questionnaire were used 
to assess all the variables, with the possible risk of social desirability bias (specially 
in this case, because maybe some participants would like to please the researcher, 
who was also the therapist). Furthermore, despite the fact that some evaluation 
tools, such as the FIQ test, the STAI and VAS scale have been widely used in 
similar studies to measure pain, other evaluation tools have been less used. For 
example the Beck Depression Inventory (BDI) and the Hospital Anxiety and 
Depression Scale (HADS) are more commonly used to measure depressive state; 
and so is the Quality of Life Scale (QoL) and Short Form-36 Health Survey (SF-36) 
as indicators of perceived health state and quality of life. As for the Individual 
Treatment Evaluation Questionnaire (ITEQ), specifically designed for this 
intervention and based on participants’ self-reports, there may have been a high 
degree of subjective bias in the replies, if participants have not reflected their 
assessment of change accurately. Another issue, that could be considered a 
limitation of the method in the study, is the fact that the Individual Assessment 
Scale was filled in by the participants alone, without them having any external, 
specialist accompaniment or guidance. In the future it might be worth considering: 
1) modifying the content of the questionnaire and using numerical scores, rather
than descriptions to define each item; 2) using existing questionnaires to observe 
changes after GIM therapy (Bonny, 1980; Weiss, 1994, quoted in Bruscia, 2000), 
especially the Guided Imagery and Music Responsiveness Scale (GIMR; Bruscia, 
1998), which Meadows (2000) evaluated as having sufficient validity and 
EFECTIVENESS OF GRPMI WITH FIBROMYALGIA PATIENTS 
166
reliability. In a similar way, as used by Moe et al. (2000), it might also be worth 
considering to the use semi-structured interviews to add the nuance of the client´s 
opinion to the treatment process, to the evaluation of this and to the actual research 
study. These self-reporting measurements could be complemented by other, more 
objective measurements, related to the routines of daily life for example. In short, 
exclusive use of self-reported questionnaires could be considered a limitation in this 
study and, in general, in evaluation of FM symptoms. Exclusive use of self-reported 
questionnaires and a variety of different questionnaire formats and modes of 
assessment tests can end up being even more biased with the unclear complex 
symptoms of this disease. Furthermore, the conclusions of this study may be limited 
by not having used specific assessment questionnaires or tools for this specific 
therapy method GrpMI. Having done that might have increased the objectiveness, 
validity, reliability and consistency of the conclusions of this work and the 
therapeutic effects of the GrpMI method. 
Another possible limitation that needs to be mentioned comes from the complexity 
of the GrpMI method itself, in which multiple components and dimensions 
intervene in an integrated way. GrpMI treatment has been shown to be effective in 
this study since, to a greater or lesser degree of statistical significance, it has 
improved the health of the participants in all variables included in the study. And 
yet due to the very nature of the treatment, the conclusions of the study can be said 
to be insufficient, as they do not differentiate or define, which of the component 
parts of the GrpMI method had the greatest influence on the improvement of health. 
The positive results may be due to the power of self-generated images, the specific 
emotional activation of the music or the effect of experiencing therapy in a group. 
This is not identified as part of the analysis. 
Although promising results have been found in this study, regarding the 
effectiveness of group treatment, in future studies it will be necessary to separate 
the effects of each component of GrpMI from the effects of group treatment in 
general. By offering care, support and opportunities for trying out different social 
relational strategies, the structure of the group process and its dynamic forces may 
provide specific benefits from group work, no matter which therapeutic method is 
applied, although some authors assume that this may be a placebo rather than a 
therapeutic effect (Allen et al., 2002). 
Finally, the fact, that the same person was both the therapist and the researcher 
throughout the whole process, may have influenced the study. Accompanying the 
therapeutic process of the experimental group and being involved in the dynamics 
behind all the therapy processes, at the same time as observing, analysing and 
dealing in details with facts and data through the distant view of a person by 
observing this person in an experimental situation, may have been a limitation to 
the conclusions of the study. In future research studies it would be helpful to work 
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with the assistance of teams of practitioners from different fields, thus increasing 
research objectivity.  
6.4. FUTURE AREAS OF RESEARCH 
The results obtained suggest some other areas that future research studies might 
look into in greater detail. 
As mentioned above, in this study, I was both the therapist and the researcher. In 
future research studies it would be helpful to work with the assistance of a research 
team, where different specialists are doing the clinical work, data collection and 
statistical analysis, thus increasing research objectivity.  
This study has attempted to address the whole complexity of FM, and in the study 
several variables have been observed and analysed. In the future, the effects of 
GrpMI could be analysed separately for each of the variables in different empirical 
situations. This could be done with a more in-depth exploration of the effect of 
GrpMI together with other working hypotheses related to the most frequent 
psychological symptoms. In this vein new research might be aimed at reducing, 
broadening and modernising both the number of variables and their 
interrelatedness. It might be particularly relevant to study the progress of a variable 
such as stress, where more “medical” evaluation tools could be used. Recent studies 
about the effects of GIM on stress could be used to compare differential treatment 
effects, and could also be used to encourage the medical doctors to participate, 
together with specialists in music therapy and GIM, in interdisciplinary studies. 
New experimental situations could be considered, in which some of the differences 
of the clinical characteristics within the FM population might be explored, thus 
looking at the symptom diversity of these people by monitoring specific categories 
or sub-groups (as different studies have suggested). As has already been discussed 
previously, by making such a differentiation at the beginning of the sample could 
also lead to a different way of approaching, developing and offering GrpMI 
therapy. Given the high prevalence of early traumatic situations in the FM 
population, it might be of special interest for future research studies to examine the 
effects of applying either GIM or GrpMI treatment on a subgroup of the FM 
population characterized by such traumatic situations, to see if this treatment proves 
to be beneficial.  
As mentioned above the benefits of being in a group were not differentiated in this 
study from those of the GrpMI method itself. For future research studies it could be 
relevant to have a control group, in which participants only talk about their worries 
without GrpMI, in order to examine more accurately the effect of this method. 
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Other future research studies might take the direction of comparing individual and 
group therapy, or a possible combination of both approaches. It is possible that 
some participants might have experienced increased benefits, if they had been able 
to continue their treatment with individual GIM sessions. 
In this same vein, future experimental treatment designs might consider including 
more GrpMI sessions, thus more firm cementing the psychological changes and 
strategies acquired during the twelve GrpMI sessions offered in this study. They 
might also consider, during the sessions, to better meet the participant interests 
and/or the possible difficulties involved in trying to use the different strategies, 
taught individually, in everyday life – and in this way reducing the natural 
limitations of generalisation.  
Equally, future studies might opt for more long-term post-treatment follow-up 
periods. In this way it would be possible to check, whether in the medium and long 
term periods treatment effects are lasting, and whether people suffering from FM 
are able to internalise changes and receive positive feedback from their 
environment to reinforce these changes. For this reason it would be good to include 
booster sessions, that could highlight the positive effects (and possibility of 
recovery) of this treatment model, and where these positive effects could be 
followed in the longer term.  
Bearing in mind the complexity of the GIM method and the unique nature of the 
therapeutic process, this quantitative study could have been supplemented by other, 
qualitative or mixed studies, which could have analysed or described the 
phenomena that occurred in the dynamic processes of this therapy. This may have 
added relevant information about the way; this complex illness in general is 
understood and treated. In line with this, self-reporting tools and/or semi-structured 
interviews could have been designed that could have reflected the subject’s 
viewpoints, which then again could have been compared with the viewpoints of 
other subjects and populations. 
This study attempts to demonstrate the effectiveness of GrpMI treatment on people 
with FM. A quantitative design was used on a medium-sized group of participants 
and positive effects, that were either statistically or tendentially significant in 
relevant variables of their symptoms such as: pain, anxiety, depression, anger and 
perception of psychological wellbeing were obtained. These results open the way to 
further use of music therapy and especially Guided Imagery and Music for treating 
FM. The results also pave the way for more research into the usefulness and 
effectiveness of GrpMI on other populations who, like FM sufferers, experience 
chronic pain. 
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Appendix E. Ethical Approval 
This study attempts to demonstrate the effectiveness of Group Music and 
Imagery (GrpMI) with women suffering from fibromyalgia (FM). It uses a 
randomized controlled trial, with a pretest-posttest control group design, and 
a three month follow-up.
 
The results show statistically or tendentially significant positive effects for 
the following relevant variables of the symptoms of fibromyalgia: pain, anx-
iety, depression, anger, impact of FM on functional capacity and health, and 
perception of psychological wellbeing,
 
The effectiveness of GrpMI intervention with women suffering from FM 
suggests that it is advisable to use music therapy and especially Group 
Imagery and Music for FM treatment. The results obtained open the way 
for further research studies focussing on the usefulness of GrpMI in other 
populations that, like FM sufferers, experience chronic pain.
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